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General introduction
Falls and medication
One-third of the elderly aged 65 years and older falls at least once a year [1,2], 
About 20-30% of them gets Injured In such a way that they lose mobility and 
Independence and are at a greater risk of early death [2,3], In the Netherlands 
only, each year about 99000 elderly visit the emergency department of a hospital 
after a fall Incident and the direct medical costs of fall-related Injuries In the elderly 
Is on average 6900 per casualty [4], Hence, not only do accidental falls have an 
Impact on the affected Individual, they have become a major socio-economic 
problem as well [5], Therefore, many researchers focused on fall risk factors, and 
the reduction or even the prevention of falls In the elderly [2,6-10],
Many epidemiological studies showed that medication use Is an Important risk 
factor for accidental falls [2,11-14], Two aspects were shown to play a major role: 1) 
the kind of medication [11,12,15-17], and 2) the number of medications that Is taken 
(polypharmacy = concurrent use of several (>4) drugs [18]) [18-21], Particularly 
psychotropic and cardiovascular drugs, diuretics and some analgesics are found 
to add to an Increased fall risk [11,12,15,18,22-26], These drugs are considered to 
be rlsk-drugs due to commonly reported central nervous system (CNS) adverse 
effects. It seems fairly self-evident that effects such as sleepiness, dizziness and 
drowsiness could underlie accidental falls. This view Is enhanced by a warning put 
In leaflets or even as obligatory medication warning labels. That warning Implies 
that If a user experiences CNS adverse effects that affect mental or physical 
capabilities, It Is discouraged to engage oneself In activities such as driving a car 
or operating machinery. Similar to such activities, quick and adequate postural 
responses are also necessary to prevent falling during standing or walking. 
Rlsk-drugs for falling should therefore prescribed restrlctedly, at the smallest doses 
and for the shortest time possible. Previous research has Indeed shown that 
withdrawal of fall-rlsk-lncreasing drugs or even just lowering the dose significantly 
reduced fall risk In an elderly population [9], Hence, a thorough evaluation of the 
medication use could have a major (positive) Impact on the Individuals’ fall risk. 
However, sensitive methods to quantitatively Investigate the fall risk of single 
medications are still lacking. In addition, only poor knowledge exists on which 
fall-related skills are possibly affected by medication. Therefore this thesis aimed to 
gain Insight Into the Influence of commonly used medicines on fall-related skills. 
This Insight could be useful to prevent accidental falls by more careful prescription 
of risk drugs and to provide a user with better Information regarding possible fall 
risk after Intake of such a rlsk-drug.
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Skills related to falling
Studies in various populations showed that accidental falls often are associated 
with deficiencies in a number of skills such as balance control, response to 
sudden events and dual-tasking during gait. Proper balance control is essential 
to prevent falling. It is rather easy to assess possible impairments in balance 
control using quiet stance tasks under various conditions. Tasks measuring quiet 
stance with eyes open or closed are mostly used in the assessment of the effects 
of medication on balance control. However, it seems likely that these tasks might 
not be sensitive enough to detect possible subtle effects. Challenging and 
demanding balance tasks such as one-legged stance or stance on a compliant 
surface could be more suitable for this and should therefore be added to the 
so-called conventional tasks mentioned above.
The ability to respond quickly and adequately to sudden events is another 
skill related to falls. This skill is often assessed using classical manual reaction 
time tasks. However, falling or tripping is mostly caused by slowed and/or 
inadequate responses to suddenly appearing obstacles during gait. Hence, it 
was suggested that the assessment of reaction times during walking would be 
more appropriate in view of accidental falls. Therefore, an obstacle avoidance 
task was developed [27,28], This task has already been used to measure the 
effects of startle, aging, or fall-prevention programs [29-31], but up till now it was 
never used to assess the effects of medication on obstacle avoidance reactions.
A third important skill related to falls is the ability to concurrently perform both 
a motor task and a secondary cognitive task (dual-tasking) [28,32], In the last two 
decades, the effects of dual-tasking on quiet stance and normal gait have been 
extensively studied (for a review see Woollacott and Shumway-Cook [33]), but the 
findings were not always consistent. In addition, often rather crude outcomes 
(e.g. gait velocity or number of errors on the secondary task) were used to 
evaluate the effects of dual-tasking. Moreover, knowledge on the effects of 
dual-tasking on less automatic gait such as limping or avoiding obstacles is 
limited, but might be more relevant in understanding the relation between 
dual-tasking and falls.
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Outline of this thesis
The first part of this thesis focuses on the composition of a set of tests which 
makes it possible to assess even subtle effects of medication on fall-related skills. 
Therefore, this part is methodological of nature.
Chapter 2 describes the study in which it was investigated whether a 
time-critical obstacle avoidance task is sensitive enough to assess the effects of 
alcohol, a substance generally known to affect gait, on obstacle avoidance skills. 
Participants had to avoid suddenly appearing obstacles while walking on a 
treadmill at a fixed velocity of 3 km/h. Obstacle avoidance performance was 
quantified by determining success rates and avoidance response times and this 
was compared between three alcohol concentration levels.
Chapter 3 describes the effect of a secondary cognitive task on gait under 
difficult circumstances, limping in particular. In this study participants walked on 
a split-belt treadmill with symmetric (2 km/h) and asymmetric (2 km/h vs. 4 km/h 
and 2 km/h vs. 6 km/h) belt speeds both with and without a concurrent cognitive 
task. For this task the participants listened to the words “high” or “low” in Dutch, 
presented in either a high or low pitch, and indicated verbally which tone was 
presented as quickly as possible. Verbal reaction times, stance phase and 
support phase proportions were compared between walking conditions.
Chapter 4 presents the study which investigated dual-task interference during 
a time-critical obstacle avoidance task in healthy seniors. The obstacle avoidance 
task described in Chapter 2 was combined with the secondary cognitive task 
described in Chapter 3. For the primary task, success rates and avoidance 
reactions were compared between single- and dual-task conditions. Performance 
on the secondary task was quantified by using composite scores (= (accuracy/ 
verbal response time(ms)) x100) [34] and was compared between three instants 
of the obstacle avoidance task (prior, during and just after obstacle crossing).
In short, this first part of the thesis supports the use of a time-critical obstacle 
avoidance task and a secondary cognitive task to measure the effects of 
medication on these fall-related skills.
In the second part of this thesis the above mentioned tasks are combined with 
more conventional methods of assessing fall-related skills. Hereby we aimed to 
gain insight into the fall risk after use of drugs frequently prescribed as a treatment 
for two important chronic conditions in the elderly: rheumatic and psychosocial 
diseases [35], Two drug classes supposed to put the user at an increased risk of
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falling were selected for the experiments; NSAIDs (non-steroidal anti-inflammatory 
drugs) and SSRIs (selective serotonin reuptake inhibitors) in particular.
In Chapter 5 a systematic literature review is given on NSAIDs and the risk for 
accidental falls in the elderly. This review showed that there is some evidence for 
an increased fall-risk with NSAIDs and that there was room for an experimental 
study on the effects of this kind of medication on fall-related skills in elderly. It was 
decided to use both conventional methods (Chapter 6) and new methods (as 
described above, Chapter 7).
Chapter 6 describes the outcomes of a RCT (randomized controlled trial) in 
which the effect of a NSAID on postural balance and manual reaction time, two 
important predictors for accidental falls, was assessed in healthy seniors. This 
study served two purposes. A first aim was to bridge the gap to the conventional 
tasks and to existing knowledge on psychomotor effects of drugs in particular. 
The second aim was to expand the set of conventional quiet stance tasks with 
stance tasks that were more challenging. In this double-blind placebo-controlled 
study, the performance on all quiet stance tasks as well as the manual reaction 
time tasks was compared between the three experimental conditions 
(indomethacin (NSAID), placebo, and baseline).
In Chapter 7 the new methods presented in the first part of this thesis are used 
to test the effects of a NSAID. The effect of indomethacin on the ability to avoid 
suddenly appearing obstacles was studied during walking, with or without 
simultaneous performance of a secondary cognitive task. The consequences of 
such a combination with regard to accidental falls was illustrated using similar 
performance outcomes as described in Chapter 4.
In Chapter 8 all above mentioned methods (a time-critical obstacle avoidance 
task, an extensive set of quiet stance tasks, and manual reaction time tasks) were 
applied to assess the effect of paroxetine, a commonly used SSRI [36], on these 
skills related to falls. For all tasks, the performance of senior long term (>90 days) 
paroxetine users was compared with that of healthy senior individuals.
Finally, in Chapter 9 the main findings and conclusions of this thesis are 
discussed and suggestions for future research are given.
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Even low alcohol concentrations affect obstacle 
avoidance reactions in healthy senior individuals
Hegeman J, Weerdesteyn V, van den Bemt BJ, Nienhuis B, van Limbeek J, Duysens J: 
Even low alcohol concentrations affect obstacle avoidance reactions in healthy 
senior individuals. BMC Res Notes 2010, 3: 243.
Abstract
Alcohol is a commonly used social drug and driving under influence is a well-established 
risk factor for traffic accidents. To improve road safety, legal limits are set for blood alcohol 
concentration (BAC) and driving, usually at 0.05% (most European countries) or 0.08% 
(most US states, Canada and UK). In contrast, for walking there are no legal limits, yet there 
are numerous accounts of people stumbling and falling after drinking. Alcohol, even at 
these low concentrations, affects brain function and increases fall risk. An increased fall 
risk has been associated with impaired obstacle avoidance skills. Low level BACs are likely 
to affect obstacle avoidance reactions during gait, since the brain areas that are presumably 
involved in these reactions have been shown to be influenced by alcohol. Therefore we 
investigated the effect of low to moderate alcohol consumption on such reactions. Thirteen 
healthy senior individuals (mean(SD) age: 61.5(4.4) years, 9 male) were subjected to an 
obstacle avoidance task on a treadmill after low alcohol consumption. Fast stepping 
adjustments were required to successfully avoid suddenly appearing obstacles. Response 
times and amplitudes of the m. biceps femoris, a prime mover, as well as avoidance failure 
rates were assessed. After the first alcoholic drink, 12 of the 13 participants already had 
slower responses. Without exception, all participants’ biceps femoris response times were 
delayed after the final alcoholic drink (avg±sd:180±20ms; p<0.001) compared to when 
participants were sober (156±16ms). Biceps femoris response times were significantly 
delayed from BACs of 0.035% onwards and were strongly associated with increasing levels 
of BAC ( r=  0.6; p<0.001). These delays had important behavioural consequences. Chances 
of hitting the obstacle were doubled with increased BACs. The present results clearly show 
that even with BACs considered to be safe for driving, obstacle avoidance reactions are 
inadequate, late, and too small. This is likely to contribute to an increased fall risk. Therefore 
we suggest that many of the alcohol-related falls are the result of the disruptive effects of 
alcohol on the online corrections of the ongoing gait pattern when walking under challenging 
conditions.
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Introduction
Alcohol is a commonly used social drug and driving under influence is a well- 
established risk factor for traffic accidents [1], To improve road safety, legal limits 
are set for blood alcohol concentration (BAC) and driving, usually at 0.05% (most 
European countries) or 0.08% (most US states, Canada and UK). For other tasks 
than driving, however, it remains unclear whether these BACs also reflect 
appropriate safety limits. Recent research showed that among working-aged 
people, ingestion of alcohol in the previous 6 hours is strongly and consistently 
related to falls at home resulting in admission to hospital or death, even with low 
levels of alcohol consumption [2], The public health impact of falls is substantial 
and concomitant costs are growing [2,3], However, reducing alcohol intake is 
often not included in intervention strategies to prevent falls. Low alcohol intake is 
generally not deemed unsafe with regard to falls, but this was never investigated 
systematically. Accidental falls have been found to be associated with impaired 
obstacle avoidance skills [4], To prevent tripping, accurate goal-directed reactions 
are required to avoid sudden obstacles in the travel path. In previous work we 
have observed that an increased percentage of obstacles that were hit (“obstacle 
avoidance failures”) is associated with the presence of smaller and later EMG 
responses in the prime movers (such as the m. biceps femoris) involved in the 
obstacle avoidance reaction [5,6], From cat studies it is known that the parietal 
cortex and the cerebellum play an important role in this reaction [7,8], Imaging 
studies have shown that acute alcohol administration significantly reduces brain 
glucose metabolism in these areas that are important for obstacle avoidance 
[9-11]. Hence, one would predict obstacle avoidance reactions during gait to be 
disturbed by alcohol ingestion. Therefore we investigated the effect of low to 
moderate alcohol consumption on such reactions in healthy senior individuals by 
means of an obstacle avoidance task.
It was hypothesized that obstacle avoidance reactions are already impaired at 
low BACs, and that the increases in the percentage of obstacles that were hit after 
alcohol consumption will be accompanied by delayed and decreased muscle 
responses in the m. biceps femoris.
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Methods
Participants
Thirteen healthy senior individuals (mean(SD) age: 61.5 (4.4) years, 9 male) 
volunteered to participate in this study. None of the participants was, or used to 
be a habitual drinker. Inclusion criteria were absence of any known serious 
neurological, orthopaedic or cognitive dysfunction, and age between 50-70 
years. Exclusion criteria were a bodyweight exceeding 100 kg or the use of 
(prescribed) medication(s) that could interfere with alcohol. As the experiment 
took place in the late afternoon, participants were instructed to just have an early 
light lunch (e.g. a sandwich), and not to drink caffeinated drinks in the 4 hours 
before arriving at the laboratory. Subjects were informed about the experimental 
procedure before they gave their written informed consent in accordance with the 
ethical standards of the Declaration of Helsinki. The protocol was approved by 
the ethical committee of the region Arnhem-Nijmegen.
Equipment and procedure
The participants were instructed to avoid obstacles while walking on a treadmill 
(ENRAF Nonius, type ENtred Reha) at a fixed velocity of 3 km/hr (Figure 1A), 
wearing their own comfortable shoes (no high heels). A wooden obstacle 
(measuring 40x30x1.5cm) with an embedded piece of iron was held by an 
electromagnet just above the treadmill surface. Its release could be triggered by 
the computer. The obstacle was always presented to the left foot. On both feet, 
three reflective markers (diameter 14 mm) were attached at heel, hallux and lateral 
malleolus. A single marker was placed on top of the obstacle. Marker positions 
were recorded by an 8-camera 3-D motion analysis system (Vicon®, Oxford 
Metrics, London, UK) at a sample rate of 100 Hz. The marker positions were 
processed in real time in order to determine the moment of obstacle release 
related to gait phase. The real time processing also enabled the experimenter to 
check online the foot position with respect to the obstacle, while the participants 
were instructed to walk at a fixed distance to the obstacle that was approximately 
10 cm from the most anterior position reached by the toes in the swing phase. If 
they deviated more than 3 cm from this position, participants received verbal 
feedback to correct the distance to the obstacle. The obstacle was not released 
until a regular walking pattern was observed and until at least five unperturbed 
strides for the trial had been completed. Stride regularity was defined as a 
maximum difference of 50 ms between two consecutive strides. The obstacle
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was dropped at one of three different phases of the step cycle (late stance 
(LSt,45-60% of the step cycle), early swing (ESw, 60-70%) or mid swing 
(MSw,70-85%)) to create different levels of difficulty to avoid the obstacle as time 
pressure increased (Figure 1B). Available response time (ART), the measure of 
time pressure, was defined as the time between obstacle release and the 
estimated moment of foot contact with the obstacle if no adjustment of the stride 
had been made [12], The obstacle release phases corresponded with ARTs 
greater than 450 ms (LSt), 300-450 ms (ESw), and 150-300 ms (MSw). Ten 
obstacles in each of the three phases of the gait cycle were presented in random 
order during a series of 30 trials.
The participants were instructed to look at the obstacle, and step over it after 
its release. Stepping to the side was discouraged, and any contact of the left foot 
with the obstacle was defined as a failure. Since the m. biceps femoris (BF) is 
known to be the prime mover involved in the avoidance reaction [6], surface elec­
tromyography (EMG) data were collected from this muscle to assess response 
times. Self-adhesive Ag-AgCI electrodes (Tyco Arbo ECG) were placed 
approximately 2 cm apart and longitudinally on the belly of the muscle, according 
to European guidelines [13], The EMG signals were sampled at 2400 Hz 
(ZeroWire®, Aurion S.r.l., Italy) and recorded synchronously with the marker data. 
Three series of 30 obstacle avoidance trials were performed, each 30 minutes 
after ingestion of a drink (Figure 1C). Subjects were informed that these drinks 
contained alcohol, and had to finish them within 10 minutes. The first (A0) was a 
placebo consisting of water mixed with orange juice (ratio 1:3) with a drop of 
vodka floated on top to give the scent of alcohol. The following two drinks (A1 and 
A2) each contained 40% vodka mixed with orange juice (ratio 1:3). We aimed to 
reach a BAC that was around the common legal limits for driving (0.05% for most 
European countries or 0.08% for most US states, Canada and UK) 30 minutes 
after A2, having used the Widmark formula [14] to adjust the alcohol dosage for 
the individual’s gender and weight. A Drager Alcotest® 7410 Plus com breathalyzer 
was used to determine the BAC before, during, and after the experimental task 
(Figure 1C). For safety reasons, all participants were taken home by a taxi after 
the experiment was finished.
Data analysis
Successful obstacle avoidance for each trial was scored. This was easily 
determined by two observers by eye, and by feedback from the participant. If 
there was any doubt about the successfulness, the marker data were checked
21
Figure 1 Methods
A. Experimental setup. B. Step cycle phases in which the obstacle was released. MSw = 
Mid Swing, ESw =  Early Swing, LSt =  Late stance. C . Protocol: assessment of BAC at 
t0-t6. AO: placebo, A1: first alcoholic drink, A2: second alcoholic drink. Solid black line: 
obstacle avoidance task.
B.
AO A1
ti t2
▲
30min 30min 30min ------- *
3^ 4^ 5^ 6^
(this happened in less than 1% of the cases). As the primary outcome measure, 
failure rates (as defined by the number of failed trials divided by the total number 
of trials) were calculated for each alcohol condition and each step cycle phase. 
To assess the EMG responses, the EMG activity of the m. biceps femoris (BF) 
was full-wave rectified and lowpass filtered at 25 Hz (zero lag, 4th order Butterworth 
filter). Background EMG was calculated for each series separately as the average
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BF activity over 25 control strides (i.e. the stride preceding that in which obstacle 
release occurred). For each participant and alcohol condition, BF response times 
were determined as the time between obstacle release and the moment at which 
BF activity exceeded the average control stride by at least 2 SDs for more than 30 
ms (for example, see Figure 2). This was done with the help of a custom made 
computer algorithm (Matlab® software, version 7.4.0, The Mathworks Inc., US). 
Each trial for which a response time was calculated was visually checked for 
correct determination of the response onset. In about 2% of the trials the onsets 
were corrected. The onsets of the avoidance responses for each subject were 
averaged for each phase of obstacle release within each alcohol condition. The 
responses amplitude was calculated as the average amplitude during the 100 ms 
following the onset of the BF response [5,15], The amplitudes were normalized 
with respect to the maximum average background activity during the whole step 
cycle in the AO condition. A similar procedure was performed to calculate and 
normalize the average control stride activity in the 100 ms following the BF 
response onset.
Figure 2 Determination of response time and amplitude of the m. biceps 
femoris (BF)
Response time was defined as the time between obstacle release (set at the origin of the 
axes) and the moment where the BF activity exceeded the activity of the control stride 
+ 2SD. Average response amplitude was calculated over 100ms after the onset of the 
response and normalized with respect to the average control stride activity.
Time (ms)
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Statistical analysis
To check whether within participants, the series were equally difficult in the three 
alcohol conditions, we compared the average ARTs in a repeated measures 
MANOVA (within-subjects factors: alcohol condition (AO, A1, A2); phase of 
obstacle release (LSt, ESw, MSw), a=0.05) with post-hoc pairwise comparisons. 
To identify the effect of BAC on avoidance failure rates we used a binary logistic 
regression with alcohol condition as categorical factor (AO as reference category, 
a=0.05) in Egret® for Windows (version 2.0.31). A statistical model was fitted to 
the data of the MSw phase to predict the probability of a failure with increasing 
BAC for the most time critical situations.
For the analysis of EMG data, we used repeated measures MANOVAs with 
post-hoc pairwise comparisons to test for differences between the three alcohol 
conditions (within subjects-factor: AO, A1, A2; a=0.05) for average BF response 
times, normalized response amplitudes, and normalized background activity. The 
relationship between BF response time and BAC was assessed by means of bivariate 
correlation (Pearson Correlation Coefficient). One sample Students’ t-test with bins of 
0.005% BAC was used to determine the BAC from which the BF response time was 
significantly delayed. These analyses were carried out in SPSS® (version 12.0.1) with 
a set at 0.05. Means are presented with their standard errors (SE).
Pilot data indicated that the difference in obstacle avoidance response time 
after 2-3 standard alcoholic drinks was 20 ms (SD: 18 ms). To be able to identify a 
difference of 20 ms in the mean response time between A0 and A2, a sample size 
of 11 subjects would be needed in this repeated measures design ((3=0.9, a=0.05).
Results
Before the start of the experiment, the BAC of each participant was 0.00%. After 
the final drink the BACs found ranged from 0.03% to 0.06%. Hence, we succeeded 
in our aim to reach BACs around or below common legal limits for driving (0.05% 
for most European countries or 0.08% for most US states, Canada and the UK). 
The series of the obstacle avoidance trials were equally difficult in the three 
alcohol conditions (A0, A1, and A2), as there were no significant main effects of 
alcohol condition on the average ARTs (F21 =0.22, p = 0.81).
Failures
Figure 3A shows the effect of alcohol on avoidance failure rates. Overall, the 
failure rate increased significantly from 4.5% (A0) to 8.8% (p<0.01) after
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consumption of two alcoholic drinks. Figure 3A also demonstrates that in each 
alcohol condition most failures were made in the MSw phase (p<0.01, compared 
to late stance). Within this phase, the failure rate increased significantly with 
alcohol consumption, from 11.7% in AO, to 19.2% and 20.5% in A1 and A2, 
respectively (p<0.01, compared to AO). Moreover, the probability of a failure not 
only increased with higher BACs, but also with lower ARTs, which corresponded 
to the MSw phase (Figure 3B). Compared to the placebo condition, chances of 
hitting the obstacle almost doubled after the final alcoholic drink (odds ratio 
(95%CI) = 1.93 (1.17,3.18); p = 0.01).
Figure 3 Effect of alcohol on failures
A. Failure rate per alcoholic condition for each step cycle phase separately, and in total. AO: 
placebo, A1: first alcohol, A2: second alcohol. (**p<0.01, compared to AO). B. Model of 
the probability of failing to avoid the obstacle with increasing blood alcohol concentrations 
for the most time critical situations.
Step cycle phase
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Figure 4 Effect of alcohol on BF response times for each step cycle phase 
separately, and In total
LSt=Late Stance, Esw=Early Swing, MSw=M id Swing. AO: placebo, A1: first alcohol, 
A2: second alcohol. (*p<0.05, **p<0.01)
**
LSt ESw MSw Total
Step cycle phase
Response time
The results for BF response times, one ofthe proposed determinants of successful 
obstacle avoidance, are shown in Figure 4. Repeated measures MANOVA 
revealed a main effect of alcohol condition on overall BF response times 
{F211=24.93, p<0.001), as well as for each phase of obstacle release separately 
(Table 1). After ingestion of 2 alcoholic drinks (mean±SD: 0.47±0.04 g alcohol/kg 
bodyweight), BF response times were delayed by 12% compared to when 
participants were sober (179±5.8 vs 160±4.7 ms, F112= 53.42, p<0.001) (Figure 
4). From the data of the individual subjects (Figure 5) it can be seen that without 
exception, BF response times for all participants were delayed following A2. 
Furthermore, even after A1, 12 of the 13 participants already responded more 
slowly. The BF response times were significantly delayed from BACs of 0.035% 
upwards (f=18.05; p = 0.003). There was a significant correlation between 
response time and level of BAC (r= 0.6; p<0.001; Figure 5).
A significant effect of obstacle release phase on BF response times was also 
found. The LSt responses were significantly slower than those in ESw (F1 ,,=52.65, 
p<0.001). In turn, ESw responses were again significantly slower than those in 
MSw (F1 j; = 49.86, p<0.001).
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Table 1 Repeated measures MANOVA with within subjects contrast for BF 
response latencies
AO =  placebo, A1 =  first alcohol, A2 =  second alcohol, LSt =  Late Stance, ESw =  Early 
Swing, MSw =  Mid Swing, Total =  all trials, Diff =  difference. Bold numbers indicate 
significance.
LSt ESw MSw Total
Diff(ms) Fv : P Diff(ms) FV! P Diff(ms) Fv : P Diff(ms) FV! P
AO vs A1 8.3 11.0 0.006 9.2 5.6 0.036 5.4 2.0 0.182 8.7 15.0 0.002
A1 vs A2 10.8 12.0 0.005 5.0 1.2 0.287 11.0 18.4 0.001 10.8 22.7 0.000
A2 vs AO 19.2 26.8 0.000 14.2 10.0 0.008 16.4 36.3 0.000 19.4 53.4 0.000
Figure 5 Individual delays in BF response times after the first (A1) and 
second (A2) drink as compared with the AO condition
Each data point represents one subject in the corresponding alcohol condition. 
The solid line shows the correlation between BAC and the delay in response time 
(**p<0.01). The dashed line represents the BAC from whereon the delay is significant 
(*p<0.05).
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Response amplitude
Figure 6 shows the results of the normalized response amplitudes. Repeated 
measures MANOVA revealed a main effect of alcohol condition on overall BF 
response amplitudes (F;i)) = 4.83, p =0.03). Post-hoc analyses yielded a significant 
effect of alcohol condition on response time in LSt, MSw, and in total (Table 2). 
A trend for decreasing amplitude with increasing BACs can be noted in all step 
cycle phases (Figure 6).
Figure 6 Effect of alcohol on normalized EMG amplitudes for the m. biceps 
femoris
LSt=Late Stance, Esw=Early Swing, MSw=M id Swing. AO: placebo, A1: first alcohol, 
A2: second alcohol. (*p<0.05)
LSt ESw MSw Total
Step cycle phase
To rule out the possible effect of background activity on amplitude, the background 
activity was analyzed as well. The normalized background activity did not change 
significantly with increasing BACs (F;i)) = 0.24, p = 0.79).
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Table 2 Repeated measures MANOVA with within subjects contrast for BF 
response amplitudes
AO =  placebo, A1 =  first alcohol, A2 =  second alcohol, LSt =  Late Stance, ESw =  Early 
Swing, MSw =  Mid Swing, Total =  all trials, Diff =  difference. Bold numbers indicate 
significance.
LSt ESw MSw Total
Diff(%) Fin  p  Diff(%) F11S p  Diff(%) Fin  p  Diff(%) F11S p
AO vs A1 18.4 3.5 0.087 15.8 4.6 0.054 17.1 4.7 0.050 16.5 9.1 0.011
A1 vs A2 14.7 11.2 0.006 4.2 2.3 0.158 1.5 2.5 0.142 10.1 9.1 0.011
A2 vs AO 33.1 8.3 0.014 20 4.7 0.052 18.6 5.7 0.035 26.5 10.3 0.007
Discussion
The present study investigated the effect of low to moderate levels of alcohol 
consumption on obstacle avoidance reactions during gait. The results clearly 
show that even with low BACs (<0.06%), reactions to sudden gait perturbations 
are seriously affected. After ingestion of 2 alcoholic drinks, obstacles were hit 
more often, BF response times were delayed and response amplitudes were 
reduced. These changes were most obvious in situations with little available 
response time.
This is the first study to investigate the effect of alcohol on responses to 
sudden gait perturbations (as a relevant task related of falls). Previous studies 
have concentrated on the effects on posture [16,17], Low doses usually increased 
body sway but in some subjects the inverse was seen, indicating that these doses 
may have an beneficial effect in some cases [17], However, it is questionable 
whether these data are actually relevant for falls since falls rarely occur during 
standing. Locomotion studies seem to be more relevant in this respect. Mallinson 
et al.[18] found that it may be possible to detect subtle dynamic imbalance 
induced by alcohol ingestion (89 ml of 40% alcohol) during tandem walking with 
eyes closed. In the present study participants had to walk on a treadmill with eyes 
open after consuming an average of 125 ml of 40% alcohol. Because the 
background activity was not significantly different between the alcohol conditions,
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and the obstacle was only released when a regular walking pattern was observed 
and after at least five unperturbed strides had been taken from the start of the 
trial, we feel confident that any differences found In the failure rate and any 
changes In BF activity reflect the effect of the Increased BAC.
Earlier research has shown that many falls are primarily due to stumbling and 
tripping [19], In order to avoid falls due to hitting an obstacle, one needs to be 
able to respond adequately to both unseen obstacles causing a stumble [20,21], 
and to obstacles suddenly appearing In the travel path [6], The muscle that shows 
the First major response In all these reactions is the m. biceps femorls [6,15,20,21], 
When compared to young adults, both an Increase In response latency and a 
decrease In response amplitudes of this muscle were found In older adults [6,22], 
These longer onset latencies and smaller amplitudes were associated with lower 
success rates [6], The underlying mechanism for the decreased amplitudes 
during the stumbling and obstacle avoidance reactions In older adults may 
Involve various age-related physiological changes, both In the CNS (e.g. fewer 
motoneurons) [23] and In skeletal muscle properties (fewer type II muscle fibers 
and overall muscle atrophy) [23,24], In contrast, In the present study the delay 
and decrease In response are more likely to be due to CNS changes. A possible 
explanation for the Increased failure rate could be that the pathways used In the 
avoidance reactions have been altered by alcohol consumption. Obstacle 
avoidance reactions are often very fast; this has led to the proposal that fast 
supraspinal pathways may be Involved that bypass the primary motor cortex 
[6,25], These pathways may Involve the parietal cortex and/or the cerebellum. For 
example In studies on cats, Drew [26] showed that the parietal cortex Is Involved 
In obstacle avoidance. They also proposed that both a fast directly descending 
pathway originating from the parietal cortex may exist along with a slower one 
Involving the motor cortex.
Another possible explanation for the Impaired obstacle avoidance skills after 
alcohol consumption lies at the level of neurotransmitters. For example, previous 
research has shown that the endorphlnerglc system [27] and GABA 
(Gamma-Amlno Butyric Acid) [28] are Intimately Involved In the actions of alcohol. 
The sedative, tranqulllzlng and/or anaesthetic properties of alcohol have been 
related to the enhancement of the flow of chlorine Ions across neural membranes 
due to GABA [28], Yet alcohol does not have this effect on all GABA receptors. 
Motor Incoordination due to ethanol Is caused by potentiation of GABAA-assocl- 
ated adenosine A2A receptors In the striatum (caudate nucleus and putamen) 
[28], Moreover, It Is suggested that alcohol-induced deterioration In motor function
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is linked to changes in patterns of brain activity rather than changes in specific 
brain regions. Specifically, changed activity in the cerebellum as well as in the 
frontal and parietal cortices are involved in the motor-incoordinating effects of 
alcohol [29],
Studies on the effects of alcohol on brain activity with leg movements are 
lacking. However, for arm movements Van Horn et al. [30] found that the human 
cerebellum and PPC (Posterior Parietal Cortex) are involved in goal-oriented limb 
movements and that this role is compromised by alcohol. In particular, alcohol 
may cause a disturbance in the ability of these brain regions to compute 
appropriate corrective behavioral responses [30], In this context it is reasonable 
to suggest that the presently observed deficits in obstacle avoidance skills may 
be due to the effect of alcohol on information processing in the PPC and the 
cerebellum. Experiments involving techniques to record brain activity during 
obstacle avoidance should be performed to test this hypothesis.
Lim itations
To limit discomfort to the subjects we used a handheld breath analyzer instead of 
blood samples. In contrast to blood analysis, these breath analyzers are easy and 
quick to use, do not require additional hard or software, and are not a burden to 
the participants. The readings of such portable devices are in good agreement 
with the results of confirmatory analyses performed by stationary devices 
(r= 0.978) [31], Furthermore, the correlation with blood analysis is quite high for 
both the readings of the handheld (r=0.940) as well as the stationary 
devices(r=0.936) [31],
To the best of our knowledge, the effect of alcohol or other substances on 
obstacle avoidance during gait has never been studied before in healthy senior 
individuals. Therefore, it is not possible to make a direct comparison with results 
from similar studies. However, the obstacle avoidance task used in the present 
study has proven to be sensitive enough to detect significant agerelated deficits 
[32], A possible limitation is the relatively small sample size. However, in this type 
of motor control studies it is quite usual to have similar group sizes (because of 
the extensive data analysis involved). Furthermore, even with the small number 
the study yielded unequivocal outcomes. Hence, a larger sample size will mostly 
accentuate the significance of the present results.
31
Conclusions
In conclusion, the present results clearly show that alcohol levels, considered to 
be safe for driving, seriously hamper the ability to successfully avoid sudden 
obstacles In the travel path. It Is suggested that many of the alcohol-related falls 
are the result of the disruptive effects of alcohol on the online corrections of the 
ongoing gait pattern when walking under challenging conditions. In general the 
use of alcohol Is primarily seen as a risk factor for driving [1,33], However, Kool et 
al. [2] estimated that approximately 20% of unintentional falls at home In a 
working-aged population may be attributable to the consumption of two or more 
standard alcoholic drinks In the preceding 6 h. Moreover, accidents can also 
occur while walking, particularly under challenging conditions such as when 
negotiating suddenly appearing obstacles. The present data show that the 
required skills for obstacle avoidance frequently fall even after consumption of a 
low dose of alcohol.
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Dual task effects for asymmetric stepping 
on a split-belt treadmill
McFadyen BJ, Hegeman J, Duysens J: Dual task effects for asymmetric stepping 
on a split-belt treadmill. Gait Posture 2009, 30: 340-344.
Abstract
Bilaterally asymmetric stepping during walking is common to a number of pathological 
gaits (e.g., hemiplegia, limping). In the present work, the attention level of asymmetric 
stepping was studied by having subjects walk on a split-belt treadmill with symmetric (2 
km/hr) and asymmetric (2 vs 4 and 2 vs 6 km/hr) belt speeds both with and without a dual 
auditory Stroop task. There was no significant change in response reaction times across 
walking conditions or between walking and standing. The proportion of stance phase was 
unchanged by the dual task during symmetric walking. Stance phase proportions, however, 
significantly increased during dual tasking for the limb on the faster belt for both asymmetric 
conditions, while they decreased for the limb on the slower belt for the most asymmetric 
condition. There were also small modifications to double support proportions and a main 
effect of dual tasking to double support proportion variability. Observed dual task changes 
showed interference by the cognitive task with asymmetric gait performance, suggesting 
that asymmetric stepping, such as seen in limping gaits, requires more attention than 
symmetric walking. Such attention may, in part, be due to the dynamic balance required in 
asymmetric limb loading and unloading.
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Introduction
A number of pathological gaits involve bilaterally asymmetric stepping. Different 
methods, such as using a rotating treadmill [1] or a split-belt treadmill [2], have 
been used to study asymmetric walking. The split-belt paradigm provides a 
controlled means to simulate limping-like, straight-ahead gait at controlled 
speeds. Research using such protocols has shown that young adults can adapt 
to different split-belt speed asymmetries accommodating new inter-limb 
coordination patterns [2,3], There also appear to be different control mechanisms 
in asymmetric gait as compared to symmetric gait in relation to muscular 
coordination at the ankle joint. These different mechanisms are due to a change 
in interaction of the timing and coordination for the unloading of one limb in late 
stance with the loading of the contralateral limb in early stance [2,4,5], In particular, 
based on the analysis of ground reaction forces and ankle muscle activity in 
limping patients, De Visser et al. [6] showed that automated phase switching 
does not rely primarily on ipsilateral mechanisms. Instead, the onset of ipsilateral 
swing is linked to the moment of load acceptance by the contralateral leg.
For their part, Reisman et al. [3] interpreted observed adaptations to different 
split-belt speeds as the storage of new inter-limb coordination patterns. These 
authors also suggested an independence of control of each limb, as well as 
independence between inter- and intra-limb coordination. Yang et al. [7], in 
looking at infant stepping on a split-belt treadmill, also concluded that each limb 
was under the control of separate pattern generators, but still coupled together.
Based on these observations one would predict that the coupling between 
the legs during limping is relatively automated but it still may require more 
attention than symmetric gait. However, this has never been tested. It has been 
established through the use of dual task protocols that normal, symmetric walking 
itself requires a certain level of attention [c.f. 8], especially in the elderly [e.g., 
9,10] and in patients who have recovered from various types of leg surgery [e.g., 
11], It is also known that the attention level of walking is increased at speeds other 
than natural speeds in both healthy [12] and pathological [11,13] walking, as well 
as when healthy subjects are forced to walk in a manner that is not habitual, such 
as at high speeds when a running gait would normally be used [14],
Asymmetric walking involves speeds and gait behaviour neither of which is 
habitual, although still performed in a stereotypic and even automatic manner. 
Understanding the attention level of asymmetric walking patterns will not only 
expand the study of the attention demands to walking under different conditions,
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but also provide Information to better understand the demands of a behaviour 
common to many pathological gaits. The goal of this work, therefore, was to study 
whether asymmetric walking (such as would be found during limping) demands 
greater attention than symmetric walking. It was hypothesized that despite Its 
automatic nature, asymmetric walking, requiring different contralateral timing and 
dynamic equilibrium control, will demand more attention expressed by Interference 
In the performance of both the simultaneous cognitive and gait tasks as compared 
to their single task performances.
Methods
Participants
Eleven healthy, young (26.2±3.8 years, 5 male) subjects were recruited from the 
Nijmegen University Medical Centre community. Based on self-reporting, subjects 
had no current neurological or musculoskeletal problems and had normal or 
corrected-to normal vision. All participants provided written consent according to 
the Declaration of Helsinki.
Equipment and procedure
Subjects walked with each foot on separate, Individually controlled treadmills 
(ForceLInk BV, The Netherlands; Figure 1). All subjects wore a harness that did 
not Impede walking and would only be engaged In the case of loss of balance. 
Belt speeds for each treadmill could be the same (symmetric condition) or 
different (asymmetric condition). Force transducers placed under the corners of 
each treadmill closest to subject’s feet were used to provide stance and stride 
times and to subsequently calculate stance phase and double support phases as 
a proportion of respective left and right stride times. Subjects also wore 
headphones that delivered the simultaneous auditory Stroop task consisting of a 
high or low pitched voice saying the words “high” or “low” In Dutch. Subjects 
were required to Indicate the pitch of the voice and to Ignore the word said. 
Twenty-one voice stimuli were given during the dual task conditions at an average 
rate of 1.5 s between stimuli onsets with approximately equal Incongruent (voice 
pitch and word do not match) and congruent (voice pitch and word match) Stroop 
stimuli (10:11). Stimuli, voice and force transducer data were all recorded at 1000 Hz.
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Figure 1 Split-belt set-up with fixed speed on the left side and varying 
speeds on the right side. Small black arrow heads indicate 
positions of force transducers used for stride timing
Three belt speed conditions were studied. These included symmetric speeds 
at 2 km/h and two asymmetric speeds with the left limb at 2 km/h and the right 
limb at either 4 km/h or 6 km/h. Subjects initially stood on the two static treadmills 
that were then brought to 2 km/h together. For the asymmetric conditions, the 
right treadmill was then further increased to the targeted higher speed. After 
establishing the targeted speeds for each side, a minimum of 15 further strides 
were given to accommodate to the speeds. Verbal confirmation of the subject 
being comfortable with the speeds was attained before collecting data. Data 
were first collected for the walking tasks only at different belt speeds from 
symmetric to progressively asymmetric. Next, subjects were introduced to the 
auditory Stroop task and performed it while standing with the treadmills off, first 
in order to confirm their understanding of the task and then to collect the single 
task Stroop condition. Followthis standing recording, subjects were then required 
to walk at the different speeds with the dual task. The instructions for the walking 
task were to walk as stable as possible while looking at a target (a cross on the
i
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wall) straight ahead. The Instruction for the Stroop task was to Indicate as quickly 
as possible whether the voice pitch was high or low. Thus, both walking and 
cognitive tasks were prioritized. Speed conditions were counterbalanced across 
subjects during the dual task conditions to minimize conditioned effects of order 
from the first block of single task data collection. Following each walking period 
for a given speed condition, the right belt speed was decreased to match the left 
one and then subjects walked until they felt comfortable (I.e., no after-effects), 
after which the two treadmills were then slowed to a stop.
Data analysis
Response reaction times (RRTs) were calculated using custom software 
programmed In Matlab 7.2 (The Mathworks Inc., US) to detect the difference 
between the start of the Stroop stimuli signal and the start of the response voice 
signal. Galt temporal data derived from the force transducers were used to 
calculate the stride time, stance time as a proportion of stride for each limb and 
double support time following heel contact for each limb. For each condition, 
temporal data were averaged over a minimum of 20 strides, and corresponded to 
the period of verbal response for the dual task conditions. RRTs were averaged 
for all 21 responses for each dual task condition. Intra-subject variability of this 
data was also calculated from each subject’s standard deviation across the 
number of strides used for the condition.
Statistical analysis
A three-way generalised repeated measures ANOVA (belt speed by dual task by 
limb side) was used to evaluate main and Interaction effects for gait variables. 
Since RRTs were only collected for dual tasks and not related to limb, a one-way 
ANOVA was used to evaluate main effects for RRT and Intra-subject variability 
across belt speed conditions (Including standing). Post hoc Student’s t-tests 
were performed for significant (p <0.05) main effects.
Results
Response reaction times tended to be slightly faster during gait as compared to 
standing (Figure 2A), but there were no significant main effects across conditions. 
Intra-subject variability In these RRTs followed the same trend as the reaction 
time amplitudes (Figure 2B), but again with no main effects found.
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Figure 2 A. Response reaction times (RRTs) and B. the intra-subject variability 
in response to the Stroop task during standing and different walking 
conditions. Error bars indicate standard deviations
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There was a main effect of belt speeds (p<0.001) on stride time corresponding 
to equal bilateral decreases with increasing belt asymmetry (Figure 3A). There 
were, however, no dual task or limb effects and no interactions between factors. 
As has been shown in the past [2], the left limb, even though maintaining the 
same speed, also decreased its time in a coupled manner with the right limb. 
Intra-subject variability in stride time resulted in a main effect for belt speed 
(p<0.001), again decreasing with increased asymmetry and a small effect for 
limb (p = 0.045), although no post hoc differences for either variable were found 
(Figure 3B). Dual task effects again were not significant. There were no interactions 
between conditions.
Despite the maintenance of stride timing bilaterally, there were main effects 
for belt speed (p<0.001) and limb (p<0.001) on the proportion of stance time 
such that stance proportion was longer on the slow side and shorter on the fast 
side for asymmetric conditions (Figure 4A). There was no dual task main effect, 
but there were significant interactions between factors of dual task and belt speed
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Figure 3 A. Stride times and B. their intra-subject variability for the left [L] 
and right [R] limbs during single (grey bars) and dual (black bars) 
tasks over the different walking conditions. Error bars indicate 
standard deviations
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(p = 0.014), dual task and limb (p = 0.002), belt speed and limb (p<0.001), as well 
as between all three factors (p = 0.023). Further analyses showed that the dual 
task did not affect stance phase proportion in the symmetric condition, but this 
variable was significantly different for dual versus single tasking for asymmetric 
conditions being increased for the faster limb at both the 2-4 and 2-6 conditions 
(p = 0.004 andp = 0.003 respectively) and decreased for the slower limb in the 2-6 
condition (p = 0.004). This difference in the slower limb did not show significance 
for the 2-4 condition. The intra-subject variability remained the same across 
conditions and limbs (Figure 4B).
When the double support phase proportions were analysed (Figure 5A), main 
effects of belt speed (decreasing with split-belt conditions; p<0.001) and limb 
(always slightly higher for the right limb; p = 0.001) were found, but there were no 
main dual tasking effects. There were significant interactions, however, between
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Figure 4 A. Stance phase periods as a proportion of stride and B. their intra- 
subject variability for the left [L] and right [R] limbs during single 
(grey bars) and dual (black bars) tasks over the different walking 
conditions. Error bars indicate standard deviations. Asterisks 
indicate differences between dual and single tasks for a given 
treadmill condition (p<0.05)
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speed and dual tasking conditions (p = 0.009) and between all three factors 
(p = 0.015). Further analyses showed that only the left limb during symmetric gait 
and during the 2-6 condition had significant differences due to dual tasking.
Finally, intra-subject variability in double support proportions (Figure 5B) 
showed main effects for belt speed (p = 0.005), for dual tasking (p = 0.032) and for 
limb side (p<0.001). In addition, there was a significant interaction between belt 
speed side and limb (p = 0.008). Specifically, variability in the slow (left) limb 
decreased in the asymmetric conditions and dual tasking caused the faster right 
limb to be less variable in the asymmetric conditions than during single task 
walking. Further analyses, however, failed to show any significant differences 
between factors.
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Figure 5 A. Double support phase periods as a proportion of stride and
B. their Intra-subject variability for the left [L] and right [R] limbs 
during single (grey bars) and dual (black bars) tasks over the 
different walking conditions. Error bars Indicate standard deviations. 
Asterisks Indicate differences between dual and single tasks for a 
given treadmill condition (p<0.05).
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Discussion
A spllt-belt treadmill protocol was used to study the attention levels required for 
asymmetric stepping. Response reaction times to the auditory Stroop task 
suggest little modification to the cognitive task, but gait data showed significant 
and clear dual task effects to relative timing of the bilateral support phases. 
Effects on the variability In the dependent variables within subjects were minimal. 
The lack of effects on the cognitive task (RRTs), specifically from standing to 
walking, was contrary to what was expected for the more challenging asymmetric 
gait. It Is possible that the cognitive task we chose was simple enough to perform 
consistently across conditions, but still Interfered with gait timing. The tendency
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for higher and more variable RRTs during standing may indicate some learning 
although these were not significant. There is precedent for such a finding for 
symmetric treadmill walking [15], Future work might include re-testing the standing 
cognitive condition at the end of walking. However, noted changes in gait timing 
variables between single and dual task walking indicate that both tasks cannot be 
executed simultaneously without some interference in performance.
As already established in early [2] and more recent [3] studies, stride timing 
was bilaterally equal for all conditions, although decreasing when one limb was 
required to speed up. This is simply the result of the need for maintaining stable 
gait and can be shown for other asymmetrical stepping situations such as curved 
path walking [16], Given that the simultaneous Stroop task of the present study 
did not affect stride timing or its variability, these aspects of bilateral timing would 
appear to be automatic features of gait, particularly on the treadmill.
The fact that subjects spent more of their stride in stance on the slow limb and 
less on the fast limb during asymmetric gait seems logical given the speeds with 
which the respective belts would transport the limb under the body. This would 
also explain the double support proportions that were slightly greater on the fast 
side (as slow limb stays longer) and slightly less on the slow side (as the fast limb 
picks up sooner). The maintenance of equal stride timing discussed above would 
then reciprocally result in a swing proportion that is shorter on the slow side and 
longer on the fast side. These differences in relative phase timings are the very 
visual quality that we identify with limping. However, what is interesting is that the 
stance phase proportion on the fast limb with increasing asymmetric speeds was 
increased during dual tasking, supporting the hypothesis for interference by the 
cognitive task on gait in such a situation. This interference shows that, although 
stride timing may be automatic in nature, asymmetric gait performance requires 
some attention. Specifically, it suggests that relative timing of the stance and 
swing phases, and perhaps particularly support on the faster side, require 
attention during asymmetric walking.
Part of the reason for the greater need in attention in asymmetric stepping 
may be the increased dynamic balance requirements in asymmetric loading and 
unloading of the limbs. As has been previously shown, walking under split-belt 
conditions elicits different control mechanisms as compared to symmetric gait, in 
particular in relation to the interaction of the timing and coordination for the 
transfer of loading between limbs [2,4,5], Also, it has been suggested that 
inter-limb coupling is re-organized and even relearned during split-belt treadmill 
walking [3], With the present data, the fact that the right and left double support
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times were similar in the split-belt conditions supports that subjects had relearned 
this pattern [see 3] and further that this relearned pattern is fairly robust. Dual 
tasking was able to interfere with the adjusted pattern somewhat but nevertheless 
these changes were relatively modest, indicating that the underlying coordination 
is still fairly automated. This is consistent with it being dependent primarily on 
subcortical structures such as the cerebellum.
The observed changes in stance phase percentages were not particularly 
large (in the order of about 2 percent between asymmetric and symmetric gaits). 
Changes in double support phases were also small. Yet, as seen from the 
variability data, relative stance phase timing is very consistent and, therefore, 
small changes are significant. The fact that intra-subject variability was consistent 
even though relative stance timing was changed during dual tasking shows the 
robust nature of the temporal aspect of this stepping behaviour by the locomotor 
control system. In particular, these changes in relative stance phase timing during 
dual tasking with low and consistent variability also suggest that this behaviour is 
probably directly due to a decision to augment stability with a greater stance 
phase, rather than an inability to maintain it.
Why would asymmetric, limping-like, stepping require more attention for 
control of support phase relative timing than symmetric stepping? A few studies 
have considered the information processing involved at cortical and subcortical 
levels for split-belt walking. Duysens et al. [17], looking at specific mechanisms 
of muscle control over such loading coordination using split-belt walking, have 
shown cortical involvement over the complex sensori-motor integration of ankle 
muscles. In addition, two papers looking at the ability to adapt to split-belt 
asymmetric speeds in persons with stroke [18] and with cerebellar deficits [19] 
have suggested that inter-limb coordination adaptation is mediated specifically 
by cerebellar influence through brainstem circuits. In the intact human, such as 
for the present study, the small intra-subject variability for all measures, even 
during dual tasking, shows that even the more complex form of locomotion 
induced by the split-belt treadmill is relatively automated. This level of automation 
may be in large part due to a dominant role by subcortical structures such as the 
cerebellum. However, the present results also show that such coordination, even 
when adaptation is achieved, still demands some attention in support phase 
relative timing, possibly related to issues of dynamic equilibrium.
Some caution must be taken in interpreting the results for over ground walking. 
Walking on a split-belt treadmill is very controlled while over ground limping would 
most likely be more variable in its timing. In addition, there can be many reasons
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for a limping gait. Usually, however, limping is related to some discomfort and a 
need to load the limbs differently in order to reduce or avoid pain whether it be 
from an external perturbation (e.g., foreign object in one’s shoe) or, more 
commonly, an internal source (e.g., tissue strain leading to pain such as arthritis 
or myofacial pain). How such discomfort, and particularly pain itself, would affect 
attention is important and cannot be addressed with the present work. 
Presumably, pain would by itself affect the attention capacity of the person [20], 
Furthermore, it is likely that the "learning” of asymmetrical gait requires more 
attention in the short term, but less in the long term as has been shown for the 
case of podokinetics (i.e., walking on a disc; [1]).
Finally, we cannot say if dual task effects might have been more prominent 
had the subjects walked without a harness. Even though the harness did not 
provide any mechanical influence and no subject required it at any time during 
the study, it is possible that it provided more confidence in dynamic balance and, 
therefore, less attention required with than without it.
Conclusions
In conclusion, although asymmetric stepping maintains some automaticity in 
stride timing, it also appears to require some attention for dynamic equilibrium 
resulting in a strategy of prolonging the proportion of time put on the shorter 
stance phase. This strategy for increased dynamic stability may be mediated by 
supraspinal control as discussed previously in the literature. Continuing from this 
controlled experiment, further research should consider overground pathological 
limping gaits.
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Dual-tasking interferes with obstacle avoidance 
reactions in healthy seniors
Hegeman J, Weerdesteyn V, van den Bemt BJ, Nienhuis B, van Limbeek J, Duysens J: 
Dual-tasking interferes with obstacle avoidance reactions in healthy seniors.
Submitted
Abstract
Dual-tasking can lead to falls, as does a deterioration of obstacle avoidance skills. Hence, 
it is expected that a combination of both would be even more detrimental, especially when 
obstacles have to be avoided under time pressure. Previous work confirmed this 
expectation, however, due to several limitations in the design of previous studies it is yet 
too early to draw any definitive conclusions on the allocation of attentional resources in 
obstacle avoidance under dual-task conditions. Therefore, the present study used a 
primary and secondary task that are both attentionally demanding, with the instruction to 
perform as well as possible on both tasks. Nineteen healthy senior individuals (60±4.7years, 
8 female) performed an obstacle avoidance task on a treadmill while walking at 3km/h as a 
single task and combined with an auditory Stroop task. Sensitive outcome parameters, m. 
biceps femoris (BF) response times, obstacle avoidance failure rates and composite 
scores ((100xaccuracy)/verbal response time), were used to evaluate the data. Increased 
obstacle avoidance failure rates (3%, p = 0.03) and delayed BF response times (21ms, 
p<0.001) were found under dual-task conditions. Composite scores were reduced during 
(p<0.001) and just after obstacle crossing (p = 0.003). In conclusion, dual-tasking while 
avoiding obstacles under time pressure affects the motor as well as the cognitive task 
when subjects are instructed to keep up their performance on both. This adds to the 
evidence indicating an increased risk of tripping or falling when attention is divided during 
walking in the presence of unexpected obstacles.
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Introduction
Poor perform ance levels on both dual-task walking and obstacle  avo idance 
associa te  with an increased risk of falling [1,2], A  com bination of these tasks, as 
a com m on but challenging activity of daily living, is expected to be even more 
informative with respect to the risk of falling. Several researchers assessed  
obstacle  avo idance com bined with a cognitive secondary task and usually found 
effects of dual-tasking on the primary motor task, even in young and healthy 
populations [3-9], Detrimental effects on the secondary  task were reported less 
frequently [10,11], which m ay suggest that the secondary task is generally 
prioritized (postu re  second  strategy’). However, due to several limitations in the 
design of previous studies it is yet too early to draw any definitive conclusions on 
the allocation of attentional resources in obstacle avo idance under dual-task 
conditions.
First, in most dual-task studies on obstacle  avo idance participants are not 
given explicit instructions regarding which task to prioritize, or these instructions 
are not reported in the paper. This leaves the question whether the detrimental 
effects on the motor tasks truly reflect a ’posture se co n d ’ strategy or are due to 
an implicit assum ption of participants that they should keep up perform ance on 
the secondary task.
A  second  limitation is that most of the studies applied an obstacle avo idance 
task that did not require continuous allocation of attention (i.e. avoiding a 
stationary obstacle), thereby allowing participants to switch attention between 
tasks. Furthermore, the studies often evaluated the effects of dual-tasking using 
rather crude outcom es (e.g. gait velocity or number of errors on the secondary 
task). Although informative, such paradigm s may not be sufficiently sensitive to 
reveal the full im age of dual-task interference. O ne exception to this is the study 
of Chen et al. [3], They used an obstacle  avo idance task that required participants 
to adjust their gait pattern within one step to succeed . This task w as com bined 
with and affected by a secondary visual reaction time task. Both tasks, however, 
relied on visual information and the detrimental effects of the combination of 
these tasks may also be due to gaze shifts from the obstacle to the visual 
secondary  task stimulus and vice versa. Although such task com binations do 
simulate a situation com m only encountered during activities of daily living, they 
probably do not reflect the effects of exceeding the limits of attentional capacity. 
Therefore, W eerdesteyn  et al. [7] used a secondary  task that involved another 
sensory m odality (i.e. an auditory Stroop task [12]) in com bination with a
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time-critical obstacle  avo idance task, but they did not evaluate secondary  task 
perform ance in great detail. Siu et al. com bined obstacle avo idance during 
overground walking with an auditory Stroop task as well [6,11], They dem onstrated 
that both spatiotem poral gait param eters and verbal response tim es remained 
unaffected under dual-task conditions in young adults [11], In older adults, 
though, gait velocity decreased  and stride length increased when stepping over 
the obstacle  in parallel with increased error rates on the Stroop task [6], However, 
the obstacle avo idance task used did not require continuous attention. Hence, it 
seem s possible that the full im age of dual-task interference w as not revealed by 
these studies.
Considering the above m entioned limitations, we studied dual-task 
interference during obstacle avo idance (1) using a primary and secondary task 
that both require continuous attention for optimal perform ance, (2) with the explicit 
instruction to perform as well as possib le on both tasks, (3) using outcom e 
param eters that are highly sensitive to identify even subtle effects on either one of 
the tasks. It w as expected that sim ultaneous perform ance of a time-critical 
obstacle  avo idance taskand  a secondary  cognitive taskw ou ld  affect perform ance 
on both tasks.
Methods
Participants
Nineteen healthy senior individuals (60±4.7years, 8 female) volunteered to 
participate in this experiment. Inclusion criterion w as age between 50-70 years. 
Sub jects were excluded if they suffered from hearing problems, serious 
neurological, orthopaedic or cognitive impairments, had poor knowledge of 
Dutch, or used m edication that affected the locom otor system. All participants 
provided written informed consent in acco rdance  with the Declaration of Helsinki. 
The regional ethics com m ittee of Arnhem  and Nijmegen approved this study.
Experimental procedures
O bstac le  avo idance task
The participants had to avoid obstacles while walking on a treadmill (EN R A F  
Nonius, Type EN-tred Reha) at a fixed velocity of 3 km/hr (Figure 1A, inset), 
wearing their own com fortable low-heeled shoes. A  wooden obstacle (measuring 
40x30x1,5cm) with an em bedded piece of iron w as held by an electrom agnet just
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Figure 1 M ethods
A. Determination of response of the m. biceps femoris (BF). Response time was 
defined as the time between obstacle release (at Time=0) and the instant where the 
BF activity exceeded the activity of the control stride + 2SD. Inset: experimental 
setup. B. Step cycle phases in which the obstacle was released. MSw = Mid Swing, 
ESw = Early Swing, LSt = Late Stance. C. Determination of verbal response time 
(VRT = time between the start of the stimulus and the start of the response) and 
illustration of the stimulus timings: BEFORE, DURING, and AFTER obstacle crossing. 
OR = obstacle release
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above the treadmill surface. Its release w as triggered by the computer. The 
obstacle  w as alw ays presented to the left foot at a d istance of approximately 
10cm from the most anterior position reached by the toes in the swing phase. 
Marker positions of the obstacle  and the heel, ankle and big toe of both feet were 
recorded by an 8-cam era 3-D motion analysis system  (Vicon®, Oxford Metrics, 
London, UK ) at a sam ple rate of 100Hz and were processed  in real time to 
determine the timing of obstacle release related to gait phase. Before the obstacle 
w as released stride regularity (a maximum difference of 50ms between two 
consecutive strides) w as needed and at least five unperturbed strides had to be 
com pleted. The obstac les were released in three different phases of the step 
cycle  (late stance (LSt,45-60% of the step cycle), early swing (ESw, 60-70%) or 
mid swing (MSw,70-85%)) to create different difficulty levels as time pressure 
increased with later obstacle presentation (Figure 1B).
The participants were instructed to look at the obstacle, and step straight over 
it after its release. Any contact of the left foot with the obstacle or stepping to the 
side of it w as defined as a failure. Su rface  electrom yography (EM G ) data were 
collected from the m. b iceps femoris (BF, the prime m over in this task [13,14]) to 
assess  the latency of the first response to the obstacle  [14], Two self-adhesive 
Ag-AgCI electrodes (Tyco Arbo EC G ) were p laced longitudinally on the belly of 
the m uscle, approxim ately 2cm apart, in acco rdance  with European guidelines 
[15], The EM G  signals were sam pled at 2400Hz (ZeroWire®, Aurion S.r.l., Italy) 
and recorded synchronously with the marker data.
Auditory Stroop task [12]
Participants listened to the words “high” or “ low ” in Dutch, presented in either a 
high or low pitch, with an interstimulus interval of 1.5s. They had to indicate 
verbally which tone w as presented as quickly as possible. The stimulus w as 
congruent when the word and pitch m atched and incongruent when they did not. 
An integrated 16-bit sound card and headphone with m icrophone were used 
(Whitcom ® PC  H eadphone) and both stimulus and response were recorded 
synchronously with the marker and EM G  data at a sam ple rate of 2400Hz.
Protocol
Both the prim ary and the secondary task were practiced before the experiment 
started. Five obstacle avo idance practice trials were performed, and the auditory 
Stroop task w as practiced until the subject felt com fortable with it while in a 
standing position and during walking on the treadmill. The actual experiment
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consisted of four series of 15 obstacle  avo idance trials each. All participants 
perform ed the first and fourth series as a single obstacle avo idance task. The 
second  and third series were performed in conjunction with a the auditory Stroop 
task (dual-task condition). Hence, each condition (single and dual task) com prised 
30 trials. The participants were instructed not to prioritize any of the tasks, but to 
try their hardest to perform both tasks as well as possible.
Data analysis
Failures on the obstacle avo idance task were noted during the experiment and 
post-hoc verified on the basis of the marker position recordings. Failure rates (the 
number of failed trials divided by the total number of trials) were calculated for 
each  step cycle  phase in both the single-task and the dual-task condition.
EM G  activity w as full-wave rectified and low-pass filtered at 25Hz (zero lag, 4th 
order Butterworth filter). For each participant and each task condition, onset 
latencies of the EM G  activity were determ ined by m eans of a com puter algorithm 
(Matlab® software, version 7.4.0, The Mathworks Inc., US) and visual inspection. 
The average EM G  activity of the stride preceding obstacle release of 25 trials w as 
calcu lated and used as the background (control) activity during unperturbed 
walking. The response time w as defined as the time between obstacle release 
and the instant at which EM G  activity during the obstacle  avo idance stride 
exceeded the average control activity plus 2 SD s  (Figure 1A). The response 
amplitude w as calcu lated as the average am plitude over 100ms following B F  
onset [13,16], The am plitudes were normalized with respect to the maximum 
average background activity during the whole step cycle in the single-task 
condition. A  similar procedure w as performed to calcu late and normalize the 
average background activity in the 100ms following the B F  response onset.
To assess  VRTs (verbal response times) on the Stroop task, the signals of 
both the stimulus and the verbal response were full-wave rectified and low-pass 
filtered at 40Hz (zero lag, 4th order Butterworth filter). For each  participant, VRTs 
were calculated as the time between the stimulus onset and the response onset 
using a custom  m ade com puter algorithm (Matlab® software). As VRT  is 
determ ined by both task characteristics as well as the strategy used, 
speed-accuracy trade-offs have to be considered [17], Quick responses usually 
result in more failures, w hereas slower responses are often more successfu l. Use 
of a com posite score ((100xaccuracy)/VRT) [17] m akes it possib le to reckon with 
both speed  and accu racy  for all congruent and incongruent stimuli. A ccu racy  
w as defined as the percentage correct responses given with no response being
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treated as a failure. Com posite scores were calculated for the stimuli presented 
prior to, during and just after obstacle  crossing, representing the timing of the 
secondary  task with respectto  obstacle release (OR, Figure 1C). The last stimulus 
and its response before obstacle  release, w as defined as prior to obstacle 
crossing (OR-1.61 ±0.11 s). If the response w as given during perturbed walking, 
the stimulus w as defined as during obstacle  crossing (OR+0.07±0.13s). The first 
stimulus during the recovery from avoiding the obstacle, w as defined as just after 
obstacle  crossing (OR+1.48±0.11s).
Statistical analysis
Failure rates were assessed  using binary logistic regression with task condition 
as categorical factor (single task as reference category, a= 0.05) in Egret® for 
W indow s (version 2.0.31). Paired t-tests were used to test for d ifferences in EM G  
outcom es between task conditions. Repeated  m easures AN O VA s with post-hoc 
pairw ise com parisons were used to identify d ifferences between the com posite 
scores. W ithin-subjects factors were Timing (prior to, during or just after obstacle 
crossing), and Congruency (congruent or incongruent stimulus).
These ana lyses were performed in S P S S  (S P S S ®  12.0.1: S P S S  Inc., Chicago, 
Illinois, USA ). M eans are presented with their standard errors (SE ). The level of 
sign ificance w as set at 0.05.
To identify a difference of 20m s in the m ean B F  response time between the 
single and dual-task condition a sam ple size of 14 subjects would be needed 
(P=  0.9, a=0.05).
Results
Failure rate
A s shown in Figure 2A, a significant increase in overall failure rate w as observed 
when the cognitive secondary task w as added to the obstacle avo idance task 
(3±1% vs. 6±1% in single and dual task; p = 0.03). A lm ost all failures were m ade 
when time pressure w as high, i.e. in M Sw  (p<0.001) com pared  to LSt, both in the 
single and dual-task condition. Within this phase the failure rate increased from 
7 %  (single task) to 14% in the dual-task condition (p<0.01; Figure 2B).
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Figure 2 Effect of a secondary  cognitive task  on A. total failure rate and B F  
response times, and B. failure rate per step cycle  phase
LSt = Late Stance, ESw  = Early Swing, MSw = Mid Swing. Sign. diff. between single- 
and dual-task condition: *p<0.05, **p<0.01
IZZI Single
** I 
.
r h 1
I I Single 
Dual
LSt ESw MSw Total
Step cycle phase
EMG outcomes
W hen  obstacle avo idance trials were perform ed as a single task, B F  response 
tim es were on average (± SE ) 151±3.3ms. In the dual-task condition these 
response times significantly Increased to 172±5.7ms. (f11s=-7.17, p<0.001, Figure 
2A). B F  response tim es Increased In all participants and a strong correlation w as 
observed between the Individual response tim es In the single and dual-task 
condition (r= 0.9, pcO .OOl). No differences between single and dual-task 
conditions were found In normalized response am plitude (single task: 143±32%, 
dual task: 139±31%; f11s = 0.52, p  = 0.61) and In normalized background activity 
(24±2.6% vs. 25±2.5%; f, ,s=-0.38, p  = 0.71).
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Auditory Stroop task: composite scores
The ana lyses revealed both main effects of Timing (F917=21.7, p<0.001), and 
Congruency (F11f:=27.1, p<0.001) and an Interaction effect between these factors 
(F917=4.44, p  = 0.03). Overall, total perform ance on the secondary task w as worse 
during obstacle crossing (8.6±0.84) com pared to before (12.3±0.39, p<0.001) 
and after obstacle crossing (10.6±0.60, p<0.001). Furthermore, the perform ance 
on the first stimulus after obstacle  crossing w as still worse as com pared  to the 
last stimulus prior to obstacle release (p = 0.003).
Overall, Incongruent stimuli resulted In lower com posite scores than congruent 
stimuli (before: f11fi=2.61, p = 0.02; during: f11s=5.20, p<0.001; after: f11s = 5.20, 
p = 0.001; Figure 3). The congruent-lncongruent difference In com posite scores 
w as significantly larger for stimuli during obstacle crossing com pared  to the 
stimuli prior to obstacle  release (m ean (± SE ) difference: 3.7±0.58; p<0.001). The 
congruent-lncongruent difference In com posite scores for the stimuli after 
obstacle  crossing w as still larger than for stimuli prior to obstacle crossing 
(1.7±0.42; p  = 0.003), but sm aller than during crossing (2.1±0.35; p<0.001).
Figure 3 Effect of stimulus timing on com poslte scores for the secondary 
cognltlve task for congruent (word and vo lce pltch match) and 
Incongruent stimuli (word and vo lce pltch do not match)
Composite score was computed as (100xaccuracy)/verbal response time. *: sign. diff. 
with congruent stimuli (p<0.05)
I I Congruent 
* Incongruent
*
d
Before During After
Stimulus moment
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Dual-task interference
To assess  whether the participants acted upon the instruction to em phasize 
perform ance on both tasks, we com pared  the change in each  of the tasks. 
Therefore, we looked at the individual differences between B F  response tim es in 
single-task and dual-task condition for the obstacle avo idance task, and at the 
individual differences between the com posite scores before and during obstacle 
release for the secondary task. A  decrem ent w as observed in both the obstacle 
avo idance task and the secondary  task for all subjects, indicating that they 
indeed followed the instruction.
Discussion
The aim of this study w as to investigate dual-task interference during time-critical 
obstacle  avo idance while participants were instructed to perform as well as 
possib le on both the prim ary obstacle  avo idance task and the secondary 
cognitive task. This study clearly showed that performing the two tasks 
sim ultaneously affects the perform ance on both tasks. The responses to suddenly 
appearing obstac les during gait were slower, but not weaker, and were less 
successfu l when there w as little time to react. The perform ance on the cognitive 
task w as affected too, especia lly  during and just after obstacle crossing.
These findings are in agreem ent with previous studies that also demonstrated 
affected obstacle  avo idance [3-9] or secondary  task perform ance under dual-task 
conditions [10,11], As most studies mainly reported detrimental effects on the 
prim ary task, this may be interpreted as evidence for a postu re  se co n d ’ strategy, 
in which the secondary  task is prioritized over the primary motor task. Such  a 
strategy could be the result of (a lack of) instruction regarding task prioritization. 
In the present study, however, we explicitly instructed participants to try their 
hardest to keep up perform ance on both tasks. The resulting data do not support 
a postu re  se co n d ’ strategy, as we observed dual-task interference in both the 
prim ary and the secondary task. It should be pointed out that the most pronounced 
differences between single- and dual-task conditions were found for the most 
difficult situations, i.e. when there w as very little time to react to the obstacle and 
when incongruent stimuli were presented, w hereas differences were more subtle 
for ‘e a s y ’ obstacles and congruent stimuli. This stresses the need for challenging 
gait tasks and sensitive outcom e m easures to study dual-task interference in 
healthy populations.
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The observation that during obstacle  crossing, dual-task interference on the 
cognitive secondary  task w as more pronounced in responses to incongruent 
com pared  to congruent stimuli is rem iniscent of the work on response inhibition 
of Redfern et al. [18], The difference in perform ance between congruent and 
incongruent stimuli can be used as a m easure for the ability to inhibit the 
processing of irrelevant auditory information. A  larger difference is thought to 
indicate more difficulty in response inhibition, as a process that im poses high 
dem ands on attentional capacity. Hence, in the present experiment, participants 
had difficulties inhibiting inadequate verbal responses during and, to a lesser 
extent, after obstacle  crossing. These findings dem onstrate that even in our group 
of healthy senior participants, additional attentional resources (needed for 
response inhibition) are not only required for obstacle  crossing, but also for 
recovering from an obstacle crossing step.
The senior participants in the present study (60±4.7 years) were healthy and 
not yet at risk of falling, thereby limiting generalization to populations who are at 
risk of falling such as elderly with physical or cognitive impairments. However, it 
seem s likely that the results of this experiment would be even more pronounced 
if the participants were persons who are indeed at risk of falling. Future studies 
should expand on the present results by assessing  a time-critical obstacle 
avo idance task under dual-task conditions in such populations.
The present study dem onstrated a useful and sensitive method to assess  
dual-task interference in time-critical obstacle avo idance during gait. It is 
suggested  that the changes in avo idance reactions found when dual-tasking add 
to an increased risk of tripping or falling when attention is divided during walking. 
This even seem s to be the case  for a group of people who are normally not 
considered being at risk of falling.
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NSAIDs and the risk of accidental falls in the elderly
A systematic review
Hegem an J, van den Bem t B J,  Duysens J, van Lim beek J: NSAIDs and the risk of 
accidental falls in the elderly: a systematic review. Drug Saf 2009, 32: 489-498.
Abstract
Accidental falls, especially those occurring in the elderly, are a major health and research 
topic nowadays. Besides environmental hazards and the physiological changes associated 
with ageing, medication use (e.g. benzodiazepines, vasodilators and antidepressants) and 
polypharmancy are significant risk factors for falling as well. Exposure to NSAIDs has been 
associated with accidental falls too, although information on this area is less consistent. 
Therefore, the main goal of this review is to provide an updated overview of all the evidence 
published on risk of falling due to NSAID use so far. A systematic literature search for 
material published between 1966 and March 2008 in PubMed, EMBASE, Cochrane 
Database of Systematic Reviews, Exerpta Medica, Current Contents, and Science Citation 
Index was combined with a check of the reference lists of all the retrieved articles. Validity 
and data extraction of the eligible articles was assessed by adapted criteria, based on 
checklists that were originally developed to assess case-control or cohort studies. From 
the 16 selected articles, two studies were rejected due to clustering of data and one was 
excluded because it contained the same data as that in one of the included articles. None 
of the articles retrieved included a randomized controlled trial. The remaining 13 studies all 
showed some lack in completeness of their statistical methods, and much variation in 
reporting of effects. The overall mean age was high in the study populations, leaving the 
results to be poorly generalizable to a larger population and other age categories. Despite 
these imperfections, all studies showed an increased risk of falling due to NSAID use (four 
significant, nine non-significant), and a tendency towards an increased fall risk with NSAID 
exposure could be noted. The results shown in the present review suggest that an increased 
risk for accidental falls is probable when elderly individuals are exposed to NSAIDs. The 
studies with the highest quality show that the community-dwelling elderly in particular 
appear to be at higher risk. This review can serve as a comprehensive overview of the 
published evidence on fall risk of elderly individuals attributable to the use of NSAIDs, and 
as an inducement for future research.
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Accidental falls
With the number of elderly steadily increasing, and their m ean age rising, the 
(physical) problem s that com e with age will need more and more attention. 
Accidental falls, for example, have becom e a major health and research topic in 
terms of causes, consequences, and prevention, and 400 potential risk factors 
have been identified already [1-5], A  crude w ay to classify these risk factors is the 
segm entation into intrinsic and extrinsic factors [6,7], S in ce  this segm entation is 
still more or less am biguous, the Effective Health Care Bulletin [1] m anaged to 
classify potential risk factors for falls and injury into five c lasses: m edication 
related factors, changes and m edical conditions associated  with ageing, 
environmental hazards, lack of exercise, and nutrition.
Medication-related risk factors for accidental falls
Medication-related factors com prise the use of drugs such as benzodiazepines, 
vasodilators, antidepressants, N SA ID s (non-steroidal anti-inflammatory drugs), 
and polypharm acy [8-12], A  Canad ian  study showed that 2 7 %  of the elderly 
individuals (>65 years of age) hold a current or recent N SA ID  prescription [13], 
Com m on adverse effects of N SA ID s include gastrointestinal and central nervous 
system  problems. The latter consist of dizziness, headaches, mood alteration 
and confusion [14], consequently putting elderly individuals at a greater risk for 
accidental falls. The focus of this review will be on N SA ID  exposure as a falls risk 
factor in particular.
M any researchers have studied the risk factors associated  with medication- 
related falls [5,13,15], Russell et al. [11], for instance, studied 300 community- 
dwelling individuals, and identified po lypharm acy as a risk factor for falls in 79%  
of the adm issions to the em ergency departm ent. However, Ziere et al. [16] showed 
that po lypharm acy itself is not a risk factor for falling unless a drug known to 
increase the risk of falls is part of the drug regimen. In fact, the odds for falling 
increased with 42%  when drugs known to increase fall risk (e.g. benzodiazepines) 
were used; from 1.3-fold when one such drug w as used, to 2.5-fold when two 
such drugs were used concom itantly, com pared  to the falls risk when no drugs 
known to increase fall risk were used.
The NSA ID s were not considered to be a drug class associated with an increased 
fall risk. Nevertheless, there have been a few attempts to study the relationship 
between other specific drug classes and falls, including some on NSAIDs. In 1999, 
Leipzig et al. [17] published a systematic review and meta-analysis on cardiac and
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analgesics drugs. The authors found a slight non-significant increase in fall risk in 
elderly individuals exposed to NSAIDs. However, since then, several new studies 
have appeared and therefore there is a need for an updated version. Our goal is to 
provide an updated systematic review of all studies published thus far that present 
odds ratios (ORs) for the risk of falls due to NSAID  use.
Study identification and selection
M edical subject headings and text words were used to perform a system atic 
search  for material published between 1966 and 31 March 2008. Our core search 
terms were ‘accidental fa lls’ or ‘fa lls’, com bined with ‘anti-inflammatory 
non-steroidal agents/drugs’ or ‘N S A ID s ’ or ‘d rugs’. This w ay a total of 995 articles 
w as retrieved from the electronic databases PubM ed and E M B A S E , used as the 
primary databases for our search. The Cochrane D atabase of System atic Review s 
as well as the databases Excerpta M edica, Current Contents, and Sc ience  
Citation Index were secondary databases and revealed no new material.
Stud ies were eligible for inclusion if they were published in the English, 
Germ an or Dutch language. They also had to involve N SA ID s and present an 
odds ratio (OR) for accidental falls, or percentages or numbers of those who had 
experienced falls with N SA ID  exposure. Two reviewers independently screened 
titles and abstracts on these inclusion criteria. After administration of these 
criteria, full-text cop ies of the remaining studies were obtained. In case  a study 
w as included but lacked relevant data, first authors were asked to provide the raw 
data on numbers of those who had and had not experience falls with and without 
the use of NSA ID s.
Am ongst the 995 articles retrieved, there were no randomized controlled 
trials, controlled trials and highly controlled trials, controlled before-and-after 
studies nor interrupted time-series studies. Only one system atic review with 
m eta-analysis on card iac  and ana lgesic  drugs w as found [17], and its references 
were used to check  suitability for our review.
Methodological evaluation
Based  on checklists that were originally developed to assess  case-control or 
cohort studies, we formulated adapted criteria as described  in the following two
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sections [18,19], Validity and data extraction of the articles were assessed  by 
m eans of these criteria, and were scored accord ing to four levels: sufficient [++], 
m oderate [+], insufficient [-], or inapplicab le [o].
Criteria for validity assessment
V1: Th is criterion tested whether there w as sufficient controlling for possible 
confounders. Confounders had to be identified in the article, and the results had 
to be adjusted for them. For this review, relevant possib le confounders were: age, 
gender and co-morbidity.
V2: The selection criteria for case s  and the rationale for controls were tested. 
C ases  were persons who experienced one or more accidental falls. Controls were 
defined as persons who had not experienced an accidental fall.
V3: W e judged the selected study design in relation to the study aim. A  cohort 
study (prospective / historical) w as considered appropriate when all persons who 
were using N SA ID s were included and, thereupon, for a fixed period of time, the 
number of accidental falls w as observed and counted. A  case-control study w as 
suitable when NSA ID  exposure w as checked after all accidental falls were counted 
in a defined period of time.
V4: This criterion tested whether appropriate m easures were taken to address 
potential sources of bias. The sources of bias can be defined as a distortion of 
evidence or data that arise from the w ay that the data are collected. Sou rces  that 
were considered relevant for this review were selection bias and information bias. 
Se lection  bias w as defined as the com position of the study groups showing 
failures. Information bias w as defined as w eakness in the m easurem ent of the 
m edication exposure in the study groups.
V5: Statistical m ethods related to study design were evaluated. The em phasis 
w as on matching, group com parison, control for confounding and handling of 
m issing data. Logistic regression, Mantel Haenszel technique or stratification of 
the O R  were considered adequate statistical methods.
Criteria for data extraction
D1: This criterion tested whether the inclusion and exclusion criteria were 
described. W hether the base population from which the study groups were 
selected w as described  properly w as also assessed .
D2: Appropriate reporting of effects in terms of statistical (O Rs with 95%  
confidence interval [CIs]) as well as quantitative m easures (e.g. number of cases 
and controls) were assessed  in this criterion.
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D3: It w as judged If control for confounding w as applied on the data by m eans 
of showing stratified adjusted odds ratios.
D4: Description of the exposure w as assessed  In this criterion. W e  defined 
two levels of description. First, extensive (E): mention of specific drugs with their 
dose. Second , sim ple (S): N SA ID s are only mentioned as a group, without any 
Information on dose.
D5: This criterion tested whether the results of the study could be generalized 
to a larger population, Including different age categories.
Two reviewers (JH  and B vd B ) Independently evaluated the quality of the 
se lected  articles using the structured checklist and a data-collectlon form. To 
extract corresponding data, N SA ID s were defined not to be equivalent to 
ana lges ics or aspirin (acetylsallcyllc acid). The definition for an accidental fall 
used w as the one provided by the Prevention of Falls Network Europe (P roFaN E),
I.e. “an unexpected event In which the participant com es to rest on the ground, 
floor or lower level” [6],
First round agreem ent w as ach ieved  In six articles. The rest were reassessed  
until both reviewers reached consensus.
Overview of research on NSAIDs and accidental falls
The Initial 995 studies that were retrieved from the electronic databases were 
reduced to 15 articles that met our Inclusion criteria for detailed data abstraction 
(Figure 1). W e  divided this selection Into 2 groups; observational studies (n=14) 
and system atic reviews (n=1). The studies used In the system atic review revealed 
no new articles com pared with those already retrieved, w hereas checking the 
references of the 14 observational studies yielded another 2 articles that met the 
Inclusion criteria for our review. From this total of 16 selected articles, 3 studies 
were rejected. This w as because of clustering of data on ana lges ics together with 
N SA ID s In two articles [20,21] and one w as excluded because  It contained the 
sam e data as that In on e of the Included articles [22], All together, these rejections 
resulted In 13 studies [23-35] eligible for our review.
Table 1 Identifies differences In settings, sam ple size and characteristics of 
the populations and study designs. W hat Is most striking Is the large variety In 
sam ple sizes and the overall high m ean age. In all studies, over 5 0%  of those who 
had experienced falls were female. In two studies [24,28], significantly more of
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Figure 1 Flowchart of the selection and inclusion of the articles
the cases  were fem ales than in the control group; in one of these studies [24], the 
cases  were significantly older than the control group as well. Of the 13 eligible 
studies, there were 9 case-control studies, 3 prospective studies, and one cross- 
sectional study. Six studies involved community-dwelling persons; the remaining 
studies investigated accidental falls in persons living in a long-term care facility.
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The outcom es of the assessm ent of validity and data extraction are presented in 
table 2. None of the studies complied with all ten criteria used in this assessment. 
From the aspect of validity, all studies show  som e lack in com p leteness of their 
statistical methods; correction for possib le confounders w as sufficiently carried 
out in only four studies. The selection of c ases  and controls, and the selected 
study design were adequate in all but one study.
Table 2 O utcom es of the assessm ent of validity and data extraction of the 
eligible articles
Four scoring levels were used: sufficient [++], moderate [+], insufficient [-], or 
inapplicable [o],
V1 = possible confounders, V2 = selection criteria cases and controls, V3 = 
study design related to study aim, V4 = address of potential sources of bias, 
V5 = statistical methods related to study design, D1 = description in- and exclusion 
criteria, D2 = reporting of effects, D3 = control for confounding, D4 = description of 
medication exposure: extensive (E) or simple (S), D5 = generalisability. See Methods 
for more detailed explanation of symbols.
First author V1 V2 V3 V4 V5 D1 D2 D3 D4 D5
Kerman [25] - + + + + + - + - - S -
Lipsitz [28] + + + + + + + + + + + + S +
Myers [31] + + + + + + + + + + + s +
Ryynaanen [33] + + + + + + + + + + - s +
Yip [35] + + + + + + + + + + + + + + + s +
Lord [29] + + + + + + + + + + + s +
Koski [26] + + + + + + + + + + + + s +
Mustard [30] + + + + + + + + + + + + + s +
Nikolaus [32] - + + + + + + + + + + - s -
Kelly [24] + + + + + + + + + + + + + + + s + +
Kallin [23] + + + + + + + + + + + - s +
Walker [34] - + + + + + + + + + + - E +
Lee [27] + + + + + + + + + + + + S + +
Data extraction showed more inconsistencies; in particular, the specification 
of the base population and the inclusion and exclusion criteria, and adequate 
reporting of effects varied greatly. Only one study presented an extensive
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description of the m edication exposure. The results of most studies were judged 
to be difficult to generalize to a larger population and different age categories. 
This w as for the mostly as a result of the overall high m ean age of the study 
populations.
Figure 2 shows an overview  of the O R s  of 12 studies with their 95%  Cl and w as 
created with the benefit of StatsD irect statistical software® (version 2.6.7 
[13/05/2008]); StatsD irect Ltd, Cheshire, UK). One study is not included in this 
final overview. It presented an O R  of 1.7 (95%C I: 0.95, 3.10), but it w as im possible 
to retrieve the raw data needed [26], The O R s  calculated in figure 2 are based on 
raw data on those who had experienced falls and those who had not, with and 
without N SA ID  exposure. Again, a large variety between the studies is observed; 
O Rs, 9 5 % C ls  as well as sam ple sizes show  vast differences. In this figure, with 
four studies presenting a significantly increased O R  and eight studies presenting 
a non-significantly increased OR, a tendency towards an increased fall risk with 
N SA ID  exposure is suggested.
Figure 2 Forest plot of the odds ratios of 12 studies with their 95% confidence 
intervals. The black squares represent the sam ple sizes
NSAID N o NSAID
+  fa ll +  fa ll
Kerman [25] 11/12 46/78
Lipsitz [28] 21/13 49/43
Myers [31] 22/9 162/175
Ryynaanen [33] 126/51 254/291
Yip [35] 15/7 56/48
Lord [29] 24/65 49/224
Mustard [30] 260/1226 234/1252
Nikolaus [32] 29/91 33/1 26
Kelly [24] 159/547 2119/8565
Kallin [23] 26/187 275/3028
Walker [34] 30/11 32/51
Lee [27] 61/112 963/2864
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Comparison with other drug classes
The main goal of this study w as to provide an updated overview  of all evidence 
published on odds ratios and falls due to NSA ID s. Thirteen studies turned out to 
be eligible in order to reach this goal; none of them were randomized clinical 
trials. Several studies presented an O R  between 1 and 2. This is in the range of 
the O R s  on accidental falls for benzodiazepines - a drug c lass known to increase 
the risk of falls - identified by Ziere et al. [16] (OR: 1.3 (95%C I, 1.0, 1.9)). In line with 
this finding, Leipzig et al. [36] presented an O R  for accidental falls of 1.48 (1.23, 
1.77) in elderly exposed to benzodiazepines. Moreover, Ensrud et al. [37] found a 
51% increased risk for falling in older wom en using benzodiazepines. These 
findings imply that elderly individuals taking N SA ID s can indeed be at a higher 
risk for accidental falls, even at a similar level as those taking drugs well known to 
increase the risk of falls.
In 1999 Leipzig et al. [36] conducted a system atic review and meta-analysis 
on psychotropic drugs to evaluate the evidence linking these risk drugs with 
accidental falls in older people. They found a small association between the use 
of most c lasses  of psychotropic drugs and falls, but the evidence w as m ethodo­
logically similar to the findings in the present review. Even  though there is more 
know ledge about evidential value in studies nowadays, heterogeneous 
m ethodology and therefore lack of univocal results is still a com m on phenom enon.
Effects of variability in methodology
For the present review, it w as clear that there w as a large variability in the studies 
selected. This finding is concordant with the conclusion of Leipzig et al. [17] in 
their review on card iac and ana lgesic drugs. The two elem ents all studies had in 
com m on were that they were solely based on observational data, and the high 
m ean age of the study population (on average >75 years). Moreover, the 
heterogeneous m ethodology and diversity on m any aspects of the studies w as 
striking. Major aspects such as correction for possib le confounders, sam ple size, 
and possible generalization of the outcom es to a larger population varied widely. 
Even the kind of populations and falls that were included showed dissimilarities. 
No single definition of an accidental fall w as used as designated standard. One 
study com prised injurious falls only, thereby very likely biasing the odds ratio, 
since injurious falls represent just a minority of all falls in elderly populations [33],
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Nevertheless, all Included studies present an Increased OR, and their results 
Imply that there Is a tendency towards an Increased risk of accidental falls when 
elderly Individuals are using NSA IDs.
Selection and information bias
O ne of our validity criteria Involved the assessm ent of selection and Information 
bias. After assessing  all eligible articles, more possible sources of bias could be 
m entioned, but they did not concern all studies. First Is the problem of recall bias 
regarding falls. There Is published evidence that retrospective reporting of falls by 
older persons Is an aspect that b iases the risk of an accidental fall [38,39], 
Consistent with G anz et al. [38], M ackenzie et al. [39] concluded that retrospective 
self-reporting of falls Is less accurate than prospective calendar-recorded fall 
data. They also found that an Injurious fall does not, by definition, result In a better 
recall of falls. This Is In contrast to G anz et al. [38], w hose system atic literature 
review showed that patients with Injurious falls were more likely to recall their falls. 
In addition to self-reported falls, careg ivers can report falls as well. The question 
arises whether this method of reporting Is free of bias. It Is likely that an accidental 
fall In dependent frail elderly will be rem em bered and reported more easily 
com pared  to a fall In more Independent elderly. Bearing this In mind, the chances 
are that the actual number of accidental falls Is higher, thereby leaving the 
Interpretation of the results presented In the selected studies with som e 
uncertainties.
Recall of medication use
Second , Is the recall of m edication use. Accurate Identification of medication 
exposure by retrospective (self) reporting showed Inconsistencies as well. MIs- 
classlflcatlon of m edication exposure can either be due to m edicines that are only 
provided or used when needed, or to a single m easurem ent of exposure, which 
does not provide for the most up-to-date exposure [23,30,40], Another aspect 
that Interferes with accurate Identification of m edication exposure Is the use of 
over-the-counter (OTC) drugs. Non-aspirin N SA ID s In particular are often used as 
OTC drugs. U se  of these drugs Is usually badly recalled [41], Lew is et al. [41] 
studied use of non-aspirin N SA ID s In 1889 subjects (median age 54 years) over 
an 8-week period. In this period, 17.5% used prescribed non-aspirin NSA ID s, and 
more than tw ice this number (44.2%) used OTC non-aspirin NSA ID s. In line with 
this finding, Saw yer et al. [42] showed that taking OTC pain m edication w as 
associated  with lower odds for taking prescribed pain m edication (OR: 0.50,
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9 5 % C i:(0.4, 0.7)). S in ce  in this current review none of the assessed  articles 
showed data on OTC medication, it remains unclear in what w ay possible use of 
OTC m edication might have influenced the results. In future studies, researchers 
should take this possib le influence into account.
More complications in fall risk assessment
Another factor that com plicates fall risk assessm ent is the use of m edications in 
general. Up to 8 0 %  of elderly individuals suffer from chronic d iseases [5,43,44], 
and the oldest individuals in particular usually require long-term m edical treatment 
and several m edications. Deterioration of physical and mental health status, and 
increasing age were found to be associated  with the use of more m edications 
[45-47], Nevertheless, there are numerous studies that have consistently found 
that po lypharm acy or just an increase in number of m edications used by a patient 
can result in up to a tripling of the risk of falling [21,28,32], Yet, Law lor et al. [44] 
showed that chronic d iseases and multiple pathology were more important 
predictors for falling than polypharm acy. They found a strong linear association 
between the number of d rugstaken  and the individual experiencing an accidental 
fall. However, after adjusting for chronic d iseases and other potential confounding 
factors, this association turned out to be non-significant. Similarly, N SA ID s are 
mostly prescribed for (chronic) d iseases of the locom otor apparatus, which 
them selves are a risk factor for falls [44,48,49], G iven that correction for possible 
confounders is generally poor in most (observational) studies on m edication use 
and the assessm ent of fall risk, confounding by indication is very likely to be the 
backdrop of the fall risks presented.
Conclusions
The results shown in the present review suggest that an increased risk for 
accidental falls is probable when elderly individuals are exposed to NSA IDs. 
G iven that correction for possible confounders is generally poor in most 
(observational) studies on m edication use and the assessm ent of fall risk, 
confounding by indication is very likely to be the backdrop of the fall risks 
presented. Bearing this in mind and considering the high incidence of co-morbidity 
in the elderly, caution should be exerted when interpreting results of studies about
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medication use and fall risk. Nevertheless, this review can serve as a comprehensive 
overview  of the published evidence on fall risk of elderly individuals due to the 
use of N SA ID s thus far, and as an inducem ent for future research with more 
evidential value. Taking the incidence of falls and their consequences in the 
growing population of elderly individuals, exem plary future research should 
com prise large randomized controlled trials, along with improved prospective 
and extensive m easuring of falls and m edication use.
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The effect of a non-steroidal anti-inflammatory 
drug on two important predictors for accidental falls: 
postural balance and manual reaction time. 
A randomized, controlled pilot study
Hegem an J, Nienhuis B, van den Bem t B, W eerdesteyn V, van Lim beek J, Duysens J: 
The effect of a non-steroidal anti-inflammatory drug on two important predictors 
for accidental falls: Postural balance and manual reaction time. A randomized, 
controlled pilot study. Hum MovSci 2011, 30: 384-395.
Abstract
Accidental falls in older individuals are a major health and research topic. Increased 
reaction time and impaired postural balance have been determined as reliable predictors 
for those at risk of falling and are important functions of the central nervous system (CNS). 
An essential risk factor for falls is medication exposure. Amongst the medications related 
to accidental falls are the non-steroidal anti-inflammatory drugs (NSAIDs). About 1-10% of 
all users experience CNS side effects. These side effects, such as dizziness, headaches, 
drowsiness, mood alteration, and confusion, seem to be more common during treatment 
with indomethacin. Hence, it is possible that maintenance of (static) postural balance and 
swift reactions to stimuli are affected by exposure to NSAIDs, indomethacin in particular, 
consequently putting older individuals at a greater risk for accidental falls. The present 
study investigated the effect of a high indomethacin dose in healthy middle-aged individuals 
on two important predictors of falls: postural balance and reaction time. Twenty-two healthy 
middle-aged individuals (59.5±4.7yrs) participated in this double-blind, placebo-controlled, 
randomized crossover trial. Three measurements were conducted with a week interval 
each. A measurement consisted of postural balance as a single task and while concurrently 
performing a secondary cognitive task and reaction time tasks. For the first measurement 
indomethacin 75mg (slow-release) or a visually identical placebo was randomly assigned. 
In total, 5 capsules were taken orally in the 2.5 days preceding assessment. The second 
measurement was without intervention, for the final one the first placebo group got 
indomethacin and vice versa. Repeated measures GLM revealed no significant differences 
between indomethacin, placebo, and baseline in any of the balance tasks. No differences 
in postural balance were found between the single and dual task conditions, or on the 
performance of the dual task itself. Similarly, no differences were found on the manual 
reaction time tasks. The present study has shown that a high indomethacin dose does not 
negatively affect postural balance and manual reaction time in this healthy middle-aged 
population. Although the relatively small and young sample limits the direct ability to 
generalize the results to a population at risk of falling, the results indicate that indomethacin 
alone is not likely to increase fall risk, as far as this risk is related to abovementioned 
important functions of the CNS, and not affected by comorbidities.
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Introduction
Accidental falls have becom e a com m on occurrence in older individuals. Many 
risk factors and predictors for falling have been defined. One essential risk factor 
for falls is m edication exposure. M edications linked to accidental falls in older 
individuals include benzodiazepines, vasodilators, antidepressants, and 
non-steroidal anti-inflammatory drugs (N SA ID s) [1-5], A  m oderate proportion of 
the older individuals are exposed to N SA ID s. This population is at increased risk 
of adverse effects [6,7] such as gastrointestinal and central nervous system  
(CN S) problems. The latter have been observed during in about 5 %  of the patients’ 
treatment with all NSA ID s, but their effects are more com m on during treatment 
with indom ethacin [8], Most com m only reported com plaints are dizziness, 
headaches, drowsiness, mood alteration, and confusion [9],
After reviewing postural balance and drug response, Sw ift [10] concluded 
that postural sway appears to be a m oderately sensitive indicator of the central 
sedative effects for a variety of drugs. As impaired balance and increased reaction 
time are important predictors for falls [11], use of N SA ID s m ay consequently put 
older individuals at a greater risk for accidental falls. A  recent system atic review 
dem onstrated that there is indeed a tendency towards an increased risk for falling 
in older individuals using N SA ID s [12], However, the evidence from previous 
ep idem iological research is not conclusive and only provides information on 
associations rather than causa l relationships. Although three experimental 
studies investigated the effect of indom ethacin on reaction time and postural 
balance [13-16], the results are inconsistent. Som e of the d iscrepancies may be 
related to the selection of outcom e m easures, and to the populations and 
indom ethacin doses that were studied. Therefore, there is a need to reinvestigate 
this question studying reaction time and postural balance, using more reliable 
outcom e m easures, and the highest dose of indom ethacin ever studied in similar 
research. This randomized controlled trial studied the effect of a high indomethacin 
dose in healthy m iddle-aged individuals on two important predictors of falls: 
postural balance and reaction time. B ased  on the results of previous research we 
hypothesized that indom ethacin will impair both postural balance and manual 
reaction time.
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Methods
Participants
Twenty-two persons (mean age 59.5±4.7 years) volunteered to participate In this 
study. Volunteers were recruited from several hobby clubs In the Nijm egen region 
(NL). Inclusion criteria were the absence  of any known serious neurological, 
orthopaedic, or cognitive dysfunction; age between 50-70 years, and no use of 
any N SA ID  In the 3 days prior to the m easurem ent day. Participants were excluded 
If they suffered from conditions considered a contra-indication for exposure to 
Indom ethacin, had hearing problems, had poor know ledge of Dutch, had a 
bodywelght In excess of 100 kg, or used any (prescribed) m edication that 
Interfered with Indomethacin, postural balance or reaction time. All participants 
provided written Informed consent In acco rdance  with the Declaration of Helsinki. 
This study w as approved by the regional eth ics com m ittee of Arnhem  and 
Nijm egen, and the Dutch Com petent Authority.
Figure 1 shows a flow diagram  displaying the progress of all participants 
through the trial. Indom ethacin w as randomly allocated to 12 participants for the 
first m easurement. One participant dropped out before the first m easurem ent 
due to adverse effects of Indomethacin. Another participant, assigned to placebo, 
declined without reason to further participation prior to the first m easurement. Of 
the remaining 20 participants (nine fem ales; m ean age 60±4.6 years), eight 
reported side effects when exposed to Indomethacin, one of them also reported 
a headache  when exposed to the placebo. Drowsiness, headache, and nausea 
were mostly reported. The perform ance of the participants with side effects did 
not differ from those without reported side effects.
Seven  participants used prescribed m edication besides the study medication 
and were all accustom ed to It. A  list of m edication used by these participants Is 
presented In Table 1. A  pharm acist determ ined that none of these m edications 
were considered to lead to problem s of any kind when taken sim ultaneously with 
Indomethacin.
Study protocol
A crossover design (Figure 2) w as selected for this double-blind, randomized, 
placebo-controlled pilot study. Three m easurem ents were planned with a week 
Interval each to com pletely w ash  out the m edication before the next measurement. 
Each  m easurem ent consisted of a set of balance tasks, as well as a sim ple and 
cho ice  manual reaction time task. Betw een and within participants, the sequence
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Figure 1 Flow chart showing the progress of all participants through the trial
Table 1 Medication used by participants In the study
N = number of participants using medication from this medication class
Medication class N Name (ATC-code)
Proton pump inhibitors 1 Lansoprazol (A02BC03)
Blood glucose lowering drugs, excl. insulin 1 Metformin (A10BA02), tolbutamide 
(A10BB03)
Platelet aggregation inhibitors, excl. 
heparin
1 Acetylsalicylic acid (B01AC06)
Diuretics 1 Hydrochlortiazide (C03AA03)
Beta blocking agents, non-selective 2 Propanolol (C07AA05)
Beta blocking agents, selective 3 Metoprolol (C07AB02)
Selective calcium channel blockers with 
mainly vascular effects
2 Amlodipine (C08CA01)
ACE inhibitors, plain 2 Lisinopril (C09AA03)
Angiotensin II antagonists, plain 1 Losartan (C09CA01)
Lipid Modifying Agents, plain 3 Simvastatine (C10AA01), Atorvastatine 
(C10AA05)
Anti-thyroid preparations 1 Carbimazole (H03BB01)
Adrenergics and other drugs for 
obstructive airway diseases
1 Salmeterol/fluticason (R03AK06)
of tasks (balance or reaction time) w as randomized. In order to eliminate learning 
effects, training for all tasks w as performed prior to the first measurement. 
Thereafter, Intake of Indom ethacln or p lacebo for the first m easurem ent w as 
random ly assigned (http://www.randomlzatlon.com, second  generator with 
random permutations) by a pharm acist and w as kept concea led  until all 
m easurem ents and ana lyses were finished. Hence, both participants and 
researcher were blinded for the assigned Intervention sequence  throughout the 
whole study.
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Indom ethacin 75 mg slow-release or a visually identical p lacebo with similar 
flavor (capsule consisted of lactose) w as taken orally tw ice daily (in the morning 
and evening). Considering the half-life of normal release and slow-release 
indom ethacin, we chose the slow-release form in order to limit the number of 
capsu les the participants had to take, but still reach the desired level in the blood. 
The participants started their intake in the morning 2 days prior to the measurement 
day, taking the final capsule  on the morning of the m easurement, in total five 
capsu les in 2.5 days. To prevent gastro-intestinal problems, all participants were 
provided with three tablets of esom eprazol 20 mg to be taken sim ultaneously with 
the capsule in the morning.
As shown in Figure 2 a baseline m easurem ent, without any intervention, w as 
done one w eek later. In this paper, the term baseline is used to describe the 
m easurem ent that w as done without intervention. For the final m easurement, the 
participants that were allocated to indom ethacin for the first m easurem ent 
received the p lacebo capsu les and vice versa. The participants returned their 
em pty capsu le  containers on the m easurem ent day.
Figure 2 Cross-over design
r ---------------î
1 week
Balance tasks: Equipment and procedure
Ba lan ce  assessm ent w as conducted using a firmly secured force platform 
(custom made), consisting of two separate aluminum plates, each  p laced on 
three force transducers that recorded the vertical ground reaction forces. Six 
DC-amplifiers processed  the force signals which were passed  through first-order 
low-pass filters (cut-off frequency 30 Hz). Then the signals were amplified and
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stored on a personal com puter after a 16-bit AD-conversion with a sampling rate 
of 500 Hz. Digital moment-of-force calculations were used to determine the virtual 
center of ground reaction forces (Center of Pressure [CO P]) in the two-dimensional 
transverse plane for each sam ple. The maximum error w as ±1 mm in both 
anterior-posterior (AP) and lateral (LAT) direction.
The participants stood barefoot on the force platform with their arms hanging 
alongside the trunk and their feet against a fixed foot frame. In this frame the 
medial sides of the heels were 8.4 cm apart and each foot w as toeing-out at a 9o 
angle from the sagittal midline (Figure 3A). The instruction w as to stand as still as 
possib le while performing five basic tests, four of which were repeated with a dual 
task. In test 1 and 2 the participants stood on both legs either with eyes open (EO ) 
or eyes closed (EC ). In test 3 they stood only on one leg (the preferred one). In 
tests 4 and 5 the participants stood on a compliant surface (4.5 cm foam), with 
either eyes open or eyes closed. Except for the last test, the tests were also 
performed in conjunction with a cognitive task (an auditory Stroop task [17] with 
an interstimulus interval of 1.5 s; the dual task condition).
A  com puter screen w as p laced at eye level, 1 m in front of the participant, 
visualizing the C O P  in between the balance tasks. Participants were deprived of 
visual feed back throughout the recording of every balance task. For the dual task 
condition an integrated 16-bit sound card and two external speakers were used. 
This task required participants to listen to the words “ high” or “ low” in Dutch, 
presented in either a high or low pitch and to verbally indicate which tone was 
presented as soon as possible (at most 18 times per balance condition). The 
answers were registered by the researcher. Before the balance m easurements, 
the cognitive task w as practiced until the participant felt com fortable with it while 
in a standing position without paying attention to balance.
The C O P  signals were passed through a digital, low-pass filter (zero phase 
Butterworth, cut-off frequency 6 Hz). Consecutively, the root mean square (RM S) 
values of C O P  amplitude and velocity were computed in both A P  and LAT direction. 
The R M S C O P  velocity w as selected as the primary measure of postural balance in 
each direction of body sway, since it has been shown that this measure is more 
reliable than the R M S C O P amplitude [18,19], C O P  fluctuations during each condition 
were recorded for 30 s, except forthe one-legged stance; in that condition fluctuations 
were recorded for 15 s. The first 5 s were always excluded from the analysis to remove 
any undesired starting effects. Each of the balance tasks was performed twice; the 
second recording with the sequence in reversed order to exclude the influence of 
fatigue. For each task, the mean R M S value w as included in the statistical analysis.
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Manual reaction time task: Equipment and procedure
The equipm ent consisted of a  button box with one b lack  hom e button and five 
orange target buttons (Figure 3B). Pa ssed  through a C I0-D I024/CTR3 interface, 
m ade by Com puter Boards Inc., the button box w as connected  to a personal 
computer. S ignals  were p rocessed  using the internal 10Mc crystal generator, 
which resulted in a  maximum error on the reaction time of 0.1 ms.
Figure 3 Experim ental setup. A. Force platform. C O P  = Center of Pressure.
B. M anual reaction tim e tasks (simple: 1 target button (b lack 
circle), choice: 3 target buttons (white circle))
A.
B.
Sim ple and cho ice  manual reaction time tasks were perform ed. Participants 
held their preferred index or m iddle finger on the hom e button and as soon as the 
light in the target button sw itched on, they had to press the target button as 
quickly as possible. W hen  they were too fast (<150 ms), too slow  (>1000 ms) or 
m ade a  failure, a  short beep rem inded them  to return to the home button. The 
failed trial w as repeated at the end of the sequence. The sim ple task  consisted of
93
15 trials with a single target button; the choice task com prised a total of 45 trials 
with three target buttons (Figure 3B). Each  task w as performed twice; the second 
series in reversed order, again to exclude the influence of fatigue. Reaction time 
(time between switching on of the target light and releasing the home button) as 
well as m ovem ent time (time between releasing the home button and pressing 
the target button) were recorded in m illiseconds. For both tasks, the median 
reaction time (RT) and m ovem ent time (MT) were included in the statistical 
analysis.
Statistical analysis
Repeated  m easures G LM  with post hoc paired t-test were carried out in S P S S ®  
(version 12.0.1) to assess  the effect of experimental condition on postural balance, 
dual task perform ance, as well as manual reaction time. Experim ental condition 
(indom ethacin, placebo, or baseline) w as a within-subjects factor and sequence 
(start crossover with indom ethacin or p lacebo) as between-subjects factor. The 
level of sign ificance w as set at .05.
Previous research on the effect of indomethacin on postural sway in a task 
with eyes open indicated increm ents of 21% [15] and 34%  [16], H ence it w as 
decided  that an increase of 25%  in sway would be relevant. Prior data indicated 
that the difference in R M S  velocity of postural sway in a task with eyes open 
between m atched pairs is normally distributed with standard deviation of 2.5 
mm/s. If the true difference in the m ean sw ay between indom ethacin and p lacebo 
w as 2 mm/s, we needed to study 18 participants in this cross-over design to be 
able to reject the null hypothesis that there w as no difference in postural sway 
between these two experimental conditions ((3=0.9, oc=0.05).
Results
Balance tasks
Table 2 sum m arizes the results of all balance tasks, both in the single and dual 
task condition, and presents the m ean va lues of the R M S  C O P  velocity (mm/s) in 
A P  and LAT direction. Note that in the tasks where nearly significant differences 
were found, postural sway in the indom ethacin condition w as always less than in 
the p lacebo and baseline condition. Moreover, most of the differences found are 
within the maximum m easurem ent error of 1 mm and are therefore of little clinical 
relevance. Repeated  m easures G LM  revealed only a main effect of experimental
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condition on the C O P  velocity of the LAT direction of the one-legged stance 
balance task in the dual task condition, F217 =10.87, p = 0.002. As shown in Table
2, significant d ifferences in postural sway, mostly in the A P  direction, were found 
between the single and dual task condition. These differences were uniform 
acrossthe  experimental conditions. No interaction effects (sequence*experim ental 
condition; highest F217= 3.31, p>0.05) or between-subjects effects (sequence) 
were found (highest F1ig =3.46, p>0.05) on all balance tasks.
Figure 4 illustrates the similarity between the experimental conditions for the 
two most difficult tasks, nam ely stance on one leg (4A) and stance on both legs 
on a com pliant surface (4B). The other tasks yielded similar results. Note in Figure 
4B that the EC  task always resulted, as expected, in higher C O P  velocities. In all 
conditions the C O P  velocity w as significantly larger with eyes c losed  and when 
standing on com pliant surface (p<0.001). This difference w as present both for 
the A P  and the LAT directions. However, the differences between EO  and EC  
tasks and on the normal and com pliant surface were uniform across the 
experimental conditions (Table 2).
The data of one participant were excluded from the secondary  cognitive task 
itself. Analysis of this participant’s perform ance showed that all incongruent 
(voice pitch and word do not match) stimuli were answered incorrectly in each 
experimental condition, even though this participant had confirm ed that the 
intention of the task w as clear. Repeated  m easures G LM  revealed no main effect 
of experimental condition in the percentages of correct answers given (highest 
F 2je=1.57, p > 0.2) of the remaining 19 participants. On average, they correctly 
answered on 95%  of the stimuli. This w as similar for all balance tasks (p > 0.3).
Manual reaction time task
Repeated  m easures G LM  yielded no main effect of experimental condition on 
both sim ple (F217= 0.58, p = 0.57) and choice {F217= 0.06, p = 0.94) reaction time 
tasks. No interaction {F217= 0.05, p = 0.96) or between-subjects {F118= 0.76, 
p = 0.39) effects were found. In other words, indom ethacin did not affect reaction 
time. Regard less of the experimental condition a within-subjects effect w as found 
between the sim ple and cho ice reaction time task (p<0.02). Both RT and MT were 
significantly longer in the choice than in the sim ple reaction time task (p<0.05).
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Figure 4 Population characteristics
A. Stance on 1 leg with eyes open; comparison between single and dual task. B. Stance 
on 2 legs on a compliant surface; comparison between eyes open and eyes closed. Bars 
represent mean (± SD) COP Velocity. ST = Single Task, DT = Dual Task, EO = Eyes 
Open, EC = Eyes Closed, LAT = Lateral direction, AP = Anterior-Posterior direction. 
*: significant difference EO-EC (p<0.001) #: significant difference single-dual task (p<0.05)
One leg, firm surface
60
I
□  ST LAT
□  DT LAT 
ZJ ST AP
W 60 
cc
ill
Indomethacin Placebo Baseline
Two legs, compliant surface
□  EO LAT
r □  EC LAT
□  EO AP
*_ —  m  EC AP
i i i
Indomethacin Placebo Baseline
Experimental condition
Discussion
This study investigated the effect of a high indomethacin dose on postural balance 
and reaction time in healthy middle-aged individuals, in the context of a possible link 
between NSAID  exposure and an increased risk for accidental falls. W e  discovered 
no negative effect of indomethacin on either one of these C N S  functions.
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The present study was a double-blind, placebo-controlled randomized controlled 
trial (RCT), the results of which provide a high level of evidence for therapeutic 
interventions [20], Given that there were no significant relevant interactions or 
between-subjects (sequence) effects, the randomization appeared to have been 
successful. Due to the crossover design every individual participated in all 
experimental conditions. Hence, correction was made for possible confounders such 
as age, gender, physical condition, and medication exposure. Another aspect of the 
strong methodology of our study was the fact that the participants were healthy 
middle-aged individuals. Even though most literature on falls describes populations 
of older individuals (>75 years), we deliberately chose to use middle-aged persons 
for our study. This group is known to use the type of medication under investigation. 
Furthermore, due to their age, this group of individuals was already more sensitive to 
m edications [21], yet they did not suffer from possible (serious) comorbidities that 
com e with increasing age. Older individuals are more sensitive to medication as well. 
Hence, the current results might be applicable to an older population as long as fall 
risk increasing comorbidities are absent.
Postural balance
The present study revealed only a small effect of indom ethacin on postural 
balance, mainly during quiet stance with eyes c losed  on the firm surface. However, 
on all tasks there w as a trend of decreased  postural sway for the indomethacin 
condition, both in the LAT and the A P  direction. This is in contrast to our 
expectations and to previous studies on indom ethacin and postural balance. [15] 
studied 15 patients with rheumatoid arthritis. They m easured body sway in the A P  
and LAT direction with eyes open and closed, after administration of indomethacin 
(2 days 3x25 mg followed by 1 day 3x50 mg). In com parison to placebo, a clear 
increase in body sway during quiet stance with eyes c losed  w as found. However, 
these authors m entioned that this could be a chance  finding since indom ethacin 
could not be detected in p lasm a at baseline. In contrast, effects of indomethacin 
on postural balance in the present study are largely in line with the findings 
reported by Telekes et al. [16], They performed a double-blind, randomized 
crossover study in 12 volunteers (aged 21-36) and concluded that a single dose 
of 50 or 100 mg indom ethacin does not significantly affect anteroposterior body 
sw ay during 60 s quiet stance with eyes closed. These negative results are fairly 
robust, especia lly  since acute studies of ana lges ics on healthy volunteers appear 
to overestim ate rather than to underestim ate the detrimental effects of ana lges ics 
on perform ance [15], Furthermore, the present study administered, in healthy
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middle-aged individuals naïve to this drug, the highest dose of indom ethacin ever 
studied in postural balance. In contrast to previous research, the present study 
assessed  postural balance both as a single task and while a concurrent secondary 
cognitive task w as performed. A  concurrent secondary task can interfere with the 
visual, vestibular, and proprioceptive regulation of postural balance. Both 
increased [22] and reduced [23] sway am plitudes have been reported when 
attention w as redirected from balance control towards a secondary cognitive 
task, indicating that the ability to maintain balance or a postural task involves 
additional attentional dem ands [24-27], Moreover, it has been shown that age 
differences in balance abilities are magnified by a concurrent cognitive task 
[27-29], Hence, this implies that the dual task paradigm  is useful to detect 
changes in postural sway. The present study showed neither significant balance 
changes between the experimental conditions while performing the Stroop task 
nor changes on the perform ance of this secondary  cognitive task itself. Therefore, 
we conclude that indom ethacin does not affect this aspect of cognitive functioning.
It may be argued that the lack in difference between tasks w as due to the lack 
of sensitivity in the m easurem ent method. However, the m ethods used have been 
sensitive enough to reveal all the expected differences between the balance 
tasks. The increase in C O P  velocity found w as in the sam e range as that reported 
in previous studies [18,19,30], Similarly, the observed increase in EC  as com pared 
to the EO  condition is com pletely consistent with former experiments [18,30],
Considering the above m entioned evidence on the sensitivity of postural 
testing, our conclusion is that indom ethacin itself does not negatively affect 
postural balance, even in more challenging situations such as performing a 
secondary  cognitive task or standing on a compliant surface. This implies that at 
least the physiological system s involved in these tasks have not been affected. 
These also include cognitive functioning.
The fact that som e participants reported feeling dizzy and lethargic when 
exposed to indom ethacin rem ains unexplained. Perhaps indom ethacin affects 
system s which would not be used to perform the present tasks, sensitive as they 
may be. For example, the current tests all involve only maintaining static balance 
w hereas in daily life one encounters m any situations requiring m aintenance of 
dynam ic balance. The latter involves m atching visual and vestibular information; 
it is conce ivab le  that indom ethacin selectively affects the integration of information 
from these sensory sources. Another possibility is that there is interference with 
system s detecting self-motion 15,31,32], Hence, it would be interesting to include 
dynam ic balance tests in future studies on indomethacin.
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Manual reaction time
The present study revealed no effect of Indom ethacln on manual reaction time. 
Previous research studying the effect of Indom ethacln on reaction times reported 
contrasting results. Llnnolla et al. [14] studied choice reaction time (CRT) In 20 
students exposed to a single dose of 50 mg Indom ethacln and com pared them 
with 30 m atched Individuals who took a p lacebo drug. The Indom ethacln group 
showed a significant prolongation of the cumulative C RT  (p < 0.05). In contrast, 
B ru ce- Jones [13] revealed a decrease  In C RT  on Indom ethacln to a maximum of 
6 .62%  below baseline before dosing, as well as a significant difference In RT 
between Indom ethacln and placebo. They tested 20 Individuals (>55 years) In a 
double-blind, placebo-controlled crossover study on C RT  after administration of 
25 mg Indom ethacln or m atched p lacebo three tim es dally for 7 days. The present 
results, based on the Intake of 75 mg Indom ethacln tw ice dally for 2.5 days, are 
again c losest to the findings of Telekes et al. [16], They assessed  reaction time In 
Individuals exposed to a single dose of 50 or 100 mg Indom ethacln In a 
com parab le  m anner as the present study, and again no significant effect of this 
drug com pared to p lacebo w as found.
For this parameter, the possibility of lack of sensitivity In the m easurem ent 
method can be excluded by the fact that our m ethods were sensitive enough to 
reveal the expected differences between the tasks assessed . Both reaction time 
and m ovem ent time were higher In the cho ice  than In the sim ple task. Therefore, 
we feel justified In concluding that high doses of Indom ethacln do not affect 
m anual reaction time In healthy m iddle-aged Individuals.
Limitations
Earlier research on the effect of m edications on the risk of falling mostly have 
studied older Individuals (>75 years of age). Therefore, the participation of healthy 
m iddle-aged Individuals In this study could be considered to limit the value of this 
study. However, a major limitation of m any of the previous studies on falls In the 
elderly Is the lack of proper correction for confounding. Therefore It Is difficult to 
focus on single factors associated  with falling. By  m eans of using a cross-over 
design and a healthy m iddle-aged sam ple we corrected for possib le confounders 
and focused on the effects of a single drug, Indomethacln, which represented the 
group of NSA IDs.
Another limitation could be the relatively small sam ple size. Yet It Is unlikely 
that a larger sam ple size would have yielded other results. Moreover, If a significant 
difference were to be found In a larger sam ple size with the direction of Intervention
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effect identified in this study, use of indom ethacin would result in less postural 
sway, implying better postural balance.
A  factor that might have influenced the perform ance of som e participants is 
the occurrence of side effects from indom ethacin exposure. S in ce  we used a high 
daily dose for 2.5 days, the possibility that these side effects might have unblinded 
participants cannot be ruled out. On the other hand, this elem ent is not 
unequivocal since there were also com plaints by one participant when taking a 
placebo.
There might be limitations in the tests currently being used. Therefore, for 
future studies, it would be an advantage to use tests, proven sensitive enough to 
assess  other functions of the C N S , involving behavior that is relevant to stumbles 
and falls. O ne such condition, currently under investigation, is the ability to avoid 
obstacles during walking. Such  conditions have been used to test for ana lgesic 
effects in patients with osteoarthritis [33] but not to test reaction time to a sudden 
obstacle, required to avoid falls.
Conclusion
The present study has shown that a high indom ethacin dose does not negatively 
affect postural balance and manual reaction time in a population of healthy 
m iddle-aged individuals. The relatively young sam ple limits the generalizability of 
these results to a larger population, especia lly  those at risk of falling. However, 
our m iddle-aged population is known alreadyto  be more sensitive to medications, 
which is also the case  in an older population. Therefore we suggest that 
indom ethacin alone is not likely to increase fall risk in an older population, as far 
as this risk is related to above mentioned important C N S  functions, and not 
affected by comorbidities.
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CNS effects of indomethacin, should patients really 
be cautioned about decreased mental alertness and 
motor coordination?
Hegeman J, van den Bemt B J, Weerdesteyn V, Nienhuis B, van Limbeek J, Duysens J: 
CNS-effects of indomethacin, should patients really be cautioned about 
decreased mental alertness and motor coordination? Submitted
Abstract
CNS (central nervous system) side effects are observed in about 5% of the patients treated 
with NSAIDs (non-steroidal anti-inflammatory drugs), but these effects are more common 
during treatment with indomethacin compared to other NSAIDs. In many European 
countries as well as in the USA, the leaflet or even the packaging of indomethacin contains 
a specific warning to refrain from activities requiring mental alertness and motor 
coordination, such as driving a car. In this placebo-controlled randomized study with 
cross-over design we attempted to find evidence for the above mentioned warning. 
Indomethacin 75mg slow-release or a visually identical placebo with similar flavor was 
taken in orally twice daily for 2.5 days. It was suggested that indomethacin affects the 
motor coordination required to successfully avoid obstacles during walking and that this 
effect will be even stronger when simultaneously performing a cognitive task puts mental 
alertness to the test. Nineteen healthy middle-aged individuals (60±4.7years, 8 female) 
were subjected to an obstacle avoidance task on a treadmill (walking velocity 3 km/hr), 
combined with a cognitive secondary task. Fast stepping adjustments were required to 
successfully avoid the obstacle, which was suddenly dropped on the treadmill. Both 
response times of the biceps femoris (BF, prime mover involved in avoidance reaction), 
measured by electromyography, and avoidance failure rates were assessed. No differences 
between indomethacin and placebo were found on the outcome measures regarding motor 
coordination, avoidance failure rates (p=0.81) and BF response times (p=0.47), nor on the 
performance on the secondary cognitive task (p=0.12). The present study showed that 
tasks which demand maximum attention remain unaffected by a high dose of indomethacin 
despite the frequently reported CNS side effects such as dizziness, drowsiness and 
headaches. A high dose of indomethacin did not affect capabilities deemed essential for 
safe walking in healthy senior individuals. Hence, the current study provides evidence to 
suggest that there might be no need to caution patients who experience CNS side effects 
after indomethacin use to avoid activities requiring quick and adequate reactions, such 
walking under challenging circumstances and maybe also driving a car.
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Introduction
The prevalence of pain In the elderly Is high. It Is estimated that over 5 0 %  of the 
elderly living at home suffer from pain, a percentage which Increases to 8 0 %  In 
long-term care patients [1,2], W hen  paracetam ol Is Insufficient to reduce the pain, 
N SA ID s (non-steroidal antl-lnflammatory drugs) are often prescribed as analgesic. 
A s a result of that, It Is estimated that over 10% of all elderly used a N SA ID  In the 
past 24 hours [3],
Although N SA ID s have proven to be effective In several Inflammatory diseases, 
their use Is often accom pan ied  with various adverse effects such as gastro intes­
tinal, respiratory, renal and central nervous system  (CN S) problems. More 
specifically, these C N S  problem s are observed In about 5 %  of the patients using 
N SA ID s [4], Most com m only reported problem s are dizziness, headaches, 
drowsiness, mood alteration, and confusion [5], The extent of C N S  side effects 
differ between the availab le N SA ID s with a relatively high prevalence with 
Indom ethacin [4], Therefore, In many European countries as well as In the USA , 
Com petent Authorities and/or pharm aceutical com panies put a specific warning 
In the leaflet or even on the packag ing of Indom ethacin. This warning Implies that 
If a user experiences C N S  effects that affect physical or mental capabilities, It Is 
d iscouraged to engage oneself In activities such as driving a car or operating 
machinery. These activities require mental alertness and motor coordination for 
quick and adequate responses,. However, the scientific basis for this warning 
remains unclear as published studies on C N S  effects of Indom ethacin on such 
com plex activities are am biguous.
Tests m easuring postural sw ay during quiet standing tasks can easily be used 
and serve as a m oderately sensitive Indicator of the C N S  effects for a variety of 
drugs [6], Postural balance Is an Important function of the C N S  and Is often 
assessed  using force plates to m easure vertical ground reaction forces during 
quiet standing. Increases In postural sway during quiet standing are usually 
Interpreted as Impaired balance control and have been determ ined as a reliable 
predictor for those at risk of falling [7], In the latest system atic review on N SA ID s 
and falls It w as shown that an Increased risk for accidental falls Is probable when 
elderly Individuals are exposed to N SA ID s [8], However, a recent randomized 
clinical trial dem onstrated that a high dose of Indom ethacin did not affect postural 
sway during quiet standing In healthy senior Individuals, despite the fact that 40%  
of the participants reported C N S  side effects [9],
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As a more complex activity, walking Is considered to require more mental 
alertness and motor coordination than ‘sim ply’ keeping balance during quiet 
standing. Particularly, walking becom es even more complex when circum stances, 
such as uneven or unknown terrain or having a conversation, make It more 
challenging. Hence, It might be more useful to assess complex walking abilities to 
test for C N S  side effects of N SA ID s related to falls. O bstacle avo idance during 
walking, for Instance, Is a task known to be sensitive enough to detect differences 
between different age groups or fallers and non-fallers [10,11], In addition, previous 
research In seniors showed that divided attention [12] or even low alcohol 
consumption [13] significantly Increased the risk of hitting an unexpected obstacle 
during walking due to delayed and weaker avo idance responses. For C N S  effects 
are a well-known consequence of alcohol consumption we expected that a high 
dose of Indomethacln could ham per obstacle avoidance skills In a similar way.
In this placebo-controlled randomized study In healthy seniors we assessed  
the effect of a high dose of Indom ethacln on mental a lertness and motor 
coordination to find evidence for the label warning of Indom ethacln affecting 
these skills. Therefore, the present study Investigated (1) whether Indom ethacln 
affects motor coordination when obstacles have to be avoided during walking, (2) 
whether this effect, If present, would be enhanced by the secondary cognitive 
task, and (3) If a high dose of Indom ethacln Impairs the perform ance on the 
cognitive task.
Methods
Study design
A crossover design w as selected for this double-blind, randomized, placebo- 
controlled study. Intake of Indomethacln or placebo for the first measurement was 
randomly assigned by a pharmacist and was kept concealed until all measurements 
and ana lyses were finished. Indom ethacln 75mg slow-release or a visually 
Identical p lacebo with similar flavor w as taken In orally tw ice dally. The choice for 
a slow-release form limited the number of capsu les the participants had to take, 
while still reaching the desired level In the blood. The participants started their 
Intake In the morning 2 days prior to the m easurement day, taking the final capsule 
on the morning of the m easurem ent, In total 5 capsu les In 2.5 days. To prevent 
gastro-intestinal problems, all participants were given esom eprazol 20mg to be 
taken sim ultaneously with the capsule  In the morning. The participants returned
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Figure 1 Flowdiagram  of all participants throughout the study
1 week
Indomethacin (n =  11 ) Placebo (n =
Indomethacin (n=9) Placebo (n =  10)
Lost to follow-up: 
Discontinued intervention 
due to adverse effects
(n=1)
Lost to follow-up: 
Discontinued intervention 
due to decline to 
participation (n=1)
Indomethacin (n = 19) Placebo (n = 19)
their em pty capsu le  containers on the m easurem ent day. The m easurem ents 
were planned with a w eek Interval each  to com pletely w ash out the m edication.
Participants
A group of 21 healthy senior Individuals (mean age 60±4.8 years, 12 male) w as 
enrolled In this study. W e  Included volunteers aged between 50-70 years.
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Participants were excluded if they suffered from serious neurological, orthopedic 
or cognitive impairments, hearing problems, had poor knowledge of Dutch, or 
used m edication that affected the locom otor system  or interfered with 
indom ethacin. All participants provided written informed consent in acco rdance  
with the Declaration of Helsinki. This study w as approved by the regional ethics 
com m ittee of Arnhem  and Nijm egen, and the Dutch Com petent Authority.
Seven participants used prescribed medication besides the study medication 
and were all adapted to it (Table 1). A  pharmacist decided that simultaneous use 
of indom ethacin and these m edications would have no consequences for either 
the user or the experiment.
Table 1 M edication used by participants in the study 
N = number of participants using medication from this medication class
Medication class
Proton pump inhibitors
Blood glucose lowering drugs, excl. insulin
Platelet aggregation inhibitors, excl. 
heparin
Diuretics
Beta blocking agents, non-selective
Beta blocking agents, selective
Selective calcium channel blockers with 
mainly vascular effects
ACE inhibitors, plain
Angiotensin II antagonists, plain
Lipid Modifying Agents, plain
Anti-thyroid preparations
Adrenergics and other drugs for 
obstructive airway diseases
N Name (ATC-code)
1 Lansoprazol (A02BC03)
1 Metformin (A10BA02), tolbutamide 
(A10BB03)
1 Acetylsalicylic acid (B01AC06)
1 Hydrochlortiazide (C03AA03)
2 Propanolol (C07AA05)
3 Metoprolol (C07AB02)
2 Amlodipine (C08CA01)
2 Lisinopril (C09AA03)
1 Losartan (C09CA01)
3 Simvastatine (C10AA01), Atorvastatine 
(C10AA05)
1 Carbimazole (H03BB01)
1 Salmeterol/fluticason (R03AK06)
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Measurements
O bstacle  avo idance task
The participants were subjected to an obstacle  avo idance task on a treadmill 
(walking velocity 3km/hr, Figure 2A, inset), wearing their own com fortable low- 
heeled shoes. A  wooden obstacle (m easuring 40x30x1.5cm) with an em bedded 
p iece of iron w as held by an electrom agnet just above the treadmill surface and it 
w as released by a trigger from the computer. The obstacle  w as only released 
when a regular walking pattern (= a maximum difference of 50ms between two 
consecutive steps) w as observed  and until at least five normal strides for the trial 
had been com pleted. The obstacle w as suddenly dropped on the treadmill in 
front of the left foot leaving only 150-550ms to react. Stepping to the side w as 
d iscouraged, and any contact of the left foot with the obstacle w as defined as a 
failure. Avo idance failure rates were assessed  using visual inspection. Surface 
electrom yography (EM G ) data were collected from the m. b iceps femoris (BF, a 
prime m over involved in the avo idance reaction [14]) to asse ss  avo idance 
response tim es [14], B F  response tim es were determ ined as the time between 
obstacle  release and the moment at which B F  activity exceeded the average 
control stride activity by at least 2 SD s for more than 30 ms (for example, see 
Figure 2A). Se e  H egem an et al. [13] for more details concerning the obstacle 
avo idance task.
Seco n d ary  cognitive task: Auditory Stroop task [15]
The participants listened to the words “high” or “ low ” in Dutch, presented in either 
a high or low pitch. They were instructed to indicate verbally which tone was 
presented as quickly as possible. The stimulus w as congruent when the word and 
pitch m atched and incongruent when they did not. Hence, incongruent stimuli 
were most difficult. Both stimulus and response were recorded synchronously 
with the data of the obstacle  avo idance task.
Experimental protocol
Both the obstacle  avo idance task and the cognitive task were practiced before 
the experiment started. Five obstacle avo idance practice trials were performed, 
and the auditory Stroop task w as practiced until the subject felt com fortable with 
it while in a standing position and during walking on the treadmill. Each  
m easurem ent consisted of four series of 15 obstacle  avo idance trials each. All 
participants performed the first and fourth series of the obstacle  avo idance task 
without cognitive task (single-task condition). The second and third series were
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A. Determination of response of the m. biceps femoris (BF). Response time was 
defined as the time between obstacle release (at Time=0) and the instant where the 
BF activity exceeded the activity of the control stride + 2SD. Inset: experimental setup.
B. Determination of verbal response time (VRT = time between the start of the stimulus 
and the start of the response) and illustration of the stimulus timings: BEFORE, 
DURING, and AFTER obstacle crossing. OR = obstacle release.
Figure 1 Methods
Tim e (m s)
stimulus
response
V RT OR
performed in conjunction with the auditory Stroop task (dual-task condition). 
Hence, each  condition (single-and dual-task) com prised 30 trials. The participants 
were instructed not to prioritize any of the tasks, but to try their hardest to perform 
both tasks as well as possible.
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Data analysis
For the obstacle  avo idance task failure rates (the number of failed trials divided 
by the total number of trials) were calcu lated for each  participant In both slngle- 
and dual-task condition of each experimental Intervention. Sim ilarly to the failure 
rates, average B F  response tim es were calcu lated for each participant as well.
Verbal response tim es (VRT) on the auditory Stroop task were calcu lated as 
the time between the stimulus onset and the response. VRTs are determ ined by 
both task characteristics (congruent or Incongruent stimulus) as well as the 
strategy used and thus speed-accuracy trade-offs have to be considered [16], 
Quick verbal responses usually Increase the risk of failures, w hereas slower 
responses often Improve the accuracy. Using a com posite score ((100xaccuracy)/ 
VRT ) [16] takes both speed and accu racy  Into account. A ccu racy  w as defined as 
the percentage correct responses given and when no response w as given this 
w as treated as a failure. Com posite scores were calcu lated for the stimuli 
presented prior to, during and just after obstacle  crossing, representing the timing 
of the secondary  task with respect to obstacle release (OR, Figure 2B). The last 
stimulus and Its response before obstacle  release, w as defined as prior to 
obstacle  crossing. If the response w as given during perturbed walking, the 
stimulus w as defined as during obstacle crossing. The first stimulus during the 
recovery from avoiding the obstacle, w as defined as just after obstacle crossing.
Statistical analysis
W e used repeated m easures ANO VAs with post-hoc pairw ise com parisons 
(S P S S ®  12.0.1: S P S S  Inc., Chicago, Illinois, U SA ) to test for d ifferences In obstacle 
avo idance outcom es (failure rates and B F  response times) and In the com posite 
scores on the secondary task. Intervention (Indom ethacin or placebo) w as set as 
wlthln-subjects factor and Seq uen ce  (start crossover with Indom ethacin or 
p lacebo) as between-subjects factor. For all ana lyses a w as set at 0.05. M eans 
for each Intervention are presented with their standard errors (SE ).
To calculate the sam ple size needed we retrieved Information from previous 
research [13], It w as shown that the average difference In B F  response tim es after 
consum ption of 2 alcoholic drinks w as 20m s (SD: 21ms) In a similar population 
[13], To be able to Identify a similar difference of 20m s In the m ean B F  response 
tim es between the Indom ethacin and p lacebo Intervention, a sam ple size of 14 
subjects would be needed In the present study ((3= 0.9, oc=0.05).
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Results
Participants
Figure 1 shows a flow diagram  displaying the progress of all participants through 
the trial. Indom ethacin w as randomly allocated to 11 participants for the first 
m easurem ent. One participant dropped out before the first m easurem ent because 
of severe nausea due to indomethacin. Another participant, assigned to placebo, 
declined further participation prior to the first m easurem ent without stating a 
reason. Of the remaining 19 participants (60±4.7years, 11 male), 8 reported side 
effects when exposed to indomethacin, one of them also reported a headache 
when exposed to the placebo. Drowsiness (n =7), headache (n=4), and nausea 
(n = 3) were mostly reported. The overall perform ance of the participants with side 
effects did not differ from those without reported side effects.
Figure 3 The effect of experimental intervention on A. the obstacle avoidance 
failure rate and B. the avoidance response times per task condition
**p<0.01: sign. diff. between single and dual task condition. Bars represent population 
mean + SE.
o
Q.
m
C D  Indomethacin 
Placebo
**
' ■ I
Single Dual
**
**
m 1
Single Dual
Task condition
114
Indomethacin, mental alertness and motor coordination
Obstacle avoidance task
The analysis revealed that obstacle avo idance failure rates were similar between 
indom ethacin and p lacebo (F117=0.06, p  = 0.81), both in the single- and dual-task 
condition (F117=0.01, p = 0.91). In the dual-task condition a significant doubling 
w as revealed in failure rates (increase from 3 %  to 6 %  on average, F117=12.6, 
p<0.01; Figure 3A), which w as similar for indom ethacin and p lacebo (F117=0.15, 
p  = 0.70).
The analysis also showed that in the single- and dual-task condition (F117=0.10, 
p  = 0.76) B F  response tim es were com parab le  between indom ethacin and placebo 
(F117=0.55, p  = 0.47). For both interventions B F  response times increased by 22 
ms on average in the dual-task condition (F117=67.4, p<0.001; Figure 3B).
Secondary task performance
The statistical analysis revealed that there were no differences between the 
com posite scores of the indom ethacin and p lacebo intervention (F117=2.73, 
p  = 0.12; Figure 4). This similarity remained present even when the task w as most 
difficult due to incongruent stimuli during obstacle crossing (F915=1.14, p  = 0.35).
Figure 4 The effect of experimental condition on the secondary  task 
perform ance stimulus per stimulus type
Congruent = word and pitch match, incongruent = word and pitch do not match. Bars 
represent population mean + SE.
o
C D  Indomethacin 
Placebo
congruent incongruent
Stimulus type
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Discussion
The present placebo-controlled randomized study Investigated the effect of 
Indom ethacln on activities that require both motor coordination as well as mental 
alertness: the avo idance of suddenly appearing obstacles during walking 
com bined with a cognitive task. The results clearly show  that Indom ethacln had 
no effect on the reaction tim es of both the primary obstacle avo idance task and 
the secondary cognitive task. This finding Is In line with the absence  of differences 
In failure rates, as reaction time Is an essential com ponent of the perform ance. 
Even In the most difficult situations no differences between Indomethacln and 
p lacebo were found.
To the best of our knowledge, the present study Is the first to assess  the effect 
of Indom ethacln on com plex attention dem anding tasks relevant to falls. Previous 
research mainly focused on psychom otor functioning [17-19], Llnnolla et al. [18] 
found that a single dose of 50 mg Indom ethacln slightly Impaired perform ance In 
driving-related attention and coordination tests such as a choice reaction time 
test, two-coordlnatlon test and a divided attention test. On the other hand, 
B ru ce- Jones et al. [17] and Saarlalho-Kere et al. [19] showed that tests of 
coordination, reactive skills, attention and psychom otor speed  remained 
unaffected after administration of Indomethacln. Recent work confirm ed these 
findings and dem onstrated that neither postural balance, nor m anual reaction 
time w as affected by a high dose of Indom ethacln In healthy seniors [9], In 
addition, the present study showed that tasks which are even more attention 
dem anding rem ained unaffected by Indom ethacln despite the frequently reported 
C N S  side effects such as dizziness, drowsiness and headaches.
Next to the effects of Indom ethacln on psychom otor functioning, previous 
research assessed  the effects of several N SA ID s on driving perform ance as well 
[20-22], Considering the Increased risk of Involvement In automobile crashes with 
N SA ID  use [20,23,24] It could be possible that C N S  side effects attribute to this. 
However, both d iclofenac and brom fenac (the latter Is w ithdrawn due to severe 
side effects [25]) were found not to Impair driving abilities [21,22], In addition, 
M cGw In  et al. [24] considered It unlikely that the crash risk could be explained by 
the Im pact of N SA ID s on cognition or psychom otor perform ance.
The current study did not assess  specific driving skills, but used a combination 
of tasks known to require motor coordination and mental alertness [12], and to be 
associated  to accidental falls [10], Sim ilar to the knowledge that driving a car 
requires full concentration In order to prevent crashes, maximum concentration
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was required to perform both study tasks simultaneously without hitting the 
obstacle. Based on the present results and our previous work [9] we therefore 
suggest that indomethacin is not expected to increase fall risk during walking in a 
senior population. Hence, the probability of an increased fall risk in elderly 
individuals exposed to NSAIDs demonstrated in our recent review [8] is very likely 
due to other (methodological) factors, such as confounding by indication.
The reported side effects after indomethacin exposure might have unblinded 
and thus influenced the participants. However, this seems unlikely since the 
performance of the participants with side effects was similar to the performance 
of the participants without side effects on all tasks. Moreover, the BF response 
times are often very fast and therefore the avoidance reaction may not be initiated 
consciously [14,26], Hence, if CNS side effects were experienced by the 
participants it seems very unlikely that this would have affected the reaction 
times.
Conclusions
A high dose of indomethacin did not affect capabilities deemed essential for safe 
walking in healthy senior individuals. Hence, the current study provides evidence 
to suggest that there might be no need to caution patients who experience CNS 
side effects after indomethacin use to avoid activities requiring quick and 
adequate reactions, such as walking under challenging circumstances or even 
driving a car.
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Unravelling the association between SSRI use 
and falls: An experimental study on risk factors for 
accidental falls in long-term paroxetine users
Hegeman J, van den Bemt BJ, Weerdesteyn V, Nienhuis B, van Limbeek J, Duysens J: 
Unravelling the association between SSRI use and falls: An experimental study 
of risk factors for accidental falls in long-term paroxetine users. Adjusted version 
accepted in Clin Neuropharmacol 2011
Abstract
SSRIs (selective serotonin reuptake inhibitors) are widely used to treat depression and are 
also associated with an increased falls risk. However, the biological mechanism underlying 
accidental falls with SSRI intake has yet to be elucidated. The present experimental study 
was designed to investigate whether obstacle avoidance skills in long-term (>90 days), 
senior paroxetine users (61 ±5.8 years) are affected during gait, simple and challenging 
postural balance tasks, as well as during manual reaction time tasks. The performance of 
the paroxetine users was compared with healthy group-matched controls (60±4.8 years). 
The results demonstrated impaired postural balance in the paroxetine users, especially 
during one-legged stance or under various dual-task conditions. Although the deficit in 
one-legged stance could indicate vestibular involvement, this was deemed unlikely since 
performance of standing on compliant surface with closed eyes remained unaffected. 
Paroxetine use also failed to affect manual reaction times or obstacle avoidance 
performance. It is suggested that paroxetine affects attentional capacities particularly in 
conjunction with balance control. Compared to healthy seniors, senior long-term paroxetine 
users appear to be at an increased risk of falling due to impairments in balance control, 
especially when attention has to be divided between two concurrent activities.
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Introduction
in 2009, 5.6% of the total Dutch population used antidepressants [1], More than 
55% of them used SSRIs (selective serotonin reuptake inhibitors); paroxetine was 
the most prescribed SSRI in over 40% of these users [1], SSRIs are now widely 
used as a first-line treatment for depression because of their relatively mild adverse 
effects, particularly because of the safety in an overdose [2], The most common 
side effects of SSRIs are of gastrointestinal nature: diarrhea, nausea, abdominal 
pain and vomiting. Less common are side effects such as headaches, hallucinations 
(both auditory and visual), dizziness or motion sickness, rashes and an altered 
sense of smell and taste. In addition, SSRIs are also associated with an increased 
falls risk [3] and this risk is of the same order of magnitude as that for tricyclic anti­
depressants (TCAs) (adjusted RR(95%CI) SSRI: 1.8(1.6-2.0), TCA: 2.0(1.8-2.2)) 
[4,5], In an attempt to gain insight into the biological mechanisms underlying the 
increased falls risk associated with antidepressants, researchers have usually 
studied short-term use or single-dose effects of antidepressants on psychomotor 
functions or simple balance skills in young or healthy adults [6-11], While the 
increased falls risk during TCA treatment is likely to be attributed to the pharmaco­
logical mode of actions of the TCAs (postural hypotension, sedation and drowsiness) 
[12], the biological mechanism underlying accidental falls associated with SSRI 
intake has not yet been elucidated. Whereas behavioral studies have failed to 
unravel this mechanism, epidemiological studies repeatedly have shown an 
increased fall risk with antidepressants primarily in older populations [3,13], 
However, the possibility of confounding factors could not be completely ruled out. 
Hence, the need for other more specific tests and behavioral studies in an elderly 
population is growing. For many years researchers have developed complex 
balance and gait tests to assess skills more relevant to falls. Furthermore, accidental 
falls are found to be associated with impaired obstacle avoidance skills during 
walking in elderly individuals [14], Thus far, only one study assessed the effects of 
antidepressants on obstructed gait in a healthy elderly group; it demonstrated that 
paroxetine did not affect the kinematics of stepping over obstacles during gait [15], 
However, it could be that the methods used (walkway experiment with a stationary 
obstacle) were not sensitive enough to reveal possible subtle effects of paroxetine.
It is expected that more specific and challenging tasks with sensitive outcomes 
relevant to falls would be helpful to unravel the association between SSRI use and 
accidental falls, thereby expanding the current knowledge of this topic. Therefore 
the present study was designed to investigate whether paroxetine affects obstacle
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avoidance skills during gait, simple and challenging postural balance tasks, and 
manual reaction time tasks in long-term (>90 days), senior users.
Methods
Participants
The participants in this study were community-dwelling paroxetine users and 
healthy controls. Participants were excluded if they suffered from serious 
neurological, orthopaedic or cognitive dysfunction, had poor knowledge of 
Dutch, or used medication other than paroxetine that affected the locomotor 
system. All participants gave their written informed consent in accordance with 
the ethical standards of the Declaration of Helsinki. The protocol was approved 
by the medical-ethical committee of the region Arnhem-Nijmegen.
Figure 1 Flow diagram of the participants in both the paroxetine and the 
control group
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Figure 1 displays a flowchart that shows the progress of all participants during 
the course of the study. For the paroxetine group three regional pharmacies 
selected clients aged 50-70 years who had been using a maintenance dose of 
paroxetine for longer than 90 days. They were sent an information letter and an 
invitation to participate in this experiment. To indicate their interest in participation, 
45 persons sent a reply card to the researcher. A questionnaire with items on 
medication use, health status and physical activity was used to assess eligibility 
for participation in the study. Of these 45 persons, eighteen were judged to be 
ineligible (neurological impairments (n=2); musculoskeletal problems (n =7), poor 
knowledge of Dutch (n=1 ), age (n=2), and use of medication that affected the 
CNS or locomotor system (n = 6)). Another two individuals declined participation 
without reason. The remaining 25 paroxetine users (mean age 61 ±5.8 years; 13 
male, Table 1) performed the whole experiment.
Table 1 Baseline characteristics of the study groups
Paroxetine Controls p-value
Gender (M:F) 13:12 12:10 -
Age (yrs) 61 (5.8) 60 (4.8) 0.32
Height (cm) 172 (11) 169 (8) 0.43
Weight (kgs) 80 (13) 74 (12) 0.13
BMI 27 (2.4) 26 (3.4) 0.18
Twenty-five group-matched for age controls were recruited from several 
regional hobby clubs. Therefore these controls were inhabitants of the same 
region as the paroxetine users. After assessment for eligibility 22 persons (mean 
age 60±4.8; 12 male, Table 1) were enrolled; three persons were excluded due to 
musculoskeletal problems (n=1) or use of medication that affected the CNS or 
locomotor system (n=2). All 22 controls performed the set of postural balance 
tasks and the manual reaction time task. Data from 19 who persons performed 
the obstacle avoidance task was obtained as data for three participants could not 
be obtained due to technical malfunctioning during the task.
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Ten pa roxe tine  use rs  and seven  con tro ls  used o the r p resc ribed  m ed ica tion  to 
w h ich  th e y  w e re  w e ll accustom ed. A  list of m ed ica tion  used by these  pa rtic ipan ts  
is p resen ted  in Table 2. A  pharm ac is t de te rm ined  tha t none of these  m ed ica tions 
w e re  cons ide red  to in dependen tly  affect the  C N S  or to lead to p rob lem s of any 
kind w ith  regard  to the  experim ent.
Table 2 M ed ica tion  used by pa rtic ipan ts  in the s tudy
C=control group, P=paroxetine group
N=number of participants using medication from this medication class.
Medication class N Name (ATC-code)
Proton pump inhibitors C 1 Lansoprazol (A02BC03)
P 1 Pantoprozol (A02BC02)
Blood glucose lowering drugs, excl. 
insulin
C 1 Metformin (A10BA02), tolbutamide 
(A10BB03)
P 2 Metformin (A10BA02), tolbutamide 
(A10BB03)
Platelet aggregation inhibitors, excl. c 1 Acetylsalicylic acid (B01AC06)
heparin p 2 Clopidogrel (B01AC04), 
Acetylsalicylic acid (B01AC06), 
carbasalate calcium (B01AC08)
Diuretics c 1 Hydrochlortiazide (C03AA03)
p 3 Hydrochlortiazide (C03AA03), 
Chlortalidon (C03BA04)
Beta blocking agents, non-selective c 2 Propanolol (C07AA05)
Beta blocking agents, selective c 3 Metoprolol (C07AB02)
Selective calcium channel blockers 
with mainly vascular effects
c 2 Amlodipine (C08CA01)
ACE inhibitors, plain c 2 Lisinopril (C09AA03)
p 2 Fosinopril (C09AA09)
Angiotensin II antagonists, plain c 1 Losartan (C09CA01)
Lipid Modifying Agents, plain c 3 Simvastatine (C10AA01), Atorvastatine 
(C10AA05)
p 8 Simvastatine (C10AA01), Pravastatin 
(C10AA03), Atorvastatine (C10AA05)
Progestagens and estrogens, fixed 
combinations
p 1 Lynestrenol and estrogen (G03AA03)
Anti-thyroid preparations c 1 Carbimazole (H03BB01)
Enzyme inhibitors p 1 Anastrozole (L02BG03)
Adrenergics and other drugs for 
obstructive airway diseases
c 1 Salmeterol/fluticason (R03AK06)
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Study protocol
Each participant performed three tasks which assessed manual reaction time, 
postural balance, and obstacle avoidance skills. The tasks are briefly described 
below; for more details see Hegeman et al. [16,17], Task sequence was 
randomized between the participants. To eliminate possible learning effects, all 
tasks were practiced prior to the actual measurement. The paroxetine users also 
completed the Hospital Anxiety and Depression Scale (HADS) [18] to assess the 
degree of anxiety and depression.
Equipment and procedure
Manual reaction time tasks
A button box with a home button and five target buttons was used to perform 
simple (15 trials, 1 target button) and choice (45 trials, 3 target buttons, more 
difficult) reaction time tasks (Figure 2A). Always starting from the home button, 
participants had to press the target button as quickly as possible after its 
illumination. If they reacted too fast (<150ms), too slow (>1000ms) or failed to 
press the target button, the trial was repeated at the end of the sequence. Both 
tasks were performed twice; the second recording occurred in reversed order to 
counterbalance fatigue effects. Reaction time (time between illumination of the 
target button and release of the home button) was recorded in milliseconds and 
median reaction times were included in the statistical analysis of both reaction 
time tasks.
Balance tasks
Postural balance was assessed using a firmly secured custom-made force 
platform consisting of two separate aluminum plates, each placed on three force 
transducers that recorded the vertical ground reaction forces. The participants 
stood barefoot on the force platform with their feet against a fixed foot frame and 
their arms hanging alongside the trunk (Figure 2B). Participants were instructed 
to stand as still as possible while performing a set of 9 balance tasks (5 as a 
single task, with 4 also under dual-task conditions). Before the balance 
measurements started, the dual-task condition with the cognitive task (an auditory 
Stroop task [19]) was practiced without paying attention to balance until the 
participant felt comfortable with it. This cognitive task required participants to 
listen to the words “high” or “low” in Dutch, presented in either a high or low pitch 
and to verbally indicate the tone as soon as possible (at most 18 times per 
balance task).
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The balance tasks In the slngle-task condition consisted of quiet stance on 
both legs either with eyes open (firm or compliant surface) and eyes closed (firm 
or compliant surface), and stance on one leg (the preferred one on the firm 
surface). In the dual-task condition these tasks, except for stance on both legs on 
compliant surface with eyes closed, were repeated with a secondary cognitive 
task.
The Root Mean Square (RMS) of the centre of pressure (COP, Figure 2B) 
velocity was selected as the outcome measure since It has been shown to be the 
most reliable [20,21], In the quantification of postural balance higher RMS values 
of this variable Indicate poorer performance. RMS values of COP velocity In the 
anterior-posterior direction were computed for all tasks. For one-legged stance, 
the RMS COP velocity was also computed In the lateral direction as lateral stability 
plays a major role In one-legged stance. Each of the balance tasks was performed 
twice; the second recording with the sequence In reversed order to exclude the 
Influence of fatigue. For every task, the mean RMS value was Included In the 
statistical analysis.
Obstacle avoidance task
The participants performed an obstacle avoidance task on a treadmill (walking 
velocity 3km/hr; Figure 2C, inset), wearing their own comfortable low-heeled 
shoes and a safety harness. A wooden obstacle (measuring 40x30x1.5cm) with 
an embedded piece of iron, held by an electromagnet just above the treadmill 
surface was released by a trigger from the computer. A regular walking pattern 
was needed and at least five unperturbed strides had to be completed before the 
obstacle was released. Fast stepping adjustments were required to successfully 
avoid the obstacle which was suddenly dropped on the treadmill in front of the left 
foot leaving at most 550ms to react. Contact of the left foot with the obstacle or 
stepping to the side was defined as a failure. Failures were noted during the 
experiment and failure rates (the number of failed trials divided by the total 
number of trials) were calculated for each participant. In addition, surface electro­
myography (EMG) data were collected from the m. biceps femoris (BF, a prime 
mover involved in the avoidance reaction [22]) to assess avoidance response 
times. BF response times were determined as the time between obstacle release 
and the moment at which BF activity exceeded the average control stride activity 
by at least 2SDs for more than 30 ms (for an example, see Figure 2C).
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Figure 2 Experimental setup. A. Manual reaction time tasks (simple: one 
target button (black circle), choice: 3 target buttons (white circle).
B. Force platform for static balance tasks (COP= Center of 
Pressure). C. Obstacle avoidance task.
A.
C.
8
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Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a 14-item, self-report 
screening scale that was originally developed to indicate the possible presence 
of anxiety and depressive states in the setting of a medical out-patient clinic [18], 
In the present study a validated Dutch version of the HADS [23] was used to 
assess the degree of anxiety and depression in the paroxetine group. As we did 
not obtain HADS scores from the control group, the HADS scores of the paroxetine 
users were compared with the scores from a random sample of Dutch senior 
individuals taken from the general population (n=1901; mean age±SD: 61±2.3yrs)
[23],
Statistical analysis
Independent t-tests were carried out in SPSS® (version 12.0.1) to assess 
differences between long-term paroxetine users and the age-matched healthy 
controls on population characteristics, manual reaction time, and postural 
balance as well as obstacle avoidance skills. The level of significance was set at 
0.05, and a post-hoc Bonferroni correction was applied. Means are presented 
with their SE (standard error).
To calculate the sample size needed for this study, we used information from 
a previous study [17], That study indicated that a relevant average difference in 
the RMS COP velocity during one-legged stance was 10mm/s (SD: 9mm/s) in a 
similar population. To be able to identify a difference of 10mm/s in this outcome 
measure, one needs to study at least 18 paroxetine users and 18 controls ((3= 0.9, 
oc=0.05).
Results
Participants
Independent t-tests showed that the average height, weight and Body Mass Index 
for both groups in this study were comparable (p>0.10, Table 1). The paroxetine 
group used on average 22mg±4 paroxetine daily and the duration of use was 
6.6±0.8 years (self-reported).
Manual reaction time
The analysis revealed that paroxetine users and controls responded equally fast 
on the simple reaction time task (paroxetine: 261ms±6.8 vs. controls: 260ms±6.4;
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p = 0.90) as well as the choice reaction time task (268ms±7.0 vs. 279ms±6.6; 
p = 0.26; Table 3).
Table 3 Results of the experimental tasks (mean±SE)
Bold numbers indicate a significant differences between the paroxetine group and the 
control group (after post-hoc Bonferroni correction a=0.008)
Task Paroxetine Controls p-value
Obstacle avoidance
Failure rate (%) 8.5 (1.5) 7.3(1.7) 0.45
Response time (ms) 164 (2.8) 161 (4.4) 0.46
Manual reaction time
Simple task (ms) 261 (6.8) 260 (6.4) 0.90
Choice task (ms) 268 (7.0) 279 (6.6) 0.26
Postural balance
One leg, firm suface, AP
Single task (mm/s) 36 (1.9) 24 (2.0) <0.001
Dual task (mm/s) 92 (11) 43 (12) 0.003
One leg, firm suface, LAT
Single task (mm/s) 45 (1.9) 36 (2.0) 0.001
Dual task (mm/s) 87 (11) 49 (12) 0.001
Two legs, firm surface
Eyes open, single task (mm/s) 8.0 (0.38) 7.4 (0.41) 0.25
Eyes open, dual task (mm/s) 11 (0.62) 8.4 (0.65) 0.01
Eyes closed, single task (mm/s) 14 (0.86) 12 (0.91) 0.16
Eyes closed, dual task (mm/s) 15 (0.99) 14(1.1) 0.36
Two legs, compliant surface
Eyes open, single task (mm/s) 15 (0.73) 13 (0.77) 0.08
Eyes open, dual task (mm/s) 19 (0.75) 15 (0.80) 0.001
Eyes closed (mm/s) 40 (2.4) 38 (2.5) 0.73
Postural balance
The analysis showed that paroxetine users had significantly higher RMS COP 
velocities than the control group on the one-legged stance task both in the single-
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and the dual task conditions (Table 3). Figure 3 presents the average RMS COP 
velocity of the one-legged stance task In the anterior-posterior (A) and lateral (B) 
direction and clearly shows that In both directions the paroxetine users had 
significantly higher COP velocities than the controls. Moreover, under dual task 
conditions In the one-legged stance task, the COP velocities of the paroxetine 
users were about twice as fast as those of the control group (92mm/s±11 vs. 
43m/s±12 (p = 0.003) for the anterior-posterior direction and 87mm/s±8 vs. 
49mm/s±8 (p=0.001) for the lateral direction). Table 3 also shows that paroxetine 
users had significantly higher RMS COP velocities than the control group on two 
other balance tasks (quiet stance on both legs with eyes open on the firm and the 
compliant surface) performed under dual-task conditions (firm surface: 11mm/ 
s±0.6 vs. 8.4 mm/s±0.7 (p = 0.01); compliant surface: 19mm/s±0.8 vs. 15mm/ 
s±0.8 (p = 0.001)).
Figure 3 The effect of paroxetine use on one-legged stance under single- 
and dual-task conditions
A. anterior-posterior direction, B. lateral direction. * p < 0.01 significant difference between 
paroxetine users and healthy age-matched controls (after post-hoc Bonferroni correction 
a=0.008). Bars represent population mean + SE.
B.
w
cc
*
T
*
■ É
C D  Paroxetine 
Controls
*
■ ____ ■
Single Dual
132
Risk factors for falls In long-term paroxetine users
Obstacle avoidance
Independent t-tests revealed that the avoidance failure rates of the paroxetine 
users were similar to the rates of the control group (paroxetine: 8.5%±1.5 vs. 
controls: 7.3%±1.7; p = 0.45; Table 3). The latencies of the avoidance responses of 
the paroxetine users were also comparable to those of the controls (164ms±2.8 
vs. 161ms±4.4; p = 0.46; Table 3).
Hospital Anxiety and Depression Scale (HADS)
Paroxetine users had a significantly higher total score on the HADS than the 
published comparison group (average (±SD): 11 ±5.9 versus 7.6±6.0, pcO.OOl). 
Paroxetine users appeared to be more anxious (7.0±3.1 vs. 3.9±3.5, p<0.001), 
but not more depressed than the comparison group (4.2±3.7 vs. 3.7±3.3, 
p = 0.45). For it is known that anxiety could affect postural balance [24-26] we 
assessed whether the anxiety scores of the paroxetine users were correlated to 
their postural balance performance. Therefore we used the performance on the 
one-legged stance task under single-task conditions on which the clearest 
difference between paroxetine users and controls was found. For the paroxetine 
users of the present study, anxiety was not correlated to postural balance (COP 
velocity anterior-posterior 36mm/s±1.9, r=  0.01, p = 0.95; lateral direction 45mm/ 
s±1.9, r=  0.12, p = 0.58).
Discussion
To the best of our knowledge this is the first study to investigate the effect of 
long-term paroxetine use on an extensive set of tasks relevant to falls. Previous 
research on this topic might have been not sensitive enough, which probably 
explains why the current body of knowledge is limited. The present study was 
designed to extend the knowledge of the association between SSRI use and 
accidental falls. A comparison was made between the performance of long-term 
paroxetine users and age-matched controls on manual reaction time tasks, 
challenging postural balance tasks, and a time-critical obstacle avoidance task 
during gait. The results demonstrated impaired postural balance with paroxetine 
use, especially during one-legged stance or under dual-task conditions. In 
contrast, paroxetine use did not affect either manual reaction times or obstacle 
avoidance performance.
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Postural balance
Earlier research mainly focused on the effect of treatment with paroxetine on 
stance with either eyes open or eyes closed in the depressed elderly [8,27], 
These studies found no differences in postural sway parameters after 6 weeks of 
paroxetine use [8,27], In contrast, the present results showed in the paroxetine 
group an increase in postural sway on all balance tasks, though it was only 
significant during one-legged stance and when a concurrent cognitive task was 
performed. It is known that impaired balance [28] and unipedal stance time 
shorter than 30 seconds [29] are important predictors for fall risk in older people. 
Moreover, many researchers have demonstrated that attention division has 
detrimental effects on postural balance (for a review see Woollacott & Shumway- 
Cook [30]). In turn these balance deficits are associated to accidental falls [31,32], 
This could imply that our paroxetine group was at a greater risk of falling.
Manual reaction time
Previous research showed no effect of paroxetine (20mg) on manual reaction 
time [33-35], Even though some essential differences between these studies and 
the present study exist, the findings are in line with our results. Having taken into 
account the variation in both the age groups and the durations of paroxetine use, 
we expect paroxetine not to affect manual reaction times in general.
Obstacle avoidance
To date only one study has investigated the effects of a single doses of antide­
pressants on obstructed and unobstructed gait; it did not affect the performance 
on these tasks [15], Despite the increased difficulty level and long-term paroxetine 
use, the results of the present study are in line with those of Draganich et al. [15] 
for we found no effect of paroxetine on both failure rates and avoidance reaction 
times. Earlier research demonstrated that an increased difficulty level is successful 
in assessing of obstacle avoidance skills [14,16,36], Hence, the present paradigm 
(obstacle avoidance under time pressure) could serve as a more sensitive tool to 
assess the effect of paroxetine on obstacle avoidance during gait. Nevertheless, 
for the present group the conclusions remain similar to those found with less 
challenging conditions. Indeed paroxetine was found not to have deleterious 
effects on gait and obstacle avoidance skills. Hence, it is suggested to be safe to 
use in elderly patients with regard to gait [15],
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However, the question arises why we see only some clear differences on the 
static balance tasks while the performance on the manual reaction time and 
obstacle avoidance tasks remained unaffected by paroxetine. One potential 
indication is the fact that dizziness is the most frequently reported symptom of 
abrupt discontinuation of treatment with paroxetine [37,38], Dizziness after 
withdrawal is more common for SSRIs with a much higher selectivity for serotonin 
than for noradrenaline [39], Paroxetine is one of the most selective and effective 
SSRIs in blocking the reuptake of serotonin. This suggests that the effects of the 
serotonergic systems in the CNS are expected to be the main cause of such 
dizziness [39], besides the effects of the histaminergic and dopaminergic system. 
The involvement of serotonin on the vestibular system is implied by the finding 
that this dizziness is likely to be vestibular in origin for slight movements of the 
head often have an intensifying effect [40], The finding that paroxetine can be 
effective in the treatment of some kinds of dizziness [41] since the presence of 
serotonin in the vestibular nuclei affects motion sensitive neural pathways [42,43] 
also implies involvement of serotonin on the vestibular system.
However, the results of the present study do not support the suggestion that 
it is primarily the vestibular system that is involved since paroxetine did not affect 
quiet standing on the compliant surface with the eyes closed. During this task 
both the proprioceptive and the visual systems - of which the input is important 
with regard to balance control - were limited and balance control mainly relied on 
the vestibular system. In addition, the increases in postural sway during the 
dual-task conditions are not likely to be due to changes in vestibular functioning. 
It has been shown that the ability to maintain static balance involves additional 
attentional demands [30,44], Moreover, age differences in balance abilities are 
known to be magnified by a secondary cognitive task [31,32], Hence, these 
results seem to indicate that paroxetine affects attentional capacities and thereby 
affects balance abilities. However, clear evidence on the effects of paroxetine on 
human attention is lacking and future research is needed to elucidate the role of 
attention in falls after paroxetine use.
It may be argued that the present results reflect the presence of depression 
more than of the use of paroxetine. Indeed it is well-known that anxiety or 
depression could affect postural balance [24-26] and are both risk factors for 
falls [45], However, in the present study we found no correlation between the 
HADS scores and postural sway in the paroxetine group. Therefore, it seems 
unlikely that the effect of anxiety or depression on balance control could explain 
the increases in postural sway found in this group. An additional question is
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whetherthe augmented sway is an acceptable risk. Darowskl et al. [12] suggested 
that the magnitude of the Increased risk of falling associated with an antidepressant 
Is about the same as the excess risk found In patients with untreated depression. 
Despite their treatment the paroxetine users In the present study appear to be at 
an Increased risk of falling since Impaired balance control Itself Is a risk factor for 
falls [46], However, this Increased risk probably does not exceed the Increased 
risk that the same patients would run If they had not taken paroxetine.
A limitation of the present study Is that we did not obtain HADS scores of the 
control group and hence, we could not assess anxiety or depression In that 
group. Nevertheless, we feel confident that the data of a similar age group from a 
previous validation study [23] served as an appropriate alternative for the 
comparison with the paroxetine users since this control group was well-matched 
and consisted of a representative sample of the elderly population.
The question arises whether the present results can be generalized to all 
antidepressants In the SSRI category since we assessed only paroxetine users. 
Future research should expand on this new knowledge by Including other SSRIs 
to further unravel the association between SSRI use and falls.
Conclusions
In conclusion, compared to healthy seniors, senior long-term paroxetine users 
appear to be at an Increased risk of falling due to Impairments In balance control, 
especially when attention has to be divided between two concurrent activities. 
However, additional research Is needed to further unravel the biological 
mechanism underlying accidental falls after SSRI Intake.
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General discussion
The purpose of this thesis was to gain insight into the extent to which medication 
could affect fall-related skills. The knowledge gained could lead to a reduction in 
medication-related accidental falls. Therefore, this thesis consisted of two parts. 
The first part dealt with the composition of a set of tasks to assess fall-related 
skills. More specifically, the aim was to investigate new sensitive tasks in assessing 
of the effect of medication on these skills. Thereupon, in the second part these 
tasks were added to existing conventional tasks to assess fall risk factors in two 
medication groups frequently prescribed to seniors and suspected to increase 
fall risk in users of such medication.
In this general discussion the main findings and conclusions of the studies 
described in the chapters of the two parts of this thesis are further discussed and 
recommendations for future research are given.
New tasks for the assessment of the effect of medication 
on fall-related skills
By means of three separate studies the first part of this thesis provides a basis for 
the use of a time-critical obstacle avoidance task and a secondary cognitive task 
to assess the effects of medication on skills related to accidental falls. Poor 
performance levels either on obstacle avoidance [1] or on dual-task walking [2] 
were previously shown to be associated with an increased risk of falling.
Previous research has demonstrated that a time-critical obstacle avoidance 
task can reveal differences in obstacle avoidance skills between young adults 
and elderly as well as fallers and non-fallers [1,3,4], However, it was unknown 
whether such a task would be sensitive enough to reveal possible effects of 
chemical substances such as medication. Alcohol is a substance well-known to 
affect CNS functions such as gait. Therefore we considered alcohol as a “gold 
standard” and assessed the effects of alcohol on obstacle avoidance skills during 
gait in healthy senior individuals (mean age (±SD) 62±4.4 years). We concluded 
that even low alcohol consumption was detrimental to these fall-related skills. 
This was most prominent in difficult situations where time pressure was high. In 
these situations fast reactions are required to successfully avoid the obstacle. It 
was suggested that the fast supraspinal pathways supposedly involved in these 
avoidance reactions were altered by the consumption of alcohol. Hence, the
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results of that study served as a ‘proof-of-prlnclple’ and we concluded that a 
time-critical obstacle avoidance task was sensitive to assess CNS (side) effects 
of medication.
As another skill related to accidental falls, dual-task walking has been extensively 
studied (for a review see Woollacott & Shumway-Cook [5] and Yogev et al. [6]). 
However, the Interpretation of many studies using a dual-task paradigm In 
conjunction with gait leaves room for speculation as to what extent attention division 
has actually occurred. To clarify this Issue, both the primary gait task and the 
cognitive secondary task should be attentlonally demanding and the Instruction 
should be not to prioritize either one of the tasks. By doing so, optimal performance 
on both tasks will be needed when performed simultaneously and the contribution 
of either one of the tasks on dual-task Interference might be revealed. Therefore, 
two studies of this thesis Investigated the effect of dual-tasking on commonly 
encountered difficulties In gait, such as limping and avoiding sudden obstacles. To 
minimize potentially conflicting sensory modalities during gait, we chose to use a 
secondary task not related to vision or locomotion and difficult enough to load the 
attentlonal system: the auditory Stroop task [7], We demonstrated In healthy young 
adults (26±3.8years) that this auditory task was useful to detect how small changes 
In gait occur when limping causes gait to be less automatic. It was shown that 
dual-tasking during asymmetric walking significantly affected the primary gait task 
whereas the secondary cognitive task remained practically unchanged. Given 
these findings, a ‘posture second’ strategy could be the case In this study, Implying 
that mainly motor functions are affected under dual-task conditions. However, It 
remained unclear If, and to what extent, mental alertness - another Important CNS 
function - was actually called upon. Therefore, we performed another study to 
Increase our Insight In dual-task Interference using sensitive outcome measures for 
both the primary and secondary task. In addition, we Investigated whether such a 
‘posture second’ strategy could also be the case when suddenly appearing 
obstacles have to be avoided during gait under dual-task conditions. Deteriorated 
obstacle avoidance reactions were found as well as decreased performance on the 
secondary cognitive task. This was considered an Indication for limited capacity of 
CNS functions and the suggestion of a ‘posture second’ strategy was rejected for 
this particular task. Hence, the methods used proved to be sensitive enough to 
reveal clear dual-task Interference on both tasks. Considering these findings, we 
concluded that the dual-task paradigm of a time-critical obstacle avoidance task 
combined with an auditory secondary task can be a useful method to investigate 
CNS adverse effects of medication.
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The assessment of fall risk factors in medication users
Both age-induced changes to the locomotor apparatus as well as medication use 
are found to be related to accidental falls in the elderly [8-13], Several tests, such 
as quiet stance tasks and obstacle avoidance tasks have been developed to 
investigate the effects of these age-induced changes [14-16] and are expected to 
be suitable to assess the CNS adverse effects of medication as well. On the other 
hand, most studies on the relation between medication use and falls were of 
epidemiological nature. It was shown that primarily psycho-active medication, 
analgesics, diuretics, and vasodilators are associated with an increased fall risk 
[9,17-20], However, the interpretation of the actual magnitude and impact of this 
risk should be viewed with some caution. Limitations frequently found in these 
observational studies comprise poor correction for possible confounders and 
scarce descriptions of the circumstances in which falls occurred [9,17-20], This 
was illustrated by the review on NSAIDs and the risk of accidental falls presented 
in this thesis. The variability in methodology of the studies reviewed hindered the 
computation of a pooled fall risk for NSAIDs. Nevertheless, an increased risk for 
accidental falls in elderly using NSAIDs was deemed probable.
Thus far, most experimental studies on medication (other than benzodiaz­
epines) failed to elucidate the actual fall risk. They usually focused on changes in 
psychomotor functioning after medication use and only few actually assessed 
fall-related motor or cognitive skills [21-23], Therefore, studies presented in the 
second part of this thesis used challenging balance tasks, a time-critical obstacle 
avoidance task and a secondary cognitive task. With this extensive set of tests it 
was expected that CNS effects of medication suspected to lead to an increased 
fall risk could be revealed and clarified.
Firstly, we focused on NSAIDs since our systematic review showed that an 
increased risk for accidental falls is probable for elderly exposed to these drugs
[24], Indomethacin is part of the commonly used NSAID group and is known to 
cause CNS adverse effects [25], We investigated the influence of this drug on 
fall-related skills in healthy seniors. Despite the fact that 40% of the participants of 
our study reported CNS adverse effects, no changes were found on either one of 
the fall-related tasks. It was concluded that indomethacin alone does not affect 
CNS functions such as mental alertness and motor coordination or other elements 
essential to the correct performance of the task. Thus it seems unlikely that 
indomethacin itself increases fall risk in seniors. It should be noted, however, that 
indomethacin is mostly used in the treatment of several inflammatory diseases.
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More generally, since pain Is a common symptom of such diseases, NSAIDs 
are often prescribed when paracetamol Is Insufficient to reduce this pain. Hence, 
pain could be an Important (confounding) factor underlying fall risk after NSAID 
use. Previous research showed that pain Is associated with an Increased propensity 
to trip over an obstacle [26] and an Increased fall risk In a general population of 
community-living older adults [27], On the other hand, It Is shown that paln-rellef In 
knee osteoarthritis reduces the propensity to trip over an obstacle [28] and 
Improves gait function [29], Nevertheless, despite the paln-rellef, the patients with 
knee osteoarthritis performed less than disease-free controls [28,29], This Indicates 
that pain Itself Is not a sufficient explanation for the deficiencies found In gait or 
obstacle avoidance. Factors otherthan CNS effects or pain, could possibly underlie 
the apparent Increased fall risk with NSAID use found In several observational 
studies [30-33] and these factors remain to be Investigated. Therefore It Is 
suggested that future research should comprise prospective measurement of falls 
and extensive monitoring of medication use, pain and fall circumstances.
Selective serotonin reuptake-inhibitors (SSRIs) are another commonly 
prescribed medication group In the elderly and are used In the treatment of 
depression and anxiety. SSRIs also cause CNS adverse effects and are associated 
with an Increased fall risk [18,34,35], Therefore, a second study was performed 
using this type of medication. In this study, we assessed fall-related skills with the 
above mentioned extensive set of tests In seniors using an SSRI, paroxetine In 
particular. Only static balance control appeared to be affected In seniors using 
paroxetine compared to healthy age-matched controls. It seemed unlikely that 
this decrement was caused by anxiety or depression for a correlation between 
the scores on the HADS (Hospital Anxiety and Depression Scale [36]) and 
postural sway was lacking. A possible explanation for the Increased fall risk found 
with SSRI use could be due to the effect of serotonin on the vestibular system, 
rather than on other fall-related CNS functions. However, this Idea could not be 
supported since paroxetine did not seem to affect quiet standing on compliant 
surface with eyes closed. It was also hypothesized that paroxetine affected 
attentlonal capacities and hence, Indirectly, balance capacities could be affected 
as well. Pacher and Ungvarl [37] assumed cardiovascular effects such as 
orthostatic hypotension and arrhythmias to be another mechanism that could 
add to an Increased fall risk with SSRI use. Hence, the relation between SSRI use 
and falls appears to be quite complex. Therefore, future research should focus on 
the reduction or even the elimination of possible confounding factors and 
prospectively monitor falls and their circumstances in seniors using SSRIs.
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Complications in understanding the relation between 
medication use and fall risk
Even though we used tests proven to be sensitive enough to detect differences in 
a selection of CNS functions relevant to fall-related skills, differences due to CNS 
adverse effects of medication were only partly revealed in this thesis. However, it 
would be impetuous to conclude that these adverse effects have nothing to do 
with fall risk. Information on adverse effects of medication is usually based on 
reports of the users. Therefore, it is likely that these reports are subject to the 
degree a user experiences adverse effects. Hence, adverse effects mentioned in 
the leaflets appear to be rather subjective and do not necessarily reflect actual 
undesired (CNS) effects which may influence fall-related skills. It seems possible 
that other systems than the CNS play a role in the experience of such undesired 
effects as well. Whereas it is suggested that dizziness after SSRI use is likely to 
be caused by the effect of serotonin on the vestibular system [38,39], dizziness 
after use of other medication could also be vestibular of origin. Other commonly 
experienced CNS adverse effects are drowsiness or confusion. These effects 
could be due, for instance, to one’s perception of his surroundings instead of 
changes in mental alertness due to medication use. Hence, it seems that 
experienced adverse effects often cannot be attributed to a single pathway. This 
is a complicating aspect in the understanding of the relation between medication 
use, its CNS effects on fall-related skills and a possibly increased fall risk. It 
becomes even more complex when drug-drug interactions result in CNS adverse 
effects.
Concluding remarks and recommendations
This thesis aimed to gain insight into the extent to which medication could affect 
fall-related skills in a senior population and, by doing so, to reduce possible 
accidental falls. We succeeded in composing a set of tests suitable and sensitive 
enough for the assessment of important CNS functions relevant to falls. We 
suggest that testing of fall-related skills is useful in assessing fall risk with 
medication use. Moreover, it is important to have various tests available for 
different medication classes affecting different CNS functions. The fact that we 
hardly found any significant effects of indomethacin and paroxetine could indicate 
that these drugs are relatively safe with regard to accidental falls. On the other
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hand, we can also conclude that It remains difficult to quantitatively evaluate the 
effect of medication on mechanisms related to fall risk.
Concerning the reduction of possible medication-related accidental falls, a 
thorough evaluation of one’s medication used and In addition the withdrawal of 
risk medication [40] has shown to be quite useful. Moreover, It Is known that 
starting a new medication such as an antl-hypertenslve agent, or antl-parklnsonl- 
an, antl-anxlety and hypnotic agents may act as a trigger for the onset of a fall 
[41], The methods addressed In this thesis could be used to quantify the effect of 
either starting with medication or the withdrawal of risk medication on fall-related 
skills In the elderly. More specifically, It enables researchers or physicians to 
evaluate this effect on the level of the Individual patient. However, performing the 
complete set of tasks might be too time- and energy-consuming for either the 
researcher or the patient, and requires laboratories In which the tests can be 
carried out. To make the reduction of medication-related falls successful, It Is 
suggested that future research on this topic should address several aspects. 
Firstly, one should Investigate which tests are most sensitive for the effects of a 
large variety of drugs. Next, one should aim to simplify those tests to make It 
possible to perform them with a little amount of time or resources. Finally, for a 
better understanding of the applicability of this approach, future experimental 
studies should aim to quantify the effect of both medication onset and withdrawal, 
preferably In large randomized controlled trials.
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Summary
In Chapter 1 a general Introduction Is given on fall risk and medication as well as 
fall-related skills. It describes the association between medication and accidental 
falls In the elderly. Many epidemiological studies showed that medication use Is 
an Important risk factor for accidental falls; particularly drugs with commonly 
reported central nervous system (CNS) adverse effects. It Is shown that withdrawal 
of such fall-risk-increasing drugs or even just lowering the dose significantly 
reduced fall risk in an elderly population. However, sensitive methods to 
quantitatively investigate the effect of this approach on fall risk and fall-related 
skills are still lacking. Therefore this thesis aimed to gain insight into the influence 
of commonly used medicines on fall-related skills. The studies described in this 
thesis investigated skills such as balance control, response to sudden events and 
dual tasking during gait.
As a commonly used social drug known to affect gait we used alcohol to 
investigate whether a time-critical obstacle avoidance is sensitive enough to 
detect changes in obstacle avoidance skills after intake of this chemical 
substance. Chapter 2 describes the study which served as a ‘proof-of-principle’. 
Alcohol, even at low concentrations considered safe for driving, affects brain 
function and increases fall risk. An increased fall risk has been associated with 
impaired obstacle avoidance skills. Low level BACs (blood alcohol concentrations) 
are likely to affect obstacle avoidance reactions during gait, since the brain areas 
that are presumably involved in these reactions have been shown to be influenced 
by alcohol. Thirteen healthy senior individuals were subjected to an obstacle 
avoidance task on a treadmill after low alcohol consumption. Fast stepping 
adjustments were required to successfully avoid suddenly appearing obstacles. 
Response times and amplitudes of the m. biceps femoris (BF), a prime mover in 
avoidance reactions, as well as avoidance failure rates were assessed. After the 
first alcoholic drink, 12 of the 13 participants already had slower responses. 
Without exception, all participants’ BF response times were delayed after the final 
alcoholic drink compared to when the participants were sober. The BF response 
times were significantly delayed from BACs of 0.035% onwards and were strongly 
associated with increasing levels of BAC. These delays had important behavioral 
consequences. Chances of hitting the obstacle were doubled with increased 
BACs. The results of this study clearly show that even with BACs considered to be 
safe for driving; obstacle avoidance reactions are inadequate, late, and too small.
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Hence, we concluded that a time-critical obstacle avoidance task was sensitive 
enough to assess CNS (adverse) effects of medication.
To test whether dual-tasking could cause detectable subtle gait changes, Chapter 
3 described the effect of a secondary cognitive task on gait under difficult 
circumstances. Bilaterally asymmetric stepping during walking common to a 
number of pathological gaits (e.g. hemiplegia, limping). In the present study, the 
attention level of asymmetric stepping was studied by having young adults walk 
on a spllt-belt treadmill with symmetric (2 km/h) and asymmetric (2 km/h vs 4 
km/h and 2 km/h vs 6 km/h) belt speeds both with and without a secondary 
auditory Stroop task. There was no significant change In verbal response time 
reactions across walking conditions or between walking and standing. The 
proportion of stance phase was unchanged by the secondary task during 
symmetric walking. Stance phase proportions, however, significantly Increased 
during dual tasking for the limb on the faster belt for asymmetric conditions, while 
they decreased for the limb on the slower belt for the most asymmetric condition. 
There were also small modifications to double support proportions and a main 
effect of dual tasking to double support variability. Observed dual task changes 
showed Interference by the cognitive task with asymmetric gait performance, 
suggesting that asymmetric stepping, such as seen In limping gaits, requires 
more attention than symmetric walking. Such attention may, In part, be due to the 
dynamic balance required In asymmetric limb loading and unloading. Hence, this 
study demonstrated that the auditory Stroop task was useful to detect small 
changes In gait when It becomes less automatic.
Dual-tasking can lead to falls, as does a deterioration of obstacle avoidance skills. 
Hence, It Is expected that a combination of both would be even more detrimental, 
especially when obstacles have to be avoided under time pressure. Previous work 
confirmed this expectation; however, due to several limitations In the design of 
previous studies It Is yet too early to draw any definitive conclusions on the allocation 
of attentlonal resources In obstacle avoidance under dual-task conditions. 
Therefore, the study presented In Chapter 4 used a primary and secondary task 
that were both attentlonally demanding, with the Instruction to perform as well as 
possible on both tasks, and evaluated this with highly sensitive outcome parameters. 
Nineteen healthy senior Individuals performed an obstacle avoidance task on a 
treadmill while walking at 3km/h as a single task and combined with an auditory 
Stroop task. M. biceps femorls (BF) response times and obstacle avoidance failure
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rates were assessed. For the secondary task a composite score ((100xaccuracy)/ 
verbal response time) was computed. Increased obstacle avoidance failure rates 
(3%) and delayed BF response times (21ms) were found under dual-task conditions. 
Composite scores were reduced during and just after obstacle crossing. We 
concluded that dual-tasking while avoiding obstacles under time pressure affects 
the motor as well as the cognitive task when subjects are instructed to keep up their 
performance on both. These findings add to the evidence indicating an increased 
risk of tripping or falling when attention is divided during walking over uneven 
terrain. In addition, it is suggested that the dual-task paradigm of a time-critical 
obstacle avoidance task combined with an auditory secondary task can be a useful 
method to investigate CNS adverse effects of medication.
In the second part of this thesis we used the tasks to assess fall-related skills to 
gain insight into the fall risk after use of drugs frequently prescribed as a treatment 
for two important chronic conditions in the elderly: rheumatic and psychosocial 
diseases. In Chapter 5 a systematic literature review is given on NSAIDs 
(non-steroidal anti-inflammatory drugs) and the risk of accidental falls in the elderly. 
Accidental falls, especially those occurring in the elderly, are a major health and 
research topic nowadays. Besides environmental hazards and the physiological 
changes associated with ageing, medication use (e.g. benzodiazepines, 
vasodilators and antidepressants) and polypharmacy are significant risk factors for 
falling as well. Exposure to NSAIDs has been associated with accidental falls too, 
although information on this area is less consistent. Therefore, the main goal of this 
review was to provide an updated overview of all the evidence published on risk of 
falling due to NSAID use so far. Validity and data extraction of eligible articles was 
assessed by adapted criteria, based on checklists that were originally developed to 
assess case-control or cohort studies. From the 16 selected articles, two studies 
were rejected due to clustering of data and one article was excluded because it 
contained the same data as that in one of the included articles. None of the articles 
included a randomized controlled trial. The remaining 13 studies all showed some 
lack in completeness of their statistical methods, and much variation in reporting of 
effects. The overall mean age was high in the study populations, leaving the results 
to be poorly generalizable to a larger population and other age categories. Despite 
these imperfections, all studies showed an increased risk of falling due to NSAID 
use (four significant, nine non-significant), and a tendency towards an increased fall 
risk with NSAID exposure could be noted. It is suggested that an increased risk for 
accidental falls is probable when elderly individuals are exposed to NSAIDs.
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Increased reaction time and Impaired postural balance have been determined as 
reliable predictors for those at risk of falling and are Important functions of the 
central nervous system (CNS). An essential risk factor for falls Is medication 
exposure. As shown In the previous chapter, NSAIDs are amongst the medications 
related to accidental falls. About 1-10% of all users experience CNS side effects. 
These side effects, such as dizziness, headaches, drowsiness, mood alteration, 
and confusion, seem to be more common during treatment with Indomethacln. 
Hence, It Is possible that maintenance of (static) postural balance and swift 
reactions to stimuli are affected by exposure to NSAIDs, Indomethacln In 
particular, consequently putting older Individuals at a greater risk for accidental 
falls. Therefore, the study presented In Chapter 6 Investigated the effect of a high 
Indomethacln dose In healthy middle-aged Individuals on Important predictors of 
falls: postural balance and reaction time. Twenty-two healthy middle-aged 
Individuals participated In this double-blind, placebo-controlled, randomized 
crossover trial. Three measurements were conducted with a week Interval each. A 
measurement consisted of postural balance as a single task and while concurrently 
performing a secondary cognitive task and manual reaction time tasks. For the 
first measurement Indomethacln 75mg (slow-release) or a visually Identical 
placebo was randomly assigned. In total, 5 capsules were taken orally In the 2.5 
days preceding assessment. The second measurement was without Intervention, 
for the final one the first placebo group got Indomethacln and vice versa. Repeated 
measures GLM revealed no significant differences between Indomethacln, 
placebo, and baseline In any of the balance tasks. No differences In postural 
balance were found between the single and dual task conditions, or on the 
performance of the dual task Itself. Similarly, no differences were found on the 
manual reaction time tasks. The present study showed that a high Indomethacln 
dose does not negatively affect postural balance and manual reaction time In this 
healthy middle-aged population. Although the relatively small and young sample 
limits the direct ability to generalize the results to a population at risk of falling, the 
results Indicate that Indomethacln alone Is not likely to Increase fall risk, as far as 
this risk Is related to the abovementioned Important functions of the CNS, and not 
affected by comorbldltles.
CNS side effects are more common during treatment with Indomethacln compared 
to other NSAIDs. In many European countries as well as In the USA, the leaflet or 
even the packaging of Indomethacln contains a specific warning to refrain from 
activities requiring mental alertness and motor coordination, such as driving a
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car. In Chapter 7 a placebo-controlled randomized study with cross-over design 
Is presented which aimed to find evidence for the above mentioned warning. 
Indomethacln 75mg slow-release or a visually Identical placebo with similar flavor 
was taken In orally twice dally for 2.5 days. It was suggested that Indomethacln 
affects the motor coordination required to successfully avoid obstacles during 
walking and that this effect will be even stronger when simultaneously performing 
a cognitive task puts mental alertness to the test. Nineteen healthy middle-aged 
Individuals were subjected to a time-critical obstacle avoidance task combined 
with a cognitive secondary task. Fast stepping adjustments were required to 
successfully avoid the obstacle, which was suddenly dropped on the treadmill. 
Both BF response times and avoidance failure rates were assessed. No 
differences between Indomethacln and placebo were found on the outcome 
measures regarding motor coordination, avoidance failure rates and BF response 
times, nor on the performance on the secondary cognitive task. This study 
showed that tasks which demand maximum attention remain unaffected by a 
high dose of Indomethacln despite the frequently reported CNS side effects such 
as dizziness, drowsiness and headaches. A high dose of Indomethacln did not 
affect capabilities deemed essential for safe walking In healthy senior Individuals. 
Hence, It Is suggested that there might be no need to caution patients who 
experience CNS side effects after Indomethacln use to avoid activities requiring 
quick and adequate reactions, such walking under challenging circumstances 
and maybe also driving a car.
SSRIs (selective serotonin reuptake Inhibitors) are widely used to treat depression 
and are also associated with an Increased falls risk. However, the biological 
mechanism underlying accidental falls with SSRI Intake has yet to be elucidated. 
Hence, there Is a need for specific tests and behavioral studies to assess this 
mechanism. The study presented In Chapter 8 was designed to Investigate 
whether obstacle avoidance skills In long-term (>90 days), senior paroxetine 
users are affected during gait, simple and challenging postural balance tasks, as 
well as during manual reaction time tasks. The performance of the paroxetine 
users was compared with healthy group-matched controls. The results 
demonstrated Impaired postural balance In the paroxetine users, especially 
during one-legged stance or under various dual-task conditions. Although the 
deficit In one-legged stance could Indicate vestibular Involvement, this was 
deemed unlikely since performance of standing on compliant surface with closed 
eyes remained unaffected. Paroxetine use also failed to affect manual reaction
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times or obstacle avoidance performance. It is suggested that paroxetine affects 
attentional capacities particularly in conjunction with balance control. Compared 
to healthy seniors, senior long-term paroxetine users appear to be at an increased 
risk of falling due to impairments in balance control, especially when attention has 
to be divided between two concurrent activities.
Finally, in Chapter 9 an outline of the main findings and conclusions of this thesis 
were presented. The limitations of the presented studies were discussed and 
recommendations for future research were given.
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Samenvatting
in hoofdstuk 1 wordt een algemene inleiding gegeven op zowel valrisico en 
medicatie als op valgerelateerde vaardigheden. Er wordt een beschrijving 
gegeven van de relatie tussen medicatie en valpartijen bij ouderen. Verschillende 
epidemiologische studies hebben aangetoond dat medicijngebruik een 
belangrijke risicofactor voor valpartijen is, in het bijzonder medicijnen waarbij 
vaak bijwerkingen gerelateerd aan het centrale zenuwstelsel (CZS) gemeld 
worden. Eerder onderzoek heeft aangetoond dat het stoppen met een dergelijk 
valrisico verhogend medicijn of zelfs slechts het verlagen van de dosis een 
aanzienlijke vermindering van het valrisico bij ouderen tot gevolg heeft. Het 
ontbreekt echter nog aan gevoelige methoden om het effect van deze aanpak op 
valrisico en valgerelateerde vaardigheden kwantitatief te kunnen onderzoeken. 
Zodoende heeft dit proefschrift als doel inzicht te krijgen in de invloed van 
veelgebruikte medicijnen op valgerelateerde vaardigheden. In de studies die 
beschreven worden in dit proefschrift werden vaardigheden zoals balans controle, 
reacties op plotselinge gebeurtenissen en het uitvoeren van dubbeltaken tijdens 
lopen onderzocht.
Hoofdstuk 2 beschrijft de studie die diende als een ‘proof-of-principle’. Het is 
algemeen bekend dat alcohol consumptie het lopen negatief kan beïnvloeden. 
Vandaar dat we alcohol gebruikt hebben om te onderzoeken of een tijd-kritische 
obstakelontwijktaak gevoelig genoeg is om veranderingen waar te nemen in het 
vermogen om obstakels te ontwijken na inname van alcohol. Het is gebleken dat 
promillages waarbij autorijden wettelijk nog is toegestaan al van invloed zijn op 
hersenfuncties en het valrisico verhogen. Een verhoogd valrisico in het algemeen 
wordt geassocieerd met een verminderd vermogen obstakels te kunnen ontwijken 
tijdens lopen. De verwachting was dat zelfs lage promillages obstakel ontwijkre- 
acties zouden beïnvloeden, omdat is aangetoond dat de hersengebieden die 
vermoedelijk betrokken zijn bij deze reacties worden beïnvloed door alcohol. 
Dertien gezonde oudere personen voerden een obstakelontwijktaak uit op een 
loopband na lage tot matige alcoholconsumptie. Om de plotseling verschijnende 
obstakels succesvol te ontwijken waren snelle stapreacties noodzakelijk. Naast 
successcores werden ook reactietijden en amplitudes van de m. biceps femoris 
(BF), een spier die vroeg geactiveerd wordt in ontwijkreacties, gemeten. Na de 
eerste alcoholische drank waren de ontwijkreacties van 12 van de 13 deelnemers 
al vertraagd. Zonder uitzondering waren de ontwijkreacties van alle deelnemers
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vertraagd na de laatste alcoholische drank In vergelijking tot de conditie waarbij 
Iedereen nuchter was. Vanaf een promillage van 0.35%o waren de gemiddelde BF 
reactietijden significant langzamer en werd er een sterk verband gevonden tussen 
deze reactietijden en een toename In BAC. De langzame reacties hadden tot 
gevolg dat de kans om het obstakel te raken was verdubbeld bij hogere 
promillages. De resultaten van deze studie laten duidelijk zien dat obstakelont- 
wljkreactles na de Inname van alcohol onvoldoende en te laat zijn, zelfs bij 
promillages die nog als veilig worden beschouwd voor autorijden. Op basis van 
deze resultaten hebben we geconcludeerd dat een tijd-kritische obstakelontwijk- 
taak gevoelig genoeg is om de (negatieve) effecten van medicatie op het centrale 
zenuwstelsel te kunnen meten.
Om te testen of het uitvoeren van een dubbeltaak tot waarneembare subtiele 
veranderingen in de manier van lopen zou leiden, beschrijft hoofdstuk 3 het effect 
van een secundaire cognitieve taak op lopen onder moeilijke omstandigheden. 
Een asymmetrisch looppatroon wordt bijvoorbeeld gezien bij mensen met 
hemiplegie of manklopen als gevolg van een andere aandoening. In deze studie 
werd onderzocht hoe het gesteld was met het aandachtsniveau tijdens 
asymmetrisch lopen. Jong volwassenen liepen hiervoor op een dubbele loopband 
(ieder been op 1 band) met symmetrische (2 km/u) en asymmetrische (2 km/u vs 4 
km/u en 2 km/u vs 6 km/u) bandsnelheden zowel met als zonder een secundaire 
cognitieve taak. Er was geen significante verandering in verbale reactietijden 
tussen de verschillende loopcondities of tussen lopen en staan. Tijdens symmetrisch 
lopen bleef het aandeel van de standfase onveranderd door de secundaire taak. 
De verhouding standfase:zwaaifase nam echter aanzienlijktoe tijdens het uitvoeren 
van een cognitieve taak in combinatie met asymmetrisch lopen voor het been op 
de snelle band, terwijl deze verhouding afnam voor het been op de langzamere 
band bij de meest asymmetrische conditie. Tevens werden er kleine veranderingen 
gevonden in de periodes dat beide voeten tegelijk contact maakten met de 
ondergrond. Hierbij speelde het uitvoeren van de secundaire cognitieve taak een 
hoofdrol. Deze veranderingen toonden aan dat asymmetrisch lopen beïnvloed 
werd door de secundaire taak, wat suggereert dat zo’n looppatroon meer aandacht 
vereist dan symmetrisch lopen. Dit kan voor een deel te wijten zijn aan de 
dynamische balans die nodig is bij de asymmetrische belasting van de ledematen. 
Dit onderzoek heeft aangetoond dat het gebruik van een secundaire cognitieve 
taak nuttig was om subtiele veranderingen in het looppatroon teweeg te brengen 
wanneer het lopen minder automatisch gaat, zoals bijvoorbeeld bij manklopen.
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Zowel het uitvoeren van dubbeltaken als een verminderd vermogen om obstakels 
te ontwijken tijdens lopen kunnen leiden tot valpartijen. Een combinatie van beide 
zou mogelijk nog desastreuzer zijn, vooral als obstakels moeten worden vermeden 
onder tijdsdruk. Eerdere onderzoeken bevestigden dit vermoeden, maar door 
een aantal beperkingen in het ontwerp van deze onderzoeken is het nog te vroeg 
om definitieve conclusies te trekken over de verdeling van aandacht wanneer 
obstakels ontweken moeten worden onder dubbeltaak omstandigheden. Daarom 
is in het onderzoek dat gepresenteerd wordt in hoofdstuk 4 gebruik gemaakt van 
een primaire en secundaire taak die beiden veel concentratie vereisen. De 
proefpersonen kregen hierbij de opdracht zo goed mogelijkte presteren op beide 
taken en dit werd geëvalueerd met gevoelige uitkomstparameters. Negentien 
gezonde oudere personen voerden een obstakelontwijktaak uit op een loopband 
(3km/u) als een enkele taak en gecombineerd met een secundaire cognitieve 
taak. Naast successcores werden ook reactietijden en amplitudes van de m. 
biceps femoris (BF), een spier die vroeg geactiveerd wordt in ontwijkreacties, 
gemeten. Voor de secundaire taak werd een composiet score ((1 OOxnauwkeurig- 
heid) / verbale reactietijd) berekend. Onder dubbeltaak omstandigheden werden 
er meer obstakels geraakt (3%) en daarbij waren de obstakel ontwijkreacties 
vertraagd (21 ms). De composiet scores waren aanzienlijk lager tijdens en vlak na 
het ontwijken van het obstakel in vergelijking tot daarvoor. Hieruit concludeerden 
we dat onder dubbeltaak condities zowel het vermijden van obstakels onder 
tijdsdruk als de cognitieve taak negatief worden beïnvloed wanneer hierbij de 
instructie gegeven is om op beide taken zo goed mogelijk te presteren. Deze 
bevindingen dragen bij aan de aanwijzingen uit eerder onderzoek dat er een 
verhoogd risico op struikelen of vallen ontstaat wanneer de aandacht verdeeld 
moet worden tijdens het lopen op oneffen of onbekend terrein. Daarnaast lijkt het 
dubbeltaak-paradigma van een tijd-kritische obstakelontwijktaak in combinatie 
met een auditieve secundaire taak tevens een bruikbare methode om CZS-gere- 
lateerde bijwerkingen van medicatie te onderzoeken omdat op deze manier 
subtiele veranderingen te detecteren zijn.
In het tweede deel van dit proefschrift hebben we de taken die valgerelateerde 
vaardigheden testen gebruikt om inzicht te krijgen in het valrisico na gebruik 
van medicijnen die vaak worden voorgeschreven in de behandeling van twee 
chronische aandoeningen bij ouderen: reumatische en psychosociale aan­
doeningen. Hoofdstuk 5 presenteert een systematisch literatuuronderzoek naar 
NSAIDs (niet-steroïdale anti-inflammatoire drugs) en het risico op valpartijen bij
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ouderen. Tegenwoordig zijn valpartijen bij ouderen een belangrijk gezondheids- 
en onderzoeksonderwerp. Naast omgevingsgerelateerde risicofactoren en de 
fysiologische veranderingen die gepaard gaan met het ouder worden, zijn het 
gebruik van geneesmiddelen zoals benzodiazepines, vasodilatoren en 
antidepressiva, en polyfarmacie eveneens belangrijke risicofactoren voor vallen. 
Gebruik van NSAIDs is ook geassocieerd met valpartijen, alleen is de informatie 
op dit gebied minder consistent. Daarom was het belangrijkste doel van dit 
literatuuronderzoek om een actueel overzicht te krijgen van alle onderzoeken die 
tot nu toe gepubliceerd hebben over het risico van vallen als gevolg van 
NSAID-gebruik. Op basis van checklists die oorspronkelijk zijn ontwikkeld om de 
kwaliteit van case-control- of cohort studies te beoordelen zijn aangepaste 
criteria opgesteld om de validiteit en data-extractie van de geselecteerde artikelen 
te beoordelen. Van de 16 geselecteerde artikelen, zijn twee studies uitgesloten 
als gevolg van clustering van gegevens en een derde artikel is uitgesloten omdat 
daarin dezelfde gegevens gebruikt waren als in één van de geschikte artikelen. 
Tussen de geschikte artikelen zat geen gerandomiseerde gecontroleerde trial. De 
overige 13 artikelen gaven veelal een onvolledige beschrijving van de statistische 
methoden en ook werd veel variatie in de beschrijving van de effecten gevonden. 
De gemiddelde leeftijd was doorgaans hoog in de bestudeerde groepen waardoor 
generalisatie naar grotere groepen en andere leeftijdscategorieën bemoeilijkt 
werd. Ondanks deze onvolkomenheden vertoonden alle studies een verhoogd 
risico op vallen als gevolg van gebruik van NSAIDs (vier significant, negen niet- 
significant) en een tendens naar een verhoogd val risico met NSAID-gebruik werd 
zichtbaar. Het lijkt daarom goed mogelijk dat er sprake is van een verhoogd 
valrisico bij ouderen die NSAIDs gebruiken.
Een adequaat reactievermogen en balanscontrole zijn belangrijke functies van 
het centrale zenuwstelsel (CZS) en een verslechtering van deze functies is een 
belangrijke voorspeller voor valpartijen gebleken. Een andere belangrijke 
risicofactor voor vallen is het gebruik van medicatie. Zoals beschreven in het 
vorige hoofdstuk behoren NSAIDs tot de medicijnen mogelijk een verband 
hebben met valpartijen. Ongeveer 1-10% van alle gebruikers ervaren bijwerkingen 
die gerelateerd zijn aan het CZS. Deze bijwerkingen, zoals duizeligheid, hoofdpijn, 
sufheid, stemmingsverandering en verwarring lijken vaker voor te komen bij 
gebruik van indometacine. Het lijkt waarschijnlijk dat de balanscontrole en snelle 
reacties op stimuli worden beïnvloed door gebruik van NSAIDs, indometacine in 
het bijzonder, waardoor oudere gebruikers een groter risico lopen om te vallen.
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Het onderzoek dat in hoofdstuk 6 gepresenteerd wordt onderzocht daarom bij 
gezonde oudere personen wat het effect was van een hoge dosis indometacine 
op belangrijke voorspellers van vallen: het evenwicht en reactietijd. Tweeëntwintig 
gezonde personen van middelbare leeftijd namen deel aan deze dubbelblinde, 
placebo-gecontroleerde, gerandomiseerde cross-over trial. Er werden drie 
metingen uitgevoerd met daartussen steeds een week interval. Iedere meting 
bestond uit handreactietijdtaken en verschillende balansstaken waarbij sommigen 
ook herhaald werden terwijl gelijktijdig een secundaire cognitieve taak uitgevoerd 
werd. Indometacine 75 mg (slow-release) of een visueel identiek placebo werd 
willekeurig toegewezen voor de eerste meting. Iedere proefpersoon slikte in totaal 
vijf capsules in de 2,5 dagen voorafgaand aan de meting. De tweede meting was 
zonder inname van capsules (baseline) en voor de laatste meting kregen de 
proefpersonen die in eerste instantie indometacine slikten nu placebo en 
andersom. Statistische toetsing toonde aan dat er geen significante verschillen 
waren in de prestaties op de balansstaken tussen indomethacine, placebo en 
baseline. Ook werden er geen verschillen in de balansstaken gevonden met en 
zonder de gelijktijdige uitvoering van een secundaire cognitieve taak, of op de 
prestaties van deze secundaire taak zelf. Daarnaast zijn er eveneens geen 
verschillen gevonden in de prestaties op de handreactietijdtaken. De huidige 
studie toonde aan dat een hoge dosis indometacine geen negatieve gevolgen 
heeft voor de balanshandhaving of handreactietijd bij gezonde mensen van 
middelbare leeftijd. Generalisatie van deze resultaten naar oudere mensen met 
een verhoogd val risico is beperkt doordat we een relatief kleine en jonge groep 
proefpersonen onderzocht hebben. Echter deze resultaten geven ook aan dat 
gebruik van indometacine alléén het val risico waarschijnlijk niet verhoogd, voor 
zover dit risico is gerelateerd aan de bovengenoemde belangrijke functies van 
het CZS en niet beïnvloed is door andere aandoeningen.
Bijwerkingen van het CZS komen vaker voor tijdens gebruik van indometacine in 
vergelijking tot andere NSAIDs. In veel Europese landen, maar ook in de Verenigde 
Staten staat er in de bijsluiter of zelfs op de verpakking van indometacine een 
specifieke waarschuwing om activiteiten te vermijden waarbij concentratie en 
coördinatie nodig is, zoals als het besturen van een auto. In hoofdstuk 7 wordt 
een placebo-gecontroleerde gerandomiseerde studie met cross-over design 
gepresenteerd die gericht was op het vinden van een bewijs voor de 
bovengenoemde waarschuwing. Iedere proefpersoon slikte in totaal vijf capsules 
indometacine 75 mg slow-release of een visueel identiek placebo met vergelijkbare
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smaak in de 2,5 dagen voorafgaand aan de meting. Er werd gesuggereerd dat 
indometacine de coördinatie die nodig is om tijdens lopen succesvol obstakels te 
kunnen ontwijken negatief zou beïnvloeden en dat dit effect sterker zou worden 
wanneer gelijktijdig een cognitieve taak uitgevoerd werd waarbij mentale alertheid 
op de proef werd gesteld. Negentien gezonde oudere personen voerden een 
obstakelontwijktaak uit op een loopband (3km/u) als een enkele taak en 
gecombineerd met een secundaire cognitieve taak. Om de plotseling 
verschijnende obstakels succesvol te ontwijken waren snelle stapreacties 
noodzakelijk. Naast successcores werden ook reactietijden en amplitudes van de 
m. biceps femoris (BF), een spier die vroeg geactiveerd wordt in ontwijkreacties, 
gemeten. Voor de secundaire taak werd een composiet score ((100xnauwkeurig- 
heid) / verbale reactietijd) berekend. Statistische toetsing liet zien dat er geen 
verschillen waren tussen indometacine en placebo op de uitkomstparameters die 
betrekking hadden op de coördinatie: successcores en BF reactietijden, noch 
verschilden de prestaties op de secundaire cognitieve taak. Deze studie toonde 
aan dat taken die maximale aandacht vragen niet beïnvloed lijken te worden door 
een hoge dosis indometacine, ondanks de vaak gemelde CZS bijwerkingen zoals 
duizeligheid, slaperigheid en hoofdpijn. Een hoge dosis indometacine lijkt geen 
invloed te hebben op vaardigheden die essentieel worden geacht voor gezonde 
ouderen om veilig te kunnen lopen. Daarom suggereren we dat patiënten die CZS 
bijwerkingen ondervinden na gebruik van indometacine misschien niet 
gewaarschuwd hoeven te worden om activiteiten te vermijden die snelle en 
adequate reacties vereisen, zoals het lopen onder moeilijke omstandigheden en 
misschien zelfs het besturen van een auto.
SSRIs (selectieve serotonine heropname remmers) worden veel gebruikt om 
depressie te behandelen en zijn daarnaast ook geassocieerd met een verhoogd 
valrisico. Echter, het biologische mechanisme achter valpartijen bij SSRI gebruik 
is nog onduidelijk. Hierdoor is er een behoefte aan specifieke tests en 
experimentele studies om dit mechanisme te verhelderen. De studie die 
gepresenteerd wordt in hoofdstuk 8 was ontworpen om te onderzoeken of 
langduring gebruik van paroxetine (> 90 dagen) door ouderen van invloed is op 
het vermogen om obstakels vermijden tijdens lopen, balanscontrole en hand- 
reactietijd. De prestaties van de paroxetine-gebruikers werd vergeleken met 
gezonde controlepersonen van dezelfde leeftijd en geslacht. De resultaten 
toonden aan dat de balanscontrole verminderd was bij de paroxetine-gebruikers, 
met name tijdens staan op één been of onder verschillende dubbeltaak
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omstandigheden. Hoewel deze verminderde balanscontrole een vestibulaire 
oorzaak zou kunnen hebben, werd dit beschouwd als onwaarschijnlijk omdat de 
balanscontrole tijdens staan op zachte ondergrond met gesloten ogen niet 
verminderd was. Paroxetine bleek de handreactietijden of het vermogen obstakels 
te ontwijken niet te beïnvloeden. Er wordt daarom gesuggereerd dat paroxetine 
met name van invloed is op het concentratievermogen in combinatie met 
balanscontrole. In vergelijking met gezonde ouderen lijken de paroxetine 
gebruikers een verhoogd risico op vallen te hebben als gevolg van verminderde 
balanscontrole, vooral wanneer de aandacht moet worden verdeeld tussen twee 
gelijktijdige activiteiten.
Tenslotte wordt in hoofdstuk 9 een overzicht gegeven van de belangrijkste 
bevindingen en conclusies van dit proefschrift. Daarnaast worden de beperkingen 
van de gepresenteerde studies besproken en aanbevelingen voor toekomstig 
onderzoek gegeven.
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Het was een mooie zomerdag in juni 2004. Bas Bloem hield een praatje bij mijn 
afstuderen en zei: “Onderzoek begint met een goed idee en de rest is bloed, 
zweet en tranen... Ik had een goed idee.. Twee jaar later kwamen Bart van den 
Bemt en Jaak Duysens met een goed idee. Tja, nu mijn proefschrift klaar is ben 
ik ‘de rest’ eigenlijk al bijna vergeten. Wat ik niet vergeten zal zijn alle collega’s, 
familie en (sport-)vrienden die direct of indirect hebben bijgedragen aan de 
totstandkoming van mijn proefschrift, waarvan ik een aantal mensen in het 
bijzonder wil bedanken.
Jaak, ik vond het prettig met je samen te werken. Door jouw jarenlange onder­
zoekservaring en je snelle feedback kwam ik steeds weer een stapje verder. 
Ondanks mijn soms wat onhandig geformuleerde teksten wist jij toch vaak precies 
wat ik bedoelde en door jouw herformulering werd het dan ineens een stuk 
helderder. Bedankt voor jouw ondersteuning en je eindeloze positieve houding.
Bart van den Bemt, ik denk dat we een hoop van elkaar geleerd hebben. Na een 
jaar onderzoek doen bij de afdeling Farmacie en vervolgens mijn promotie­
onderzoek weet ik inmiddels een stuk meer over medicijnen. Door je betrokkenheid 
bij mijn onderzoek is jouw bewegingswetenschappelijke kennis is in de afgelopen 
jaren flink gegroeid. Daarnaast zorgde jouw kritische en meer klinische blik ervoor 
dat ik de resultaten ook in een ander daglicht kon plaatsen.
Vivian, bedankt dat je jouw kennis over vallen en valgerelateerde vaardigheden 
met me wilde delen. Jouw scherpe analyses en up-to-date kennis van de literatuur 
vormden een goede basis voor de artikelen die voortgekomen zijn uit dit promotie­
onderzoek.
Bart Nienhuis, ik weet niet hoe je het deed (en doet), maar als jij het lab 
binnenkwam waren vrijwel meteen alle technische problemen verdwenen. Zonder 
jouw ondersteuning was het een stuk lastiger geweest om mijn experimenten uit 
te voeren. Ik vond het fijn dat jij bij de promotie-overleggen meestal niet in de 
discussies verzandde en vrijwel altijd het overzicht hield.
Jacques, een vraag over statistiek eindigde meestal (ongevraagd) in een soort 
privé-college. Bedankt voor deze leerzame momenten. Jouw ervaringen met
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commerciële contract research organizations leidden tot de oprichting van de 
onafhankelijke CRO Sint Maartenskliniek Nijmegen. Ik ben blij dat ik hierbij nauw 
betrokken mocht zijn en ik pluk hier in mijn huidige baan de vruchten van.
Zonder proefpersonen was dit onderzoek niet mogelijk geweest. Ik wil daarom 
iedereen bedanken die vrijwillig heeft deelgenomen aan één of meerdere van de 
experimenten. Ik kijk hier met veel plezier op terug. Vooral het alcohol-experiment 
zal ik me lang blijven herinneren... ondanks dat ik zelf niet meedronk werd het 
steeds weer erg gezellig.
Mijn stagiaires Rebecca en Eline wil ik bedanken voor hun inzet tijdens de 
verschillende onderzoeken. Doordat ik jullie eigenlijk steeds een stapje voor wilde 
blijven moest ik ook in de versnelling, met resultaat!
De experimenten van dit promotie-onderzoek zijn mede mogelijk gemaakt door 
een nauwe samenwerking met de Maartensapotheek. Daarnaast wil graag ik 
Wilma Göttgens (apotheek Blanckenburgh), Bas van der Steeg (apotheek 
Neerbosch-Oost) en Margreet van der Geest (apotheek Groesbeek) bedanken 
voor hun hulp bij het werven van proefpersonen voor mijn antidepressiva- 
experiment. Ook wil ik Henk de Jong (Rijkswaterstaat) bedanken voor het ter 
beschikking stellen van een ademtester voor het alcohol-experiment.
Brad McFadyen, your sabbatical to Nijmegen gave me the chance to work with you 
on your experiment with the split-belt treadmill. Even though it was late autumn and 
hence, cold and rainy, your family came over for a holiday in the Netherlands. They 
even had time to participate in the experiment and it was great to meet them too. 
Thank you for the instructive weeks and for the co-authorship in your article.
Professor Allum, the foundation for my scientific career was more or less laid in 
the year that I worked in your lab in Basel. Next to improving my knowledge on 
static and dynamic posture control, making posters and writing articles, we also 
worked on our skiing skills during several trips to Meiringen-Hasliberg. Thankyou 
for this year full of opportunities.
Mijn tijd bij RD&E was een stuk minder leuk geweest als ik niet zoveel enthousiaste, 
verrassende, inspirerende en betrokken collega’s had gehad. Aan de beproefde, 
en inmiddels beroemde, ontelbare variaties op de cake van de week, foute (kroeg)
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sporten en kroegentochten, verendingen, lunches op de trap, fluitconcerten en 
de onvergefelijke vrljdagmlddag’onderzoekjes’ zoals pelotte-meppen, de 5-grote- 
stappentest, muurzltten, wupple-werpen en rolstoelrljden blijf Ik met veel plezier 
terugdenken. Bedankt allemaal!
Samen met Miranda, Joyce, Berbke en Wllco heb Ik gewerkt aan het opstarten 
van de CRO Sint Maartenskliniek Nijmegen. Bedankt voor jullie Inzet en de vele 
leerzame momenten.
Ellen, goed voorbeeld doet goed volgen. Je maakte me wegwijs In de obstakeltaak 
en was een zeer bekwame plankjeshanger. Vier jaar lang was je mijn roomle en 
onder het genot van liters thee hebben we Hef en (onderzoeks-)leed met elkaar 
gedeeld. Na een tijdje kregen we er met draakje een bereisde kamergenoot bij 
die ook nog eens gek was op foute muziek. Ik denk dat jij als geen ander weet wat 
mij tijdens mijn promotle-onderzoek heeft beziggehouden en daarom ben Ik erg 
blij dat je straks als paranimf naast me zult staan.
Katrijn en Astrld, bedankt dat Ik gebruik mocht maken van jullie Matlab-knobbels. 
Hierdoor was Ik enorm geholpen bij de analyse van de dubbeltaakdata. Ik wens 
jullie nog veel succes met je eigen promotie.
Irene, Marloes en Joyce, Ik vond het heel bijzonder om met jullie een zeer select 
gezelschap te vormen tijdens onze studie Bewegingswetenschappen. Irene, met 
jouw doorzettingsvermogen en enthousiasme kan je aanstande promotle-onder- 
zoek haast niet mislukken. Succes! Marloes, Ik vond het super dat je een tijdje 
met me kwam werken In het lab In Basel. Joyce, jij was mijn kruiwagen naar de 
SMKtoen Ik hem nodig had. Zie hier het resultaat.
Naast mijn onderzoek was Ik trouwe deelnemer aan de SMK-bedrljventeams voor 
de Marlkenloop en de Zevenheuvelenloop. Ik heb veel plezier beleefd aan de 
trainingen en aan het samen lopen met andere collega’s uit de kliniek. ‘Harde 
kern’-lopers Bauke, Petra, Slep, Koen, Karin, Reml, Els en (als drijvende kracht) 
Léon Schoonhoven, bedankt voor de gezellige en ontspannen sfeer, zelfs tijdens 
de (soms) stevige trainingen van Miranda en Noël.
Niet alleen het hardlopen vormde een welkome afwisseling op mijn onderzoek. 
De afgelopen jaren heb Ik met verschillende Boosters een squashballetje mogen
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slaan. Ik wil hierbij vooral mijn team- en trainingsmaatjes Janneke, Robin, 
Christiaan, Boudewijn, Nina, Wendy, Jeanine, Sanne en Marcel bedanken voor 
deze sportieve uitlaatklep.
Enzo, toen ik je leerde kennen was je nog !even’ een digitale schaar aan het 
ontwerpen voordat we naar Rock Werchter gingen. Met deze creativiteit in mijn 
achterhoofd heb ik je gevraagd of je de kaft van mijn proefschrift wilde ontwerpen. 
Je had aan een half woord genoeg om tot een fantastisch resultaat te komen. 
Thanxl
Twee handen op één buik, zo werden we vaak beschreven tijdens de opleiding 
Fysiotherapie. Fleur, deze beschrijving zit ons na bijna 15 jaar nog steeds als 
gegoten. Wat hebben we een hoop meegemaakt samen. De vakantie naar La 
Gomera van onze eerste echte vakantiedagen, dagjes naar de sauna, lekker 
zeilen of gewoon een theetje, met jou is het altijd gezellig en kan ik mezelf zijn. Ik 
vind het dan ook heel bijzonder dat jij als paranimf naast me zult staan bij mijn 
promotie.
Hermy, Hennie en Rob, wat bof ik met jullie als schoonfamilie. Gedurende mijn 
hele promotie-onderzoek hebben jullie met me meegeleefd en mijn vorderingen 
op de voet gevolgd. Bedankt! Gel land, dit geldt uiteraard ook voor jou,ooka lheb  
jij alleen maar het staartje van mijn onderzoek meegemaakt.
Mama, papa bedankt dat jullie me de mogelijkheid hebben gegeven om te gaan 
studeren. Mama, bedankt voor je steun en interesse in het reilen en zeilen van 
mijn onderzoek. Je vond het moeilijk dat ik het mooie fysiotherapeutische vak 
verlaten heb. Ik hoop dat ik je met dit proefschrift laat zien dat het niet voor niets 
is geweest. Natuurlijk wil ik ook Koen, Mijke en Leo bedanken voor hun interesse 
en steun gedurende mijn promotie-onderzoek.
Lieve Pierre, nu ben ik dan eindelijk bewezen slimmer dan jij . Ook al leek het 
soms dat ik er weinig mee deed, ik ben er van overtuigd dat dit proefschrift zonder 
jouw adviezen nu (nog) niet klaar was geweest. De vele fijne vakanties met jou 
waren een heerlijke afwisseling op mijn onderzoek en ik was er dan ook altijd 
even helemaal uit. Bedankt voor je liefde, creativiteit, en continue steun. Samen 
met jou durf ik de hele wereld aan!
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Want er is a ltijd  een boo t naar de horizon
En een vliegtuig naar de p lek  daar waar de wereld oo it begon
Of een luchtballon, avonturen tegemoet
En een boekje waarin staat hoe het moet
Dus wees n iet bang dat je  dood gaat
Of dat de wereld b ijt
Bedank m aar dat als je  hier b lijft dat uite indelijk de tijd  z ich b lijft herhalen  
Dus ga je  mee verdwalen?
(Ernst van der Pasch, Verdwalen)
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